Refine
Year of publication
Document Type
- Doctoral Thesis (204) (remove)
Language
- English (204) (remove)
Has Fulltext
- yes (204)
Is part of the Bibliography
- no (204)
Keywords
- DNA (2)
- EPR (2)
- G-Quadruplex (2)
- GPCR (2)
- Metabolism (2)
- NMR (2)
- rhodopsin (2)
- solid-state NMR (2)
- vascular endothelial cells (2)
- 19F NMR shifts for fluoroarenes (1)
Institute
- Biochemie, Chemie und Pharmazie (204) (remove)
Standard biorelevant media reflect the average gastrointestinal (GI) physiology in healthy volunteers. The use of biorelevant media in in vitro experiments has become an important strategy to predict drug behaviour in vivo and is often combined with in silico tools in order to simulate drug plasma profiles over time. In addition to the healthy population, the effects of disease state or co-administration of other drugs on plasma profiles must be considered to assure drug efficacy and safety. Thus, there is a need for a more accurate representation of the human GI physiology when it is altered by disease or co-administered drugs in in vitro dissolution experiments.
This thesis focused on the development of biorelevant media and dissolution tests reflecting GI physiology in circumstances where the gastric pH is elevated. Diseases linked to an elevated gastric pH are hypochlorhydria and achlorhydria, but these days treatment with acid-reducing agents (ARAs) is the single greatest cause of elevation in gastric pH. pH-dependent drug-drug interactions (DDIs) with ARAs are frequent, as the ARAs are used in a number of diseases using a variety of drugs. As the drugs currently on the market are often poorly soluble and ionisable, their dissolution is highly dependent on the pH of the GI tract, especially the gastric pH.
The thesis research consisted of several steps. In the first step, physiological changes in the human GI tract during the therapy with ARAs were identified. Parameters of the standard biorelevant gastric medium FaSSGF were adjusted to the identified changes to reflect the impact of ARA co-administration on the gastric physiology. The media aim to assess the potential extent of the ARA impact on gastric physiology by introducing biorelevant media pairs, ARA pH 4 and pH 6 media, of which one reflects a lesser, and the other a stronger impact of ARAs.
In the second step these ARA media were implemented in in vitro dissolution set-ups.
The dissolution of poorly soluble ionisable drugs was assessed using one-stage, two-stage and transfer model set-ups, as well as using a more evolved in vitro system TIM-1. Comparison of results from dissolution set-ups using the standard, low pH, gastric biorelevant medium FaSSGF (pH 1.6 or 2), and the same set-ups using ARA pH 4 and pH 6 media, shows a decrease in dissolution rate and extent for weakly basic compounds PSWB 001 and dipyridamole, and an increase in rate and extent of dissolution for the weakly acidic compound raltegravir potassium, when the gastric pH is elevated. Due to different physicochemical properties, the extent of the impact of physiological changes during ARA therapy (when either ARA pH 4 or pH 6 medium is selected) on dissolution varied among the model drugs. Thus, the bracketing approach, which considers a range of the possible ARA co-administration impact on drug dissolution, was confirmed to be best practice in assessing the impact of ARAs.
In the third step, dissolution data from in vitro experiments with ARA media was implemented into in silico models. The predictions using various in silico model approaches in Simcyp™ Simulator (minimal and full PBPK model, dissolution input using DRM and DLM) successfully bracketed in vivo data on drug administration during ARA therapy and correctly predicted an overall decrease in plasma concentration for the two model weakly basic compounds and an increase in plasma concertation for the model weakly acidic compound.
In all assessed scenarios, the ARA methods proved to be an essential part of evaluating and predicting the impact of ARAs on drug pharmacokinetics, and appropriately predicted the extent of a possible impact of ARAs on the drug plasma profiles. Thus, the ARA biorelevant media and dissolution tests were demonstrated to be valuable tools reflecting administration of drugs when the gastric pH is elevated and able to predict the impact of ARA therapy on drug administration.
The ability to evaluate the impact of human (patho) physioloy on drug behaviour in the gastrointestinal tract is of great importance, as the GI conditions play a significant role in drug release and absorption. Thus, there is great interest on the part of the pharmaceutical industry and regulatory agencies to develop best practices in this field, especially for pH-dependent DDIs. The media and dissolution tests developed in this thesis are biorelevant methods appropriate for evaluation of the impact of elevated gastric pH on drug efficacy and safety. Such methods, used as a risk assessment tool, in connection with evaluation of the efficacy window and potential toxicity, may help to increase confidence about decisions as to whether a pH-effect will occur and whether it is relevant or not, prior to conducting clinical studies. They may also enable changes in inclusion/exclusion criteria during recruiting for large-scale efficacy trials. In fact, the biopharmaceutic approach to drug development is becoming standard practice on a number of fronts, including metabolic DDIs, renal and hepatic insufficiency, powering decision-making process and possibly even waiving certain types of clinical studies.
...
Resistant microbes are a growing concern. It was estimated that about 33,000 of people die because of the infections caused by multidrug resistant bacteria each year in Europe (ECDC, 2018, https://www.ecdc.europa.eu/). Bacteria can acquire resistance against toxic compounds via different mechanisms and intrinsic active efflux is one of the first mechanisms deployed by bacterial cells. The membrane-localized efflux pumps catalysing this reaction, extract toxic compounds from the interior of the cell and transport these to the outside, thereby maintaining sub-lethal toxin levels in the cytoplasm, periplasm and membranes. Gram-negative three-component efflux pumps, analysed in this study, are composed of an inner membrane protein, a member of the Resistance-Nodulation cell Division (RND) superfamily, an Outer Membrane Factor (OMF) protein and a Membrane Fusion Protein (MFP) that connects the two afore mentioned components into an active efflux pump. The pumps described in this work, AcrAB-TolC and EmrAB-TolC, are drug efflux pumps belonging to the RND and MFS superfamilies, respectively, while CusCBA is an efflux pump that belongs to the RND heavy metal efflux family. Another efflux pump that was used as a model for the design of an in vitro assay for the silver ion transport studies, CopA, belongs to the P-type ATPase superfamily. All pumps analysed in this study are part of the resistance system of Escherichia coli, which is a highly clinically relevant pathogen.
In order to examine the AcrAB-TolC, CopA and CusA efflux pumps, the individual components were separately produced in E. coli, purified to monodispersity and reconstituted in large unilamellar vesicles, LUVs. Means for the optimized production and adequate conditions for efficient reconstitution were presented in this study. The activity of AcrB in LUVs was detected using fluorescence quenching of the dye 8-hydroxy-1,3,6 pyrenetrisulfonate (pyranine), which is incorporated inside the proteoliposomes and is sensitive to the pH changes in its surrounding. The inactive AcrB variant with a substitution in the proton relay network, D407N, showed no activity in proteoliposomes, which correlates with the measurements done in empty liposomes. When AcrA was co-reconstituted with AcrB D407N proteoliposomes it did not restore protein activity. To test the assembly of the AcrAB-TolC pump out of its single components, an in vitro assay was established where the complex assembly was tested with AcrAB- and TolC-containing liposomes. These experiments showed putative AcrAB-TolC formation in the presence or absence of a pump substrate, taurocholate, as well as in the presence of the pump inhibitor, MBX3132. The assembly appeared stable over time and results were invariant in the presence or absence of a pH gradient across the AcrAB-containing membrane.
After determination of the ATPase activity of the P-type ATPase, CopA, in detergent micelles, the protein was reconstituted in LUVs. Quenching of the Ag+-sensitive dye Phen Green SK (PGSK), present on the inside of the CopA-containing proteoliposomes, was observed in presence of ATP and Ag+. Under the same conditions, but in absence of Ag+-ions, quenching was reduced by 80 % after 300 seconds. No PGSK-quenching was observed in control liposomes in the presence of ATP and Ag+. The additional presence of sodium azide led to minimal reduction of the PGSK-quenching as expected since sodium azide is not an inhibitor of P-type ATPases, but the quenching rate was similar to that of the same experimental condition with control liposomes.
The RND superfamily member CusA, as part of the tripartite CusCBA efflux pump, has been proposed to sequester Ag+ or Cu+ from either the cytoplasmic or periplasmic side of the inner membrane. The periplasmic transport of silver ions was implied from an in vitro assay where the quenching of a pH sensitive dye, 9-amino-6-chloro-2-methoxyacridine (ACMA), indicates acidification of the lumen of the proteoliposomes containing CusA when an inwardly directed pH was imposed. The same experiment with the CusA D405N variant, which was previously reported to be an inactive variant, also led to ACMA quenching, although at a slightly lower rate. Under application of an inwardly directed pH and a (negative inside), CusA-containing proteoliposomes showed a strong quenching of the incorporated PGSK dye, suggesting strong Ag+ influx.
The Major Facilitator Superfamily-(MFS-) type EmrAB-TolC pump has an analogous structural setup as the RND-type AcrAB-TolC pump. To examine the efflux of one of its substrates, carbonyl - cyanide m-chlorophenylhydrazone (CCCP), a plate-based susceptibility assay was used. The presence of the EmrAB-TolC pump confers lower susceptibility levels towards CCCP in E. coli, compared to cells not expressing the pump or cells expressing only the MFS component, indicating that EmrAB-TolC extrudes CCCP.
The work done in this study opens up a path towards investigation of drug and metal resistance in vitro. The methodologies to obtain proteoliposomal samples of multicomponent efflux pumps and subsequent measurements of drug/metal ion and H+ fluxes, as well as the determination of pump assembly are crucial for the future research on pump catalysis and transport kinetics. The in vivo drug-plate assays done in this work provide initial insights for future investigations of the drug susceptibility of E. coli expressing the MFS-type tripartite efflux pumps.
Over the last decade, cryo-EM has developed exponentially due to improvements in both hardware (“machine”-based) and software (“algorithm”-based). These improvements have pushed the best achievable resolutions closer to atomic level, bridging “gaps” not covered by other biophysical techniques, and allowing more difficult biological questions to be addressed. Thus, this PhD project was designed and constructed to apply cryo-EM to answer biological questions, while allowing simultaneous cryo-EM method development.
The biological focus of this research is pentameric ligand-gated ion channels (pLGICs), specifically the serotonin receptor type-3 receptor (5HT3R), which also belongs to the Cys-loop receptor family. 5HT3R plays an important role in fast synaptic signal transduction in response to agonist and antagonist binding. Binding to its native ligand results in opening of the channel at the transmembrane domain, allowing cations to pass through, resulting in membrane depolarization and conversion of the chemical signal into an electrical one.
This work consisted mainly of two specific aims. One was focused on conformational investigation of 5HT3R in its ligand-bound open conformation, using cryo-electron microscopy (cryo-SPA), in order to understand the gating mechanism upon ligand activation. The other one was to combine SPA with cryo-ET and STA to push the resolution limitation of conventional cryo-ET and STA workflows.
In the end, three different cryo-EM conformations of membrane-embedded 5HT3R were resolved using cryo-SPA, two structures in resting closed forms, one C5-symmetric and one C1-asymmetric, and one serotonin-bound open form. These three structures presented a number of novel features related to the transition of the receptor to its ion-conductive state. Specifically, the serotonin-bound receptor shows asymmetric opening, which was speculated to occur via an intermediate asymmetric Apo state. In addition to the cryo-SPA work, application of cryo-ET and STA to the study of 5HT3R in native vesicles is described in this thesis. Additional work on methods development, focused on combining SPA and STA techniques, along with preliminary results on tobacco mosaic virus are also detailed and discussed.
Moreover, previously unreported asymmetric arrangements of the subunits of the homopentameric 5HT3R around the pore axis were revealed. The asymmetric open state is stabilized by phospholipids inserted at the interface between subunits, at a site well-documented for the binding of allosteric pLGIC modulators. These results not only give structural support to a large body of functional data on the effects of lipids on the function of this receptor family, but also provide structural guidance for future studies in this field. Meanwhile, the SPA-STA combined methods developed during the course of this work have the potential to help resolve higher resolution tomography-based structures, which would benefit researchers seeking to do in-situ-based structural studies.
Um sich an ändernde Umwelteinflüsse und metabolische Bedürfnisse anpassen zu können, ist es für Zellen essenziell, dass Boten-RNA (engl. messenger RNA, mRNA) stetig und schnell nach der Translation abgebaut wird. In Prokaryoten ist dafür der Proteinkomplex Degradosom verantwortlich, in dem Endo- und Exoribonukleasen RNase E und PNPase das RNA-Transkript in kleinere Fragmente und schließlich einzelne Nukleotide spalten. Die DEAD-Box Helikase RhlB im Komplex dient zusätzlich dazu, mögliche Sekundärstrukturen in der RNA zu entfalten, welche sonst die weitere Degradation behindern würden. Es konnte gezeigt werden, dass RhlB’s sehr geringe katalytische Aktivität – gemessen durch ATP-Verbrauch und Rate an entwundener RNA – signifikant durch die allosterische Bindung an Komplexpartner RNase E erhöht wird. Gleichzeitig deuten andere Studien darauf hin, dass RhlB eine mögliche Selektivität für doppelsträngige RNA-Substrate mit 5‘-Einzelstrang-Überhängen aufweist.
Diese Arbeit liefert neue Erkenntnisse in Bezug auf die Kommunikation zwischen den Degradosom-Komponenten RhlB und RNase E aus E. coli, indem das potenzielle Wechselspiel zwischen RhlBs RNA-Selektivität und der allosterischen Aktivierung durch RNase E untersucht wurde. Der vielseitige Einsatz NMR-spektroskopischer Techniken sowie die Verwendung kurzer RNA-Substrate mit spezifischen Strang-Eigenschaften ermöglicht es, mit einen ungewöhnlichen, RNA-zentrierten Ansatz an diese unzureichend verstandene Protein-Interaktion heranzugehen.
Zunächst wurden hierzu eine Reihe kurzer doppelsträngiger RNA-Konstrukte hergestellt, die sich nicht nur in ihren Einzelstrang-Merkmalen unterscheiden, sondern auch die thermodynamischen Anforderungen eines DEAD-Box Helikase Substrats erfüllen, und gleichzeitig eine ausreichende NMR-spektroskopische Signal-Zuordnung erlauben. Die thermale Stabilität, das Faltungsverhalten sowie die 1H Imino-protonen- und 13C HSQC-Zuordnungen aller geeigneten Konstrukte wurden erfolgreich bestimmt.
Um den Einfluss spezifischer RNA-Substrate sowie die Bindung zweier verschiedener RNase E Fragmente auf RhlBs ATP-Umsatzrate zu untersuchen, wurde sich zunächst eines photometrischen Phosphat-Assays bedient. Damit konnte deutlich gezeigt werden, dass RhlB in Abwesenheit des Komplex-Partners nicht in der Lage ist, signifikante Mengen an ATP umzusetzen, unabhängig davon, welches RNA-Konstrukt eingesetzt wird. Die Bindung der RNase E Fragmente erhöhte signifikant die ATP-Hydrolyse-Rate der Helikase, wobei die größte Aktivierung für den RNA-Duplex mit 5‘-Einzelstrang sowie ein einzelsträngiges Substrat zu beobachten ist. Da diese Ergebnisse deutlich eine RNA-Abhängigkeit beim ATP-Umsatz der Helikase zeigen, wurde untersucht, ob diese Unterschiede ihren Ursprung bereits in der Bindung der spezifischen RNA-Substrate haben. Mittels einer Mischapparatur, die es erlaubt die enzymatische Reaktion direkt im Spektrometer zu initiieren sowie zeitaufgelöster 31P NMR-Experimente konnte die allosterische Aktivierung der ATP-Hydrolyse-Rate von RhlB auch unter NMR-spektroskopischen Messbedingungen nachgewiesen werden.
Da die Ergebnisse des ATPase Assays deutlich eine RNA-Abhängigkeit bei der ATP-Umsatz-Rate der Helikase zeigen, wurde zusätzlich untersucht, ob diese Unterschiede ihren Ursprung in den Affinitäten für die verschiedenen RNA-Substrate haben und ob diese durch die Bindung von RNase E and RhlB beeinflusst werden. Um im gleichen Zuge zu überprüfen, ob die Bindung der RNA an RhlB die RNA-Konformation oder Basenpaarung ändert, werden 1H NMR-Titrationsexperimente durchgeführt. Es konnte erstmals gezeigt werden, dass RhlB eine inhärente Präferenz für Duplexe mit 5‘-Überhang gegenüber Konstrukten mit 3‘-Überhang oder stumpfen Enden besitzt, was sich in einer erhöhten Affinität zeigt. Zusätzlich offenbaren die Messungen, dass RNase Es allosterische Bindung selektiv die Affinität gegenüber Konstrukten mit Einzelstrang-Überhang erhöht, während die Affinität zu RNA Duplexen ohne Überhang sogar verringert wird. Diese Ergebnisse liefern erstmals einen Nachweis, dass RNase E aktiv Einfluss auf RhlBs RNA-Bindung nimmt. Weder die Bindung der RNA and RhlB noch an den RhlB/RNase E Komplex scheint die Basenpaarung oder Konformation der RNA-Substrate zu beeinflussen, da lediglich eine homogene Peak-Verbreitung aller Imino-Protonen-Signale im 1H NMR-Spektrum beobachtet werden konnte.
The electron transport chain (ETC) is used by cells to create an electrochemical proton gradient which can be used by the ATP synthase to produce ATP. ETC, also called respiratory chain, is formed in mitochondria by four complexes (complex I-IV) and mediated by two electron carriers: cytochrome c and ubiquinone. Electrons are passed from one complex to another in a series of redox reactions coupling proton pumping from the negative (N) side of the membrane to the positive (P) side. Complex I can introduce electrons into the ETC by oxidizing NADH to NAD+ and reducing quinone (Q) to quinol (QH2). The process accomplishes pumping of four protons across the membrane. Complex II is another electrons entry point. It catalyzes the oxidation of succinate to fumarate while reducing Q to QH2. Complex III, also called cytochrome bc1 complex, can transfer the electrons from QH2 to cytochrome c and couple to proton pumping. In complex III the Q-cycle contributes four proton translocations: two protons are required for the reduction of one quinone to a quinol and two protons are released to the P side. Complex IV (cytochrome c oxidase), the terminal complex of the ETC, catalyzes the electron transfer to oxygen and pumps four protons to the P side. Structures of ETC complexes are available. However, the structure of a hyperthermophilic cytochrome bc1 complex has not been elucidated till now. Additionally, the dimeric crystal structure of cytochrome c oxidase from bovine has been discussed controversially.
To build up a functional complex, cofactors are required. The active site of A- and B-type cytochrome c oxidases contain the high spin heme a which is synthesized by the integral membrane protein heme A synthase (HAS). HAS can form homooligomeric complexes and its oligomerization is essential for the biological function of HAS. HAS is evolutionarily conserved among prokaryotes and eukaryotes. Despite its importance, little is known about the detailed structural properties of HAS oligomers.
During my PhD studies, I focused on the cytochrome c oxidase (AaCcO), the cytochrome bc1 complex (Aabc1) and the heme A synthase (AaHAS) from Aquifex aeolicus. This organism is one of the most hyperthermophilic ones and can live at extremely high temperatures, even up to 95 °C. Respiratory chain complexes provide energy for the metabolism of organisms, and their structures have been studied extensively in the past few years. However, there has been a lack of atomic structures of complexes from hyperthermophilic and ancient bacteria, so little is known about the mechanism of these macromolecular machines under hyperthermophilic conditions. Therefore, my PhD studies had four main objectives: 1) to structurally and functionally characterize AaCcO, 2) to reveal the mechanism of Aabc1 thermal stability based on its structure, 3) to determine the oligomerization of AaHAS, 4) to provide valuable insights into the relationship between function and oligomerization of AaHAS.
1) Structure of AaCcO
Heme-copper oxidases (HCOs) catalyze the oxygen reduction reaction being the terminal enzymes in the plasma membranes in many prokaryotes or of the aerobic respiratory chain in the inner mitochondrial membrane. By coupling this exothermic reaction to proton pumping across the membrane to the P side, they contribute to the establishment of an electrochemical proton gradient. The energy in the proton electrochemical proton gradient is used by the ATP synthase to generate ATP. HCOs are classified into three major families: A, B and C, based on phylogenetic comparisons. The well-studied aa3-type cytochrome c oxidase from Paracoccus denitrificans (P. denitrificans) represents A-family HCOs. So far, the only available structure of the ba3-type cytochrome c oxidase from Thermus thermophilus represents the B-family of HCOs. This family contains a number of bacterial and archaeal oxidases. The C-family contains only cbb3-type cytochrome c oxidases.
The AaCcO is one of the ba3-type cytochrome c oxidases. Based on the genomic DNA sequence analysis, it has been revealed that A. aeolicus possesses two operons coding for cytochrome c oxidases (two different subunit I genes, two different subunit II genes and one subunit III gene). So far, only subunits CoxB2 and CoxA2 were identified. The presence of the additional subunit IIa was reported in 2012. Moreover, a previous paper reported that AaCcO can use horse heart cytochrome c and decylubiquinol as electron donors and the typical cytochrome c oxidase inhibitor cyanide does not block the reaction completely.
In the course of my PhD studies, I performed heterologous expression of AaCcO in Pseudomonas stutzeri (P. stutzeri) and co-expression with AsHAS in Escherichia coli, respectively. The subcomplex CoxA2 and CoxB2 can be purified from P. stutzeri, however, it lacks heme A. Additionally, a protocol for the heterologous production of cytochrome c555 from A. aeolicus was established. In parallel, I also purified the AaCcO from native membranes according to previously reported methods with some modifications. The activity of AaCcO with its native substrate, cytochrome c555, was 14 times higher than with horse heart cytochrome c.
To enable a detailed investigation and comparison of AaCcO and other cytochrome c oxidases, the cryo-EM structure of AaCcO was determined to 3.4 Å resolution. It shows that the three subunits CoxA2, CoxB2, and IIa are tightly bound together to form a dimer in the membrane. Surprisingly, CoxA2 contains two additional TMHs (TMH13 and TMH14) to enhance the protein stability. The cofactors heme a3, heme b, CuA and CuB are also identified. Interestingly, two molecules of 1,4-naphthoquinone and cardiolipin were observed in the dimer interface. Based on the structure analysis, the AaCcO possesses only the K-pathway for proton delivery to the active site and proton pumping.
...
B-cell acute lymphoblastic leukaemia (B-ALL) is characterized by the overproduction of lymphoblasts in the bone marrow (BM), and it is the most common cancer in children while being comparatively uncommon in adults. On the other hand, in chronic myeloid leukaemia (CML), 70% of cases are found in patients older than 50 years, making it uncommon in children. All CML cases and up to 3% of paediatric B- ALL (and 25% of adult B-ALL) cases are due to fusion gene BCR-ABL1, which gives rise to the cytoplasmatic, constitutively active oncoprotein, tyrosine kinase BCR-ABL1 through a reciprocal translocation between chromosomes 9 and 22. The constitutively active BCR-ABL tyrosine kinase leads to deregulation of different signal transduction pathways such as cell growth, proliferation and cell survival. The role of the bone marrow microenvironment (BMM) can mediate disease initiation (only in mice), progression, therapy resistance, and relapse, as has been increasingly recognized over the last two decades. In general, the BMM is a very complex arrangement of various cell types such as osteoblasts, osteoclasts, endothelial cells, adipocytes, mesenchymal stromal cells, macrophages and several others. In addition, the BMM is composed of multiple chemical and mechanical factors and extra cellular matrix (ECM) proteins which contribute to the BMM’s features influencing leukaemia behaviour. Considering the incidence of B-ALL and CML in children and in adults respectively, we hypothesized that the young and/or an aged BMM might also play a previously unrecognized role in the aggressiveness of B-ALL and CML. We proposed that BM, transduced with BCR-ABL1-expressing retrovirus in the murine transduction/transplantation model of B-ALL, transplanted into young versus old recipient mice would lead to a more aggressive disease in young mice, and similarly CML would be more aggressive in old recipient mice. In close recapitulation with the human incidence, induction of CML led to a significantly shorted survival in old recipient mice. On the other hand, induction of B-ALL showed a shortened survival in young compared to old syngeneic mice, as well as in a xenotransplantation model. Among the highly heterogenous composition of the BMM, we implicate young BM macrophages as a supportive niche for B-ALL cells. The results were found to be mostly due to potential soluble factors differentially secreted from young and old macrophages. Therefore, we hypothesized that the chemokine CXCL13, which has been demonstrated to play a role in B cell migration and act as a diagnostic marker in the cerebrospinal fluid of patients with neuroborreliosis, might be responsible for the observed phenotype. CXCL13 was found to be more highly expressed in healthy and leukaemic young mice as well as in conditioned medium of young macrophages. Using a variety of in vitro experiments, CXCL13 showed to significantly increase the proliferation and the migration of leukaemia cells when exposed to young macrophages, and the phenotype was rescued while using a CXCL13 neutralizing antibody. The CXCL13 role was also confirmed in vivo, since macrophage ablation led to a prolongation of survival in young mice and a reduction of CXCL13 levels. The use of an additional mouse model, leukaemia cells with CXCR5 deficiency, led to a significant prolongation of survival of young mice, confirming the importance of the CXCL13-CXCR5 axis in B-ALL. In line with our murine results, we found that human macrophages and CXCL13 levels were higher in pediatric B-ALL patients than in adults. Consistent with our murine data, the expression level of CXCR5 may act as a prognostic marker in B-ALL, as well as a predictive marker for central nervous system relapse in human B-ALL. The overall findings show that a young BMM, and in particular macrophages, influences B-ALL progression. We specifically identified CXCL13, secreted by young macrophages, as a promoter of proliferation of B-ALL cells, influencing survival in B-ALL via CXCR5. The CXCR5-CXCL13 axis may be relevant in human B-ALL, and higher CXCR5 expression in human B-ALL may act as a predictive marker.
The members of the multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) transporter superfamily mediate export of a wealth of molecules of physiological and pharmacological importance. According to the Transporter Classification Database (TCDB), the MOP superfamily is mainly categorized into six distantly related families functionally characterized families: the multidrug and toxic compound extrusion (MATE), the polysaccharide transporter (PST), the oligosaccharidyl-lipid flippase (OLF), the mouse virulence factor (MVF) the agrocin 84 antibiotic exporter (AgnG), and the progressive ankylosis (Ank) family. Among these, the multidrug resistance MATE family transporters are most ubiquitous, being present in all domains of life: Archaea, Bacteria and Eukarya. As secondary active transporters, they utilize transmembrane electrochemical ion gradients of Na+ and/or H+ in order to drive the efflux of xenobiotics or cytotoxic metabolic waste products with specificity mainly for polyaromatic and cationic substrates. Active efflux of drugs and toxic compounds carried out by multidrug transporters is one of the strategies developed by bacterial pathogens to confer multidrug resistance. MATE proteins provide resistance to, e.g., fluoroquinolone, aminoglycoside antibiotics, and anticancer chemotherapeutical agents, thus serving as promising pharmacological targets for tackling a severe global health issue. Based on their amino acid sequence similarity, the MATE family members are classified into the NorM, the DNA-damage-inducible protein F (DinF), and the eukaryotic subfamilies. Structural information on the alternate conformational states and knowledge of the detailed mechanism of the MATE transport are of great importance for the structure-aided drug design. Over the past decade, the crystal structures of representative members of the NorM, DinF and eukaryotic subfamilies have been presented. They all share similar overall architecture comprising 12 transmembrane helices (TMs) divided into two domains, the N-terminal domain (TMs 1-6) and the C-terminal domain (TMs 7-12), connected by a cytoplasmic loop between TM6 and TM7 (Fig. II.1). Since all available MATE family structures are known only in V-shaped outward-facing states with the central binding cavity open towards the extracellular side, a detailed understanding of the complete transport cycle has remained elusive. In order to elucidate the underlying steps of the MATE transport mechanism, structures of distinct intermediates, particularly inward-facing conformation, are required.In my PhD project, structural and functional studies have been performed on a MATE family (DinF subfamily) transporter, PfMATE, from the hyperthermophilic and anaerobic archaeon Pyrococcus furiosus. This protein was produced homologously in Pyrococcus furiosus as well as heterologously in Escherichia coli, and used for the subsequent purification and crystallization trials by the vapor diffusion (VD) and lipidic cubic phase (LCP) method. To the best of my knowledge, PfMATE is the first example of a successful homologous production of a membrane protein in P. furiosus. Due to the very low final amount of the purified protein from the native source, the heterologously produced PfMATE samples were typically used for the extensive structural studies. Crystal structures of PfMATE have been previously determined in an outward-facing conformation in two distinct states (bent and straight) defined on the arrangement of TM1. A pH dependent conformational transition of this helix regulated by the protonation state of the conserved aspartate residue Asp41 was proposed. However, it has been discussed controversially, leading to the hypothesis about TM1 bending to be rather affected by interactions with exogenous lipids (monoolein) present under the crystallization conditions. Based on these open questions, an experimental approach to investigate the role of lipids as structural and functional modulators of PfMATE has been taken in the course of my PhD project. The interplay between membrane proteins and lipids can affect membrane protein topology, structure and function. Considering differences between archaeal and bacterial lipid composition, cultivation of P. furiosus cells and extraction of its lipids was followed by the mass spectrometry (MS) based lipidomics for identification of individual lipid species in the archaeal extract. In order to assess the effects of lipids on PfMATE, different lipid molecules were used for co-purification and co-crystallization trials. This dissertation presents a workflow leading to the structure determination of a MATE transporter in the long sought-after inward-facing state, which has been achieved upon purification and crystallization of the heterologously produced PfMATE in the presence of lipids from its native source P. furiosus. Also, the PfMATE outward-facing state obtained from the crystals grown at the acidic pH conditions sheds light on the previously proposed pH-dependent structural alterations within TM1. It is interesting to note that the inward and outward-facing states of PfMATE were obtained from the crystals grown under similar conditions, but in the presence and absence of native lipids, respectively. This observation supports the hypothesis about physiologically relevant lipids to act as conformational modulators or/and a new class of substrates, expanding the substrate spectrum of the MATE family transporters. Comparative analysis of two PfMATE states reveals that transition from the outward to the inward-facing state involves rigid body movements of TMs 2-6 and 8-12 to form an inverted V, facilitated by a loose binding of TMs 1 and 7 to their respective bundles and their conformational flexibility. Local fluctuations within TM1 in the inward-facing structure, including bending and unwinding in the intracellular half of the helix, invoke its highly flexible nature, which is suitable for ion and substrate gating.
...
Currently, due to the misuse of antibiotics, we are facing a major public health problem. The resistance to antibiotics of certain bacterial strains makes the treatment of infections very complex.
In this context, the present thesis project concerns the study of a bacterial efflux complex capable of transporting antibiotics from the cytoplasm to the outside of the cell. This complex is composed of an inner-membrane Major Facilitator Superfamily (MFS) transporter (EmrB, E. coli multidrug resistance), a channel of the outer membrane TolC (Tolerance to Colicin E1) and a periplasmic adapter (EmrA, E. coli multidrug resistance). Unlike RND-type efflux systems (such as AcrAB-TolC), little is known about the MFS-type EmrAB-TolC system. It is therefore important to study the entire complex on a structural and functional level, to analyse the marked differences between these two types of transport systems. The goal of my thesis project was to study at least one EmrAB-TolC complex from a structural point of view. For my studies the aim was to isolate the complex directly from bacteria overexpressing the three protein partners. In a first step, 15 homologous EmrAB-TolC systems were identified and their corresponding genes amplified from genomic DNA of different Gram-negative bacteria. Among the genes of the 15 systems, the genes coding for the E. coli and V. cholerae systems were further studied. The expression vectors encoded fluorescent markers for the monitoring of the expression levels of different proteins and for studying the formation of complexes. In a first step, the different protein expression levels (EmrB-mRFP1 and EmrA-sfGFP) were studied for several expression strains of E. coli by measuring the red and green fluorescence levels and by Western blot (anti-His, Myc, and Strep for EmrB, EmrA, and TolC). The E. coli strain C41(DE3) was best suited for co-expression of EmrAB-TolC. In a second step, the FSEC (Fluorescence detection Size Exclusion Chromatography) methodology was used to identify a complex suitable for structural study. Thus this method enabled the observation that the EmrAB-TolC complex of E. coli was produced in higher amount than that of V. cholerae. The final co-purification protocol consists in perfoming a gentle lysis of the bacteria using lysozyme, then after solubilization with DDM, the purification is started by a Ni2+-NTA affinity chromatography step followed by a size exclusion chromatography step. Finally, the fractions containing the three protein partners are used for the detergent-exchange by amphipol A8-35 before the structural study by electron microscopy. Negative stain EM-micrographs displayed elongated objects with a length of 33 nm in side view. An average image of EmrAB-TolC shows similarities to that of the AcrAB-TolC complex observed under similar conditions. Similarities included the characteristic densities of TolC. Whereas differences were found in the lower part of EmrAB which is thinner than the lower part of AcrAB. The densities visible above the amphipol-ring correspond to EmrA, which displays a channel-like structure as in AcrA. The channel however seems to extend further towards the amphipol belt. Since EmrB does not have an extended periplasmic domain as the RND proteins have, these densities are therefore solely assigned to EmrA. EmrA, on the other side, contacts TolC akin to the interaction of AcrA/MexA to their cognate outer membrane channels (TolC/OprM) in a ‘tip-to-tip’ fashion.
As one of the most widespread infectious diseases in the world, it is currently estimated that approximately 296 million people globally are chronically infected with Hepatitis B virus (HBV), the consequences of HBV infection cause more than 620,000 deaths each year. Although safe and effective HBV vaccines have reduced the incidence of new HBV infections in most countries, there are still around 1.5 million new infections each year. HBV remains a major health problem because there is no large-scale effective vaccination strategy in many countries with a high burden of disease, many people with chronic HBV infection are not receiving effective and timely treatment, and a complete cure for chronic infection is still far from being achieved.
Since its discovery, HBV has been identified as an enveloped DNA virus with a diameter of 42 nm. For efficient egress from host cells, HBV is thought to acquire the viral envelope by budding into multivesicular bodies (MVBs) and escape from infected cells via the exosome release pathway. It is clear that HBV hijacks the host vesicle system to complete self-assembly and propagation by interacting with factors that mediate exosome formation. Consequently, the overlap with exosome biogenesis, using MVBs as the release platform, raises the possibility for the release of exosomal HBV particles. Currently, virus containing exosomal vesicles have been described for several viruses. In light of this, this study explored whether intact HBV-virions wrapped in exosomes are released by HBV-producing cells.
First, this study established a robust method for efficient separation of exosomes from HBV virions by a combination of differential ultracentrifugation and iodixanol density gradient centrifugation. Fractionation of the density gradient revealed that two populations of infectious viral particles can be separated from the culture fluids of HBV-producing cells. The population present in the low-density peak co-migrates with the exosome markers. Whereas the population that appeared in the high-density fractions was the classical HBV virions, which are rcDNA-containing nucleocapsids encapsulated by the HBV envelope.
Subsequently, the characterization of this low-density population was performed, namely the highly purified exosome fraction was systematically investigated. Relying on the detergent sensitivity of the exosome membrane and the outer envelope of the HBV virus, disruption of the exosome structure by treatment with limited detergent revealed the presence of HBsAg in the exosomes. At the same time, mild and limited NP-40 treatment of highly purified exosomes and a further combination of density gradient centrifugation resulted in the stepwise release of intact HBV virions and naked capsids from the exosomes generated by HBV-producing cells. This implies the presence of intact HBV particles encapsulated by the host membrane.
The presence of exosome-encapsulated HBV particles was consequently also verified by suppressing the morphogenesis of MVBs or exosomes. Impairment of MVB- or exosome-generation with small molecule inhibitors has significantly inhibited the release of host membrane-encapsulated HBV particles as well. Likewise, silencing of exosome-related proteins caused a diminution of exosome output, which compromised the budding efficiency of wrapped HBV.
Moreover, electron microscopy images of ultra-thin sections combined with immunogold staining visualized the hidden virus in the exosomal structure. Additionally, the presence of LHBs on the surface of exosomes derived from HBV-expressing cells was also observed.
As expected, these exosomal membrane-wrapped HBV particles can spread productive infection in differentiated HepaRG cells. In HBV-susceptible cells, as LHBs on the membrane surface, this type of exosomal HBV appeared to be uptaken in an NTCP receptor-dependent manner.
Taken together these data indicate that a fraction of intact HBV virions can be released as exosomes. This reveals a so far not described release pathway for HBV. Exosomes hijacked by HBV act as a transporter impacting the dissemination of the virus.
Mechanistic and structural insights into the quality control of the MHC I antigen processing pathway
(2022)
The human body is permanently exposed to its environment and thus to viruses and other pathogens, which require a flexible response and defense. Alongside to the innate immune system, the adaptive immune system provides highly specialized protection against these threats. The major histocompatibility complex class I (MHC I) antigen presentation system is a cornerstone of the adaptive immune system and a major constituent of cellular immunity. Pathogens such as viruses that invade a cell will leave traces in the form of proteins and peptides which are degraded and loaded onto MHC I molecules. MHC I peptide loading is performed by peptide loading complex (PLC) in the membrane of the endoplasmic reticulum as part of a multifaceted and comprehensive quality control machinery. Monitored by multiple layers of quality assurance, the MHC I molecules consequently display the immune status of the cell on its surface. In this context, the captured fragment of the virus serves as a call for help issued by the cell, alerting the adaptive immune system to the infection to mount an appropriate immune response.
The three-dimensional structure as well as the mechanistic details of parts of this complex machinery were characterized in the context of this dissertation. Among other tools, light-modulable nanotools were developed in this thesis, which permit external regulation of cellular processes in temporal and spatial resolution. Furthermore, methods and model systems for the biochemical characterization of cellular signaling cascades, proteins, as well as entire cell organelles were developed, which are likely to influence the field of cellular immunity and protein biochemistry in the future.
This cumulative work comprises a total of six publications whose scientific key advances will be briefly outlined in this abstract. In the introduction, the scientific background as well as the current state of research and methodological background knowledge are conveyed. The results section condenses the main aspects of the publications and links them to each other. Further details can be retrieved from the attached original publications.
In “Semisynthetic viral inhibitor for light control of the MHC I peptide loading complex, Winter, Domnick et al., Angew Chem Int Ed 2022” a photocleavable viral inhibitor of the peptide loading complex was produced by semi-synthesis. This nanotool was shown to be suitable for both purifying the PLC from human Raji cells as well as reactivating it in a light-controlled manner. Thus, this tool establishes the isolation of a fully intact and functional peptide loading complex for biochemical characterization. In addition, a novel flow cytometric analysis pipeline for microsomes was developed, allowing cellular vesicles to be characterized with single organelle resolution, similar to cells.
In “Molecular basis of MHC I quality control in the peptide loading complex, Domnick, Winter et al., Nat Commun 2022” the peptide loading complex was reconstituted into large nanodiscs, and a cryo-EM structural model of the editing module at 3.7 Å resolution was generated. By combining the structural model with in vitro glycan editing assays, an allosteric coupling between peptide-MHC I assembly and glycan processing was revealed, extending the known model of MHC I loading and dissociation from the PLC. These mechanisms provide a prototypical example for endoplasmic reticulum quality control.
In a related context, in “Structure of an MHC I–tapasin–ERp57 editing complex defines chaperone promiscuity, Müller, Winter et al., Nat Commun 2022” a recombinantly assembled editing module comprised of MHC I-tapasin-ERp57 was crystallized for X-ray structural biology. The resulting crystal structure at a resolution of 2.7 Å permitted the precise identification of characteristic features of the editing module and particularly of the peptide proofreading mechanism of tapasin. This study provided pivotal insights into the tapasin-mediated peptide editing of different MHC I allomorphs as well as similarities to TAPBPR-based MHC I peptide proofreading.
In “TAPBPR is necessary and sufficient for UGGT1-mediated quality control of MHC I, Sagert, Winter et al. (in preparation)” novel insights concerning the peptide proofreader TAPBPR and its close interplay with the folding sensor and glucosyltransferase UGGT1 were obtained. It was shown that TAPBPR is an integral part of the second level of endoplasmic quality control and is indispensable for effective MHC I coordination by UGGT1.
In “Light-guided intrabodies for on-demand in situ target recognition in human cells, Joest, Winter et al., Chem Sci 2021” intracellular nanobodies were equipped with a photocaged target recognition domain by genetic code expansion via amber suppression. These intrabodies, acting as high-affinity binding partners endowed with a fluorophore, could be used in a light-triggered approach to instantaneously visualize their target molecule...
The majority of B-cell precursor acute leukemias in infants are associated with the chromosomal translocation t(4;11)(q21;q23), resulting in the fusion of the mixed-lineage leukemia (MLL) and ALL1-fused gene of chromosome 4 (AF4) genes. While the fusion protein MLL-AF4 is expressed in all t(4;11) patients and essential for leukemia progression, the distinct role of the reciprocal fusion protein AF4-MLL, that is expressed in only 50-80% of t(4;11) leukemia patients (Meyer et al., 2018), remains unclear. In addition, t(4;11) leukemia could so far exclusively be generated in vivo in the presence of AF4-MLL and independent of the co-expression of MLL-AF4 (Bursen et al., 2010).
In a multifactorial approach inhibiting histone deacetylases (HDACs) and expressing the dominant negative mutation of Taspase1 (dnTASP1), both MLL fusion proteins were targeted simultaneously to evaluate a possible cooperative effect between MLL-AF4 and AF4-MLL during the progression of leukemia. Of note, neither HDACi nor dnTASP1 expression negatively affect endogenous MLL, but rather endorse its function hampered by the MLL fusion proteins (Ahmad et al., 2014; Bursen et al., 2004; Zhao et al., 2019). The mere expression of dnTASP1 failed to induce apoptosis, whereas dnTASP1 could elevate apoptosis levels significantly in HDACi-treated t(4;11) cells underlining the therapeutic potential of co-inhibiting both MLL fusion proteins.
Next, the impact of inhibiting either MLL-AF4 or AF4-MLL in vivo was resolved using whole transcriptome analysis. In PDX cells obtained by the Jeremias Laboratory (Völse, 2020) that co-expressed both t(4;11) fusion proteins, the knock-down of MLL-AF4 revealed the down-regulation of pivotal hemato-malignant factors. The expression of dnTASP1 led to massive deregulation of cell-cycle genes in vivo. Considering that the inhibition of particularly MLL-AF4 but not AF4-MLL impaired leukemic cell growth in vivo (Völse, 2020), the results of this work suggest a cooperative effect between both fusion proteins, while the loss of AF4-MLL during leukemia progression appears not essential.
Thereafter, a possible short-term role of AF4-MLL during the establishment of t(4;11) leukemia was analyzed. For this purpose, an in vitro t(4;11) model was constructed to investigate the transforming potential of transiently expressed AF4-MLL in cells constitutively expressing MLL-AF4, putatively reflecting the situation in vivo. Due to the lack of a leukemic background of the applied cell line, the aim was to investigate the long-term potential of AF4-MLL to significantly alter the epigenome rather than mimicking the development of leukemia. Strikingly, short-term-expressed AF4-MLL in cooperation with MLL-AF4 exerted durable epigenetic effects on gene transcription and chromatin accessibility. The here obtained in vitro data suggest a clonal evolutionary process initiated by AF4-MLL in a cooperative manner with MLL-AF4. Importantly, no long-term changes in chromatin accessibility could be observed by the transient expression of either MLL-AF4 or AF4-MLL alone.
All in all, considering endogenous MLL, MLL-AF4 and AF4-MLL in a targeted treatment is a promising approach for a more tailored therapy against t(4;11) leukemia, and AF4-MLL is suggested to act in a cooperative manner with MLL-AF4 especially during the development of a t(4;11) leukemia.
This cumulative dissertation examines learning in chemistry laboratories, focusing on the challenges and benefits of problem-based learning (PBL) for novices in the lab. It addresses the lack of consistent understanding about what should be learned in labs and why it's important. The research aims to understand what students learn, how they learn, and how lab learning can be improved.
A central concept in PBL labs is Information Literacy, defined as a sociocultural practice enabling learners to identify and use information sources within a specific context as legitimized by the practice community.
The first publication, Wellhöfer and Lühken (2022a), investigates the relationship between PBL and learner motivation. It identifies factors that can foster students' intrinsic motivation in a PBL lab. Autonomy is found to be a key factor, increasing student motivation and presenting a model of the autonomous scientific process. This model involves four steps: information acquisition, designing and applying experimental procedures, experimental feedback, and autonomous process optimization. The results suggest that intrinsic motivation in PBL labs can be enhanced by enabling students to independently execute these steps.
The second publication, Wellhöfer and Lühken (2022b), examines the information process students undergo during their first PBL lab. Using a sociocultural framework, it explores Information Literacy to understand students' handling of information and their perceptions of the information process. The findings reveal that in PBL labs, developing a practical, applicable experimental procedure is crucial for problem-solving and significantly shapes the information-acquisition process. This process is iterative, influenced by new information, leading to more precise information needs. Students assess information quality based on its usefulness for their problem, implementability (considering cognitive understanding, available equipment, and psychomotor skills), and safety.
Furthermore, the role of privileged knowledge forms in evaluating the quality of text sources is explored. Students viewed non-scientific sources as "poor" and scientific sources as "good," yet used both for information gathering. There were discrepancies between their assessment of source quality and actual use, indicating that perception of source quality doesn't always affect their practical decisions.
The third publication, Wellhöfer, Machleid, and Lühken (2023), investigates students' information practices in the lab, focusing on discourse between novice learners and experienced assistants. It shows that theoretical knowledge isn't sufficient for independent practical action, and students need actionable social information from experienced community members. The results highlight that information literacy in the lab for newcomers to a community of practice has distinctive features, and physical experience and tacit knowledge are crucial for learning the methods and group-specific knowledge of the practice community. The article demonstrates how learning information literacy in a practice community requires a social and physical experience and provides insights on how educators can support this process.
This work investigated the influence of the CRISPR/Cas9 mediated knockout of 5-lipoxygenase (5-LO) on different adherent tumour cell lines derived from solid tumours. For this, the 5-LO expressing tumour cell lines HCT-116, HT-29, and U-2 OS were transiently transfected using a plasmid carrying the CRISPR/Cas9 complex sequence to the ALOX5 gene. Subsequently, cells were selected using Puromycin and analysed via Western blotting and DNA Sanger sequencing. Cells that were transfected with a control plasmid missing the guide RNA sequence, were used as a control for all experiments.
Differential gene expression analysis, performed after next-generation RNA sequencing, revealed that the expression of various genes was altered after the knockout of 5-LO. In HCT-116 cells, 28 genes were expressed differentially in all 5-LO knockout single-cell clones, while in HT-29 cells the expression of 18 genes and in U-2 OS cells of 234 genes was influenced by the knockout of 5-LO. These findings were validated by real-time qPCR. A lot of the genes that were influenced by the 5-LO knockout are known to be connected to epithelial-mesenchymal-transition (EMT), a process necessary for tumour metastasis. The results from RNA sequencing were the starting point for further investigations. In the following, different aspects of the tumour cell lines were examined. In HT-29, as
well as in U-2 OS cells, it was shown that knockout of the 5-LO resulted in impaired cell proliferation. Also, the formation of three-dimensional tumour spheroids was altered. In HT-29 cells, the knockout of 5-LO increased the number of cells in spheroids. In contrast, in U-2 OS cells, the number of cells per spheroid was decreased, even though the diameter of the spheroids was increased, due to more loosely packed spheroids. The difference between 5-LO positive and negative U-2 OS cells became even more obvious after embedding the spheroids in an artificial extracellular matrix. In that scenario, cells lacking the 5-LO formed smaller spheroids that did not have the same ability to grow into the extracellular matrix as 5-LO positive cells did. Also, directed cell migration was strongly influenced by the knockout of 5-LO. In both, HCT-116 and U-2 OS cells, directed cell migration towards a serum gradient was increased in 5-LO knockout single-cell clones. Pharmacological inhibition of the enzyme was used to investigate, whether canonical or non-canonical functions were responsible for the previously mentioned effects.
Therefore, vector control cells were treated with the 5-LO inhibitors Zileuton and CJ-13610 in different concentrations. Interestingly, only some of the effects mediated by the complete knockout of 5-LO could be reproduced by inhibiting the enzyme, leading to the suggestion, that canonical, as well as non-canonical functions of 5-LO, play a role in these tumour cells.
To conclude, it was shown in this study, that 5-LO affects various cellular functions when expressed in adherent tumour cell lines. These cell line-dependent effects result in altered gene expression, enhanced proliferation, and spheroid formation, as well as impaired cell motility, and can be mediated by enzymatic activity as well as other non-canonical functions.
In optogenetischen Anwendungen, welche die Manipulation von zellulären Aktivitäten durch Licht ermöglichen, werden die Eigenschaften von mikrobiellen Rhodopsinen, einer Familie natürlich vorkommender lichtgesteuerter Proteine, ausgenutzt.
In der vorliegenden Arbeit wurden die einwärts transportierende Protonenpumpe NsXeR, sowie die auswärts Natriumionenpumpe KR2 untersucht. Des Weiteren wurden Tandem Proteine betrachtet, die mikrobielle Rhodopsine kombinieren mit dem Chemokinrezeptor CXCR4, der durch SDF1 aktiviert und anschließend in Endosomen internalisiert wird.
Für die Untersuchung des Mechanismus, der die Vektorialität in NsXeR bestimmt, wurde eine umfassende elektrophysiologische Studie durchgeführt. In Patch Clamp Messungen an NsXeR exprimierenden NG108-15 Zellen wurden bei kontinuierlicher 561 nm Beleuchtung aktive Einwärtsströme entgegen eines elektrochemischen Gradienten gemessen. Ein Einfluss des intrazellulären pHs auf die steady-state Ströme und deren Abfallkinetik konnte nicht festgestellt werden. Der Vergleich der exponentiellen Abfallrate k2 mit den Übergängen im NsXeR Photozyklus, lässt den Schluss zu, dass der ratenlimitierende Schritt der MII Zerfall ist.
Die elektrogenen Schritte im NsXeR Photozyklus wurden mit elektrischen Messungen an der black lipid membrane (BLM) an NsXeR Proteoliposomen bestimmt. Die Belichtung mit 20 ns Lichtpulsen bei 556 nm rufen Spannungssignale hervor, die exponentiell gefittet wurden, wobei drei elektrogene Schritte identifiziert werden konnten. Bei pH 7.4 betrugen die ermittelten Zeitkonstanten etwa 220 µs, 1 ms und 15 ms, denen 42%, 10% und 48% an der Gesamtladungsverschiebung zugeordnet wurden. Die elektrogenen Schritte konnten den Übergängen im Photozyklus zugeordnet werden, wobei der erste Schritt mit t1 dem MI Aufbau (Deprotonierung Schiff’sche Base, Protonenabgabe zur intrazellulären Seite) zugeschrieben wurde. t2 wurde dem MI→MII Übergang (Switch, Zugänglichkeitsänderung vom Intra- zum Extrazellulären) zugeordnet und t3 korreliert mit dem MII Zerfall (Reprotonierung Schiff’sche Base, Protonenaufnahme von der extrazellulären Seite).
Die Kinetik und der Ladungstransportanteil des zweiten elektrogenen Schritts haben keine starke pH Abhängigkeit, was sich dadurch erklären lässt, dass t2 durch eine Konformationsänderung bestimmt wird. t1 und t3 werden bei höheren pH Werten beschleunigt, was sich bei t1 mit einer erleichterten intrazellulären Protonenabgabe erklären lässt. Für t3 wurde eine Reprotonierung durch eine Donor Gruppe Asp76 vorgeschlagen. Die pH-sensitive Änderung der relativen Ladungstransferanteile des ersten und dritten elektrogenen Schrittes (∆ΨI und ∆ΨIII) wurden durch eine mögliche Verzögerung der frühen Protonenabgabe bei niedrigen pH Werten erklärt.
Der mutmaßliche Protonenakzeptor Asp220 wurde gegen Asn und Glu ausgetauscht und in Patch Clamp sowie UV-Vis Spektroskopie Messungen untersucht. Für D220N wurden keine Pumpströme und kein Einfluss auf die maximale Absorptionswellenlänge λmax festgestellt. D220E dagegen führte zu einer Erniedrigung des pKa-Werts der Schiff’schen Base und zu einer Verminderung der Iss-Abfallsrate k2 in Patch Clamp Dauerbelichtungsmessungen (D220E k2 = 27.1 ± 1.8 Hz, Wildtyp k2 = 83.1 ± 2.6 Hz). Daraus konnte geschlossen werden, dass Asp220 wesentlich für den Protonentransport ist und nicht als Gegenion für die protonierte Schiff’sche Base dient.
In Patch Clamp Experimenten bei 561 nm Dauerbelichtung und zusätzlicher gepulster Belichtung bei 355 nm wurde der Blaulichteffekt an NsXeR untersucht, bei dem Proteine im M Intermediat ein Photon absorbieren und unter Reprotonierung der Schiff’schen Base in den Grundzustand zurückkehren.
Für NsXeR konnte eine Potentialabhängigkeit für die Richtung der transienten Ströme, die durch die
355 nm Belichtung hervorgerufen wurden, festgestellt werden. Beim NsXeR Blaulichteffekt scheint eine
Reprotonierung der Schiff’schen Base von beiden Seiten möglich zu sein, was auf die unterschiedlichen Zugänglichkeiten in den beiden M Zuständen MI und MII zurückgeführt wurde. Es wurde ein Modell vorgeschlagen, welches auf einem potentialabhängigen Gleichgewicht zwischen MI und MII basiert.
In Patch Clamp Messungen an KR2 exprimierenden NG108-15 Zellen wurden die Pumpströme untersucht, die durch den auswärts Transport von Na+ und H+ hervorgerufen wurden. Die Na+-Konzentrationen der intra- und extrazellulären Lösungen wurden symmetrisch variiert und die steady-state Ströme Iss bei 532 nm Dauerbelichtung betrachtet. Mit steigender Na+-Konzentration zeigte sich ein Übergang von einer linearen Potentialabhängigkeit der Iss, zu einem sättigungsähnlichen Verhalten bis hin zu einer fast glockenförmigen Form. Da die exponentielle Abfallrate der steady-state Ströme k2 in ihrer Potentialabhängigkeit mit den Iss korrelierte, konnte geschlossen werden, dass die Ströme überwiegend kinetisch limitiert sind. Die Erhöhung der Rate k2 mit steigender Na+-Konzentration zwischen -120 mV und -60 mV deutet darauf hin, dass die Na+-Aufnahme von der intrazellulären Seite bei diesen Bedingungen die Limitierung für die Pumpe darstellt.
Unter Na+-“freien” Bedingungen wurde der Einfluss des intrazellulären pHs untersucht. Für die Rate k2 wurde eine Erhöhung bei niedrigen pH Werten festgestellt und die Potentiale E0 (Iss = 0 pA) verschoben bei niedrigem intrazellulärem pH zu hyperpolarisierenden Potentialen. Daraus lässt sich schließen, dass die steady-state Ströme durch den Transport von Protonen hervorgerufen wurden.
In Messungen mit gepulster 530 nm Belichtung wurden die transienten Pumpströme gemessen und durch exponentielles Fitten des Stromabfalls drei elektrogene Schritte identifiziert. Eine Abhängigkeit vom Potential und der Na+-Konzentration konnte nur für den dritten Schritt mit der Rate 1/τ3 festgestellt werden, wobei 1/τ3 mit der Na+-Konzentration und bei positiveren Potentialen steigt. Unter Na+-“freien” Bedingungen steigt 1/τ3 auch mit niedrigeren intrazellulären pH Werten. Die elektrogenen Schritte wurden dem KR2 Photozyklus zugeordnet, wobei ein Modell angewendet wurde, das einen M1→M2 Übergang einführt. Diesem wurde der zweite elektrogene Schritt zugeordnet. Die relativen Ladungstransportanteile Q2 und Q3 des zweiten und dritten elektrogenen Schrittes sind sowohl potential- als auch Na+-abhängig. Um dieses Verhalten zu erklären, wurde ein Modell vorgeschlagen, bei dem ein Ausgleichsladungstransfer in Form von einer Protonenabgabe und -wiederaufnahme während des Photozyklus eingeführt wurde.
In Patch Clamp Messungen wurde die erhaltene Funktionalität der ChR2 Mutante ChR2(L132C) mit erhöhter Ca2+-Permeabilität im Tandem Protein tCXCR4/CatCh nachgewiesen. Auch die Internalisierung von tCXCR4/CatCh konnte anhand der zeitabhängigen Abnahme des CatCh-Signals nach der CXCR4-Aktivierung durch SDF1 in Strommessungen beobachtet werden. Für tCXCR4/Arch, ein Tandem Protein mit einer Protonenpumpe, wurde die SDF1-induzierte Internalisierung mit Hilfe der konfokalen Laser-Scanning-Mikroskopie betrachtet und eine Kolokalisierung der Fluoreszenz des im Tandem exprimierten YFP und der eines gelabelten CXCR4-spezifischen Antikörpers in intrazellulären Vesikeln beobachtet. Bei Behandlung mit dem CXCR4 Antagonisten AMD3100 wurde die Kolokalisierung hauptsächlich in der Zellmembran festgestellt, da die Internalisierung blockiert war. Die Tandem Protein könnten als in intrazellulären Organellen wirkende optogenetische Werkzeuge eingesetzt werden für z.B. die Manipulation der intrazellulären Ca2+-Konzentration.
Bezüglich der Arzneimittelforschung galt für sehr lange Zeit das Paradigma "ein Gen, ein Medikament, eine Krankheit". In jüngerer Zeit ändert sich dieses Paradigma jedoch auf Grund von redundanten Funktionen und alternativen sich kompensierenden Signalmustern, die insbesondere bei Krebserkrankungen vorherrschend sind. Daher kann die logische Konsequenz nur sein, Multi-Target-Strategien gegenüber Single-Target-Ansätzen in Betracht zu ziehen. Auf Grund der Schwierigkeit, mit einer Kombination von zwei Einzelwirkstoffen, in diesem Fall BET- und HDAC-Inhibitoren eine konsistente Biodistribution und Pharmakokinetik zu erreichen, wurde nach Einzelmolekülen gesucht, die mehrere inhibitorische Aktivitäten aufweisen. Dies wurde hier zunächst durch die einfache Konjugation von zwei unterschiedlichen Pharmakophoren erreicht.
Insgesamt wurden vier verschiedene Liganden dieses Typs synthetisiert und einer von ihnen, Verbindung 14, zeigte sehr vielversprechende Ergebnisse. 14 vereint den BET Inhibitor JQ1- mit dem HDAC Inhibitor CI994 und hat eine hemmende Wirkung sowohl gegen BRD4- als auch HDAC-Proteine wie durch DSF- und nanoBRET-Assay gezeigt werden konnte. Außerdem zeigten in vitro Assays in PDAC-Zellen, dass 14 ein noch potenterer dualer BET/HDAC-Inhibitor ist als die Kombination aus JQ1 und CI994. Während die Effekte von 14 auf das BETi-Antwortgen MYC denen von JQ1 ziemlich ähnlich sind, sind insbesondere die HDAC-inhibitorischen Effekte nachhaltiger und verstärkt, wahrscheinlich aufgrund einer längeren Verweildauer von 14 auf HDAC als dies bei CI994 der Fall ist. Dies ist durch das hohe Niveau der acetylierten Lysine von Histon H3 im Western Blot erkennbar. Dieses veränderte Expressionsverhalten hatte einen großen Einfluss auf das Zellwachstum und überleben in allen getesteten PDAC-Zelllinien. Hier wurde die Überlegenheit von 14 gegenüber der gleichzeitigen Behandlung der Zellen mit JQ1 und CI994 sehr deutlich. Wurden PDAC-Zellen mit dem dualen Inhibitor 14 behandelt, hatte dies ein geringeres Wachstum und Überleben der Krebszellen zur Folge als mit beiden ursprünglichen Molekülen, unabhängig davon, ob diese einzeln oder simultan verabreicht wurden. Außerdem wurde 14 mit Gemcitabin, einem gut verträglichen Chemotherapeutikum, kombiniert, dass bei PDAC allein nur eine begrenzte Aktivität aufweist. Es stellte sich heraus, dass die Reihenfolge, in der die Medikamente verabreicht werden, einen großen Einfluss auf die Effektivität hatte. Der durch 14 induzierte Stopp des Zellzyklus verhindert den Einbau von Gemcitabin in die DNA, wenn 14 vor oder gleichzeitig mit Gemcitabin verabreicht wird. Wenn jedoch die Behandlung mit 14 nach der Verabreichung von Gemcitabin folgt, wird der durch Gemcitabin induzierte S-Phasen-Arrest und Replikationsstress aufrechterhalten. Im Vergleich zu den meisten früheren Studien, die sich mit dualen BET/HDAC-Inhibitoren beschäftigten, ist dies eine große Verbesserung, da es bisher keinen signifikanten Unterschied zwischen der Verwendung eines dualen BET/HDAC-Inhibitors und der Kombination von zwei Einzelinhibitoren gab.
Als Proof of Concept unterstützten die Daten weitere Bemühungen zur Entwicklung zusätzlicher dualer BET/HDAC-Inhibitoren. Daher wurden zwei weitere Generationen dualer BET/HDAC Inhibitoren entwickelt, die jedoch bisher nicht an die Eigenschaften von 14 anknüpfen konnten. Vor allem die 3. Generation bietet jedoch Raum für Optimierungen, so dass hier möglicherweise noch ein potenter dualer Inhibitor zu finden ist. Sollte es in Zukunft einen zugelassenen dualen BET/HDAC-Inhibitor geben, ist es jedoch nicht unwahrscheinlich, dass keine der hier verwendet BET inhibierenden Strukturen verwendet werden, aber Struktur des HDAC inhibierenden Teils immer noch vergleichbar ist. Der Grund dafür ist, dass die HDAC Inhibitoren größtenteils relativ einfach aufgebaut. So lange das wichtigste, die zinkbindende Gruppe vorhanden ist, scheint der Linker sowie die Capping-Gruppe zweitranging zu sein. Die größere Herausforderung wird vermutlich die Suche nach dem passenden BET Inhibitor sein und die Wahlmöglichkeiten sind schon jetzt vielfältig.
Generell lässt sich sagen, dass die Idee der dualen BET/HDAC-Inhibitoren äußerst vielversprechend und es wert ist, weiter verfolgt zu werden. Dies liegt vor allem an den guten Testergebnissen, die mit Verbindung 14 erzielt wurden. Mit Hilfe dieser Art von Inhibitoren könnte es in Zukunft möglich sein, die Überlebensrate von PDAC-Patienten zu erhöhen, wenn nicht als alleiniges Medikament, so vielleicht als Zusatz zur Chemotherapie. Darüber hinaus scheint der Einsatz von dualen BET/HDAC-Inhibitoren nicht nur auf die Behandlung von PDAC beschränkt zu sein und kann auch bei anderen Krebsarten angewendet werden. NMC zum Beispiel ist ein ebenso seltener wie tödlicher Subtyp des schlecht differenzierten Plattenepithelkarzinoms und zeichnet sich durch eine Fusion des NUT-Gens mit BRD4 aus, wodurch es potenziell anfällig für eine BET-Inhibition ist. Tatsächlich zeigte 14 auch hier einen größeren positiven Effekt auf die getesteten NMC-Zellen als JQ1 oder CI994 und veranlasste die Zellen unter anderem zur Differenzierung. ...
Necroptosis is an immunogenic form of programmed cell death characterized by plasma membrane accumulation of activated mixed lineage kinase domain-like (MLKL) that eventually leads to membrane disruption and release of danger-associated molecular patterns (DAMPs). Necroptotic cell death is tightly controlled by checkpoints, including compartmentalization as well as post-translational modifications (PTMs), like phosphorylation and ubiquitination of receptor-interacting protein kinase (RIPK) 1, RIPK3 and MLKL. Removal of plasma membrane-located activated MLKL via endocytosis or exocytosis can counteract necroptosis, but up till now, the exact mechanisms by which necroptosis is regulated downstream of MLKL activation and oligomerization are not fully understood.
Ubiquitination is a key post-translational modification that regulates various cellular processes including cell survival and cell death signaling via ubiquitination of RIPK1, RIPK3 and MLKL. M1-linked (linear) poly-ubiquitination is mediated exclusively by the linear ubiquitin chain assembly complex (LUBAC) which critically regulates cell fate and immune signaling via death receptors such as TNF receptor 1 (TNFR1).
In this study, we demonstrate that M1 poly-Ubiquitin (poly-Ub) increases during necroptosis which can be blocked by inhibition of LUBAC activity with the small-molecule HOIL-1-interacting protein (HOIP) inhibitor HOIPIN-8 or by loss of LUBAC catalytic subunit HOIP. Intriguingly, HOIPIN-8, as well as the HOIP inhibitor gliotoxin, and HOIP knockdown effectively prevent TNFα/smac mimetic/zVAD.fmk-induced necroptotic cell death in cells of human origin, without affecting necroptotic RIPK1 and RIPK3 phosphorylation, necrosome formation and oligomerization of phosphorylated MLKL. We demonstrate that HOIPIN-8 treatment inhibits MLKL translocation to intracellular membranes and accumulation in plasma membrane hotspots as well as MLKL exocytosis. We further confirm that HOIPIN-8 treatment suppresses necroptotic cell death in primary human pancreatic organoids (hPOs). Using time-lapse imaging and live/dead staining, we demonstrate loss of organoid structure and hPO cell death induced by smac mimetics and caspase inhibitors, thus providing a novel platform to investigate necroptosis in near physiological settings. Inhibition of LUBAC activity with HOIPIN-8 prevents hPO collapse and extends cell viability. Of note, loss of the M1 Ub-targeting deubiquitinating enzymes (DUBs) OTU DUB with linear linkage specificity (OTULIN) and cylindromatosis (CYLD) in human cell lines does not affect necroptosis induction and HOIPIN-8-mediated rescue of necroptosis. Intriguingly, inhibition of LUBAC activity with HOIPIN-8 does not block necroptotic cell death in murine cell lines.
Using massive analyses of cDNA ends (MACE)-seq-based global transcriptome analysis we confirm that necroptosis induces a pro-inflammatory cytokine profile which is dependent on LUBAC function and necroptotic signaling. Loss of LUBAC activity prevents the MLKL-dependent production and release of pro-inflammatory cytokines and chemokines.
Finally, we identify Flotillin-1 and -2 (FLOT1/2) as putative targets of necroptosis-induced M1 poly-Ub. Ubiquitin-binding in ABIN and NEMO (UBAN)-based pulldowns of M1 poly-ubiquitinated proteins revealed enrichment of FLOTs after necroptosis induction which is dependent on LUBAC activity and can be blocked with necroptosis inhibitors Nec-1s, GSK’872 and NSA, targeting RIPK1, RIPK3 and MLKL, respectively. Of note, loss of FLOT1/2 potentiates necroptosis suppression induced by LUBAC inhibition with HOIPIN-8.
Together, these findings identify LUBAC-mediated M1 poly-Ub as an important mediator of necroptosis and identify FLOTs as novel putative targets of LUBAC-mediated M1 poly-Ub during necroptosis. In addition, by modeling necroptosis in primary human organoids, we further expand the spectrum of experimental models to study necroptosis in human cellular settings.
The Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes high fever, rash, and recurrent arthritis in humans. The majority of symptoms disappear after about one week. However, arthritis can last for months or even years (in about 30% of cases), which makes people unable to work during this period. The virus is endemic in Sub-Saharan Africa, the Indian Ocean islands, India, and Southeast Asia. It has additionally caused several large outbreaks in the last few years, affecting millions of people. The mortality rate is very low (0.1%), but the infection rates are high (sometimes 30%) and the number of asymptomatic cases is rare (about 15%). The first CHIKV outbreak in a country with a moderate climate was detected in Italy in 2007. Furthermore, the virus has spread to the Caribbean in late 2013. Due to climate change, globalization, and vector switching, the virus will most likely continue to cause new worldwide outbreaks. Additionally, more temperate regions of the world like Europe or the USA, which have recently reported their first cases, will likely become targets. Alarmingly, there is no specific treatment or vaccination against CHIKV available so far.
The cell entry process of CHIKV is also not understood in detail, and was thusly the focus of study for this project. The E2 envelope protein is responsible for cell attachment and entry. It consists of the domain C, located close to the viral membrane, domain A, in the center of the protein, and domain B, at the distal end, prominently exposed on the viral surface.
In this work, the important role of cell surface glycosaminoglycans (GAGs) for CHIKV cell attachment was uncovered. GAGs consist of long linear chains of heavily sulfated disaccharide units and can be covalently linked to membrane associated proteins. They play an important role in different cell signaling pathways. So far, solely cell culture passage has revealed an increased GAG-dependency of CHIKV due to mutations in E2 domain A, which was associated with virus attenuation in vivo. However, in this work it could be shown that cell surface GAGs promote CHIKV entry using non-cell culture adapted CHIKV envelope (Env) proteins. Transduction and infection of cell surface GAG-deficient pgsA-745 cells with CHIKV Env pseudotyped vector particles (VPs) and with wild-type CHIKV revealed decreased transduction and replication rates. Furthermore, cell entry and transduction rates of GAG-containing cells were also dose-dependently decreased in the presence of soluble GAGs. In contrast, transduction of pgsA-745 cells with CHIKV Env pseudotyped VPs was enhanced by the addition of soluble GAGs. This data suggests a mechanism by which GAGs activate CHIKV particles for subsequent binding to a cellular receptor. However, at least one GAG-independent entry pathway might exist, as CHIKV entry could not be totally inhibited by soluble GAGs and entry into pgsA-745 was, albeit at a lower rate, still possible. Further binding experiments using recombinant CHIKV E2 domains A, B, and C suggest that domain B is responsible for the GAG binding, domain A possibly for receptor binding, and domain C is not involved in cell binding. These results are in line with the geometry of CHIKV Env on the viral surface. They altogether reveal that GAG binding promotes viral cell entry and that the E2 domain B plays a central role for this mechanism.
As no vaccine against CHIKV has been approved so far, another goal of this project was to test new vaccination approaches. It has been published that a single linear epitope of E2 is the target of the majority of early neutralizing antibodies against CHIKV in patients. Artificial E2-derived proteins were created, expressed in E.coli, and successfully purified. They consisted of 5 repeats of the mentioned linear epitope (L), the surface exposed regions of domain A linked by glycine-serine linkers (sA), the whole domain B plus a part of the β-ribbon connector (B+), or a combination of these 3 modules. Vaccination experiments revealed that B+ was necessary and sufficient to induce a neutralizing immune response in mice, with the protein sAB+ yielding the best results. sAB+, as a protein vaccine, efficiently and significantly reduced viral titers in mice upon CHIKV challenge, which was not the case for recombinant Modified Vaccinia virus Ankara (MVA; MVA-CHIKV-sAB+), as a vaccine platform expressing the same protein. These experiments show that a small rationally designed CHIKV Env derived protein might, after optimization of some vaccination parameters, be sufficient as a safe, easy-to-produce, and cheap CHIKV vaccine.
Epigallocatechin-3-gallate (EGCG) is a catechin found in green tea and was, in this work, found to inhibit the CHIKV life cycle at the entry state in in vitro experiments using CHIKV Env VPs and wild-type virus. EGCG was recently published to inhibit attachment of several viruses to cell surface GAGs, which is in line with the role for GAGs in CHIKV entry revealed in this work. EGCG might serve as a lead compound for the development of a small molecule treatment against CHIKV.
Electrospinning is a versatile and promising drug delivery technology for the development of tailor-made drug delivery systems for various clinical applications. By applying high voltages to drug-loaded polymer solutions, solid polymeric nanofibers can be generated, which encapsulate active pharmaceutical ingredients (APIs) into their polymer matrix. During the electrospinning process, the fibers are deposited on a collector and form a nonwoven network of drug-loaded polymer fibers. These fibers are spatially distributed in aligned or random orientation, providing the opportunity to design highly tunable structural and mechanical properties, which can be adapted to the biological requirements of the intended application site. The mechanically flexible fiber networks can therapeutically be administered to a multitude of pharmaceutical application sites. Their highly porous fiber structure exhibits a large surface-to-volume ratio, which is ideal for controlled drug release kinetics from the polymer matrix upon contact with biological fluids, such as tear fluid, saliva, mucus, wound exudate or gastro-intestinal fluid. For application at the target site, fiber mats are cut into patches. As the patch size determines the quantity of applied API, the electrospinning process must ensure homogeneous distribution of the API throughout the entire fiber mat area.
In this thesis, electrospinning was established as a formulation technology for the rational fabrication of tailor-made multifunctional drug carrier systems for local and site-specific drug delivery to the epithelial interfaces skin, oral mucosa as well as cornea. For adequate characterization and analysis of the drug delivery systems, a broad panel of robust and predictive analytical tools, based of novel investigation techniques for physicochemical characterization of electrospun fibers, was developed.
The initial part of the thesis thematically focuses on the development of predictive analytical techniques, to determine fiber morphology and physicochemical properties, as well as fiber composition and drug release. By designing two model formulations with contrasting properties, and subsequent analysis and characterization with a set of newly developed techniques and state-of-the-art methods, a comprehensive toolset has been made available and evaluated, aiming at advancing and standardizing respective techniques in the scientific field of electrospun drug delivery systems.
Starting with the initiation of the electrospinning formulation process, which often relies on empirical data rather than analytical methods to predict successful processability, analysis of rheological properties of electrospinning solutions was used to rationally detect the minimum polymer concentration required for electrospinning.
For analysis of fiber morphology, scanning electron microscopy is a common technique. However, little attention is given to underlying readout parameters. By analyzing the fiber orientation and diameter of the respective fibers, predictive results regarding mechanical properties could be obtained, which were subsequently confirmed by measuring elongation force with tensile testing. Confocal Raman microscopy, a label-free method for chemically- selective imaging of the fiber samples, was introduced as a complementary visualization technique, enabling the detection of fiber composition and drug distribution.
A novel technique for investigation of water contact angles on the fiber surface of highly hydrophilic polymers was introduced, which provides predictive data regarding interaction with body fluids and the resulting drug release kinetics. Subsequent release testing in a newly developed setup for analyzing drug release from electrospun fibers in low-volume body compartments, confirmed the anticipated drug release kinetics from measurement of the surface hydrophilicity.
By combining complementary analytical methods, including spectral composition analysis, morphology visualization, characterization of physico-chemical properties and drug release kinetics, as well as the application of multivariate data analysis, a robust and predictive toolset has been established, which can support comparability of future electrospinning studies and the translation from the lab bench into clinics.
Based on the analytical toolset, the main part of the thesis focuses on the development and preparation of electrospun platform drug delivery systems for application on epithelial barriers. Electrospun fiber mats are thin, flat, and mechanically flexible, which allows close adherence to epithelial surfaces and reduction of diffusion paths, which enables efficient drug delivery to the skin, oral mucosa, as well as the cornea.
Electrospun fibers bear a high potential for application as wound dressings, while simultaneously controlling the local delivery of APIs to the wound area. Their close resemblance to the extracellular matrix of human skin provides a suitable microenvironment for cellular proliferation and migration for wound closure. In this work, insulin, a fragile proteohormone with growth factor characteristics, was successfully encapsulated into the core of coaxially electrospun fibers, thus maintaining bioactivity throughout and after the electrospinning process. The shell has been designed from biocompatible polymers, which, upon contact with aqueous wound exudate, partially dissolve and form pores through which bioactive insulin is released in a controlled manner. The shell layer provides a hydrophilic surface for interaction with body fluids and skin cells, and possesses substantial mechanical strength, flexibility, and high tensile elongation required for application on wounds. The biocompatibility of the wound dressing was investigated by interaction with primary human dermal fibroblasts and keratinocytes, which displayed healthy cell morphologies without indicating any elevated levels of cytotoxicity markers.
To investigate the effect of insulin on cell migration, in vitro scratch assays on human skin cells were performed. Increased cellular migration speed and wound closure could be observed, indicating improved wound healing. Bio relevance of in vitro wound healing potential results was advanced by development of 3D ex vivo human epidermal skin wound models from reduction surgery donor material. These complex wound models were treated with electrospun insulin fibers and analyzed by proteome analysis to reveal significant increases in wound healing-associated signaling pathways, which could be attributed to a material-driven remarkably positive impact on wound healing of the electrospun fibers...
The DNA damage response (DDR) is a vast network of molecules that preserves genome integrity and allow the faithful transmission of genetic information in human cells. While the usual response to the detection of DNA lesions in cells involves the control of cell-cycle checkpoints, repair proteins or apoptosis, alterations of the repair processes can lead to cellular dysfunction, diseases, or cancer. Besides, cancer patients with DDR alterations often show poor survival and chemoresistance. Despite the progress made in recent years in identifying genes and proteins involved in DDR and their roles in cellular physiology and pathology, the question of the involvement of DDR in metabolism remains unclear. It remains to study the metabolites associated with specific repair pathways or alterations and to investigate whether differences exist depending on cellular origin. The identification of DDR-related metabolic pathways and of the pathways that cause metabolic reprogramming in DDR-deficient cells may produce new targets for the development of new therapies.
In this thesis, nuclear magnetic resonance spectroscopy (NMR) was used to assess the metabolic consequence of the loss of two central DNA repair proteins with importance in diseases context, ATM and RNase H2, in haematological cells. An increase in intracellular taurine was found in RNase H2- and ATM-deficient cells compared to wild-type cells for these genes and in cells after exposition to a source of DNA damage. The rise in taurine does not appear to result from an increase in its biosynthesis from cysteine, but more likely from other cellular processes such as degradation pathways.
Overall, evidence for metabolic reprogramming in haematological cells with faults in DNA repair resulting from ATM or RNase H2 deficiencies or upon exposition to a source of DNA damage is presented in this study.
Large international airports were identified as sources of ultrafine particles (UFPs) (Hu et al., 2009; Yu et al., 2012; Hsu et al., 2013; Keuken et al., 2015; Hudda and Fruin, 2016). Since September 2017 UFP emissions originating from the Frankfurt International Airport, Germany are monitored by the Hessian Agency for Nature Conservation, Environment and Geology (HLNUG) showing elevated UFP concentrations during airport operating hours (05:00–23:00 CET) (Ditas et al., 2022). Referring to that, the organic chemical composition of aviation-related UFPs emerging from the Frankfurt Airport was analysed by performing a comprehensive non-target screening of UFP filter samples.
Aluminium-filter samples were collected at an air quality monitoring station 4 km north of the Frankfurt Airport, using a 13-stage impactor system (Nano-MOUDI). The chemical
characterization of UFPs in the size range of 10-18 nm, 18-32 nm and 32-56 nm was accomplished by ultra-high-performance liquid chromatography, heated electrospray ionisation and mass analysis using an Orbitrap high-resolution mass spectrometer. Non-target screening revealed that the majority of detected compounds belong to homologous series of two different types of organic esters, which are base stocks of aircraft lubrication oils.
In reference to five different jet engine lubrication oils of various manufacturers, the corresponding lubricant base stocks and their additives, two amines and one organophosphate, were identified in the UFPs by the use of matching retention time, exact mass and MS/MS fragmentation pattern of single organic molecules. The quantitative analysis of the jet engine oil constituents in the aviation-related UFPs with diameters < 56 nm was accomplished by standard addition. By characterizing the Nano-MOUDI, loss factors for each size stage were determined and used for correction accordingly. Particle-number size distribution measurements, conducted parallel to the filter sampling, enabled the determination of the jet engine oil contribution to the UFP mass.
Furthermore, the nucleation and particle formation potential of a commonly used synthetic jet engine lubrication oil was investigated in the laboratory. Thermodenuder experiments at 20 °C and 300 °C were carried out to monitor the gas-to-particle partitioning behaviour of jet engine oils. At 300 °C a significantly higher number of particles with a mean diameter of ~10 nm are formed, leading to a more than fivefold increase in total particle numbers compared to 20 °C. Particle diameters of the newly formed oil particles in the laboratory experiment appeared in the same size region as UFPs emerging from Frankfurt Airport. Particles originating from the Frankfurt city centre direction showed larger diameters.
Results indicate that aircraft emissions strongly influence the total mass of 10-18 nm particles. The jet oil fraction decreases for bigger particles (e.g., 18-56 nm), implying that these oils form new particles in the cooling exhaust gases of aircraft engines. In addition, non-target screening and in vitro bioassays on aviation-related PM2.5 filter samples were combined to provide indications for potential toxicologically relevant compounds in dependence of different wind directions and airport operations. Most recently, the applied non-target screening method was also used to identify seasonal variations in the organic aerosol composition in Beijing.
The post-transcriptional modification of the canonical nucleoside uridine into its rotational isomer pseudouridine occurs in non-coding as well as coding RNA and is the most abundant post-transcriptional modification in all kingdoms of life. While the occurrence of pseudouridine has been linked to the enhancement of stability and the codon-anticodon interaction in tRNAs, enhancement of the translation efficiency in rRNAs, regulatory functions in spliceosomal snRNA and nonsense codon suppression in mRNA, its exact role in many RNAs is still ambiguous. The uridine to pseudouridine isomerization can either be catalyzed by one of various standalone pseudouridylases or it can be performed in an RNA-guided manner by H/ACA ribonucleoproteins. In eukaryotes, the guide RNA always adapts a conserved bipartite, double-hairpin conformation. Each hairpin contains an internal RNA-loop motif, which can recruit a specific substrate RNA via base pairing. The catalytically active RNP is formed by the interactions of the guide RNA with four proteins. While Cbf5 forms the catalytically active center, Nop10 and Nhp2 perform auxiliary functions and Gar1 is involved in substrate turnover. Up until now, most structural knowledge about H/ACA RNPs has been derived from archaeal complexes, while the exact structure-function-relationships between RNA and proteins in eukaryotic RNPs is still ambiguous. While archaeal H/ACA RNPs share many similarities with eukaryotic RNPs and act as good model system, there are also many differences between them like eukaryotic specific protein domains as well as the overall bipartite complex structure, dictated by the snoRNA. Investigating pseudouridylation by eukaryotic H/ACA RNPs opens up a broad area of research and helps to gain a better understanding of this enzyme class – especially since malfunction of H/ACA RNPs has been linked to the genetic disease Dyskeratosis congenita as well as several types of cancer.
The main goal of this thesis was to gain new insights into the RNA/protein interactions in the eukaryotic snR81 H/ACA snoRNP from Saccharomyces cerevisiae on a structural as well as dynamical level. In the first part of this thesis, the main goal was to in vitro prepare a functionally active snR81 H/ACA RNP. The guiding snoRNA was prepared by in vitro transcription and purification, while the Saccharomyces cerevisiae proteins were recombinantly expressed from Escherichia coli. Apart from the full length, bipartite snR81 snoRNP, several sub-complexes of the RNP were reconstituted. Therefore, snoRNA constructs were designed and prepared, which only contained a single hairpin motif of the complex. Furthermore, snoRNA constructs in which the apical hairpin stem was replaced by a stable tetraloop were prepared, to investigate the influence of the apical stem on protein binding and activity. Also, for the eukaryotic proteins, a shortened version of Gar1 (Gar1Δ) was utilized, which lacks the eukaryotic specific RGG domains, that have been characterized as accessory RNA binding motifs. Reconstituted snoRNPs were utilized in catalytic activity assays, monitoring the turnover rate of uridine to pseudouridine. For this purpose, radioactively labeled substrate RNAs were prepared by phosphorylation and splinted ligation of oligonucleotides and were objected to reconstituted H/ACA RNPs under single as well as multiple turnover conditions. In the second part of this thesis, the RNA/protein interactions were dissected via single molecule FRET spectroscopy. Therefore, the snoRNA was labeled with an acceptor fluorophore via NHS ester/amine-reaction. Furthermore, the snoRNA contained a biotin-handle, allowing immobilization of the complex during the experimental time-window of the spectroscopic analysis. Eukaryotic specific protein Nhp2 was labeled with a donor fluorophore via “click” chemistry, which included the chemical synthesis and incorporation by genetic code expansion of non-canonical amino acids. The interactions of Nhp2 with the different snoRNA constructs (standalone-hairpins “H5” and “H3”, as well as hairpins lacking the apical binding motif “H5Δ” and “H3Δ”) were monitored on a single molecule level.
In summary, it was possible to gain new insights into the complex structure and the dynamical behavior of the still sparsely characterized eukaryotic H/ACA RNPs. Especially, new knowledge could be obtained about the hairpin specific behavior on the bipartite RNA complex structure, including the rather ambiguous role of the protein Nhp2 and the contribution of the eukaryotic specific features of Gar1 in their interaction with the guide/substrate RNA.
Die Steuerung biochemischer Prozesse oder die Verbesserung von Materialien erfordert zunächst ein tiefgründiges Verständnis über die zugrundeliegenden Systeme. Zur Untersuchung eignet sich Licht als ideales Werkzeug, da hiermit nützliche Informationen über die chemische Struktur, ihre Eigenschaften sowie den zusammenhängenden, schnellen Reaktionsabläufen erhalten werden können. Um die Aufklärung zu erleichtern können kleine, chemische Verbindungen eingeführt werden, welche beispielsweise ein Fluoreszenzmarker, eine photolabile Schutzgruppe oder eine photoschaltbare Verbindung sein können. Von jeweils einem Vertreter dieser Moleküle wurden unterschiedliche Studien durchgeführt, dessen Ergebnisse in dieser Arbeit in insgesamt drei Projekten zusammengefasst werden.
Zunächst wurde die Funktionalität der Helikase RhlB untersucht, die der Familie der DEAD-Box Proteine zugeordnet wird, und RNA-Duplexe in ihre Einzelstränge entwindet. Als RNA-Modellduplex diente JM2h, an dem ein RNA-Einzelstrang fluoreszenzmarkiert war (M2AP6). Die Einführung dieses Markers ermöglichte die Durchführung von statischen Fluoreszenzmessungen sowie von Mischexperimenten, die mit Hilfe der stopped-flow-Technik durchgeführt wurden. In den einleitenden Studien wurde die Helikase weggelassen, wodurch der Fokus auf den Fluoreszenzeigenschaften der RNA gelegt wurde. Die Ergebnisse hierzu zeigten, dass die Fluoreszenzintensität des Einzelstrangs durch Zugabe des komplementären Strangs deutlich abnimmt, wobei das Minimum bei einem äquimolaren Verhältnis erreicht wird. Die dazugehörigen stopped-flow-Messungen zeigten eine Beschleunigung der Hybridisierungsreaktion, wenn höhere Konzentrationen des Gegenstrangs in der Lösung vorhanden waren. Nach anschließender Zugabe der Helikase zur Lösung wurde ein Anstieg der Fluoreszenzintensität erwartet, der vom separierten Einzelstrang M2AP6 herrühren sollte. Dieser Anstieg wurde jedoch erst nach weiterer Zugabe von ATP beobachtet, der auf eine ATP-Abhängigkeit der Entwindungsreaktion von RhlB hindeutet. Diese Abhängigkeit wurde auch bereits für andere Helikasen der DEAD-Box Familie entdeckt. Die korrekte Funktionalität sowie die ATP-Abhängigkeit wurden in stopped-flow-Messungen verfiziert, bei denen der Fluoreszenzanstieg auch zeitaufgelöst betrachtet werden konnte. Für die spektralen Korrekturen der Fluoreszenzspektren wurde ein selbstgeschriebenes MATLAB-Programm namens FluCY verwendet (engl.: Fluorescence Correction & Quantum yield), welches eine schnelle und fehlerfreie Verarbeitung des Datensatzes ermöglichte.
Die zwei im folgenden beschriebenen Projekte handeln von photoaktivierbaren Molekülen. Zum einen photolabile Verbindungen, welche die Funktion z.B. eines Biomoleküls durch eine chemische Modifikation deaktivieren können. Durch eine lichtinduzierte Reaktion kommt es zur Abspaltung der Modifikation und die Funktion ist wiederhergestellt. In dieser Arbeit wurden verschiedene photolabile Schutzgruppen untersucht, die denselben Chromophor BIST (BIsStyryl-Thiophen) tragen. Durch die Einführung dieses Chromophors absorbierten sämtliche untersuchte Verbindungen sehr effizient sichtbares Licht (epsilon(445)=55.700 M^(-1) cm^(-1)), wodurch der photoinduzierte Bindungsbruch mit Wellenlängen durchgeführt werden, die bei einer biologischen Anwendungen keinen Schaden an der Zelle anrichten würden. Hieraufhin wurden in statischen und zeitaufgelösten Absorptionsmessungen Teilschritte der Freisetzungsreaktion untersucht, indem nach Photoanregung die Absorptionsänderungen auf verschiedenen Zeitskalen analysiert wurden. Die ultraschnelle Dynamik im Piko- bis Nanosekundenbereich (10^(-12)-10^(-9) s) wird durch eine spektral breite, positive Absorptionsänderng dominiert. Diese impliziert, dass die Deaktivierung über den Triplettpfad abläuft, der die vergleichsweise niedrigen Freisetzungsausbeuten erklärt (phi(u) < 5). Aufgrund des hohen Extinktionskoeffizienten reichen dennoch bereits niedrige Strahlungsdosen aus, um eine Freisetzung zu initiieren. Der geschwindigkeitsbestimmende Schritt dieser Reaktion ist dem Zerfall des aci-nitro Intermediats zugeordnet. Für ein sekundäres Amin, welches mit BIST geschützt wurde, ist eine Lebensdauer des Intermediats von 71 µs gefunden worden.
In einigen Fällen ist es erwünscht, eine vorliegende Aktivität nicht nur ein-, sondern auch ausschalten zu können, wofür photochrome Verbindungen (oder Photoschalter) verwendet werden. Die in dieser Arbeit untersuchte Verbindung ceCAM ist ein Alken-Photoschalter und vollführt bei Bestrahlung mit Licht eine cis/trans-Isomerisierung. ceCAM ist das Cyanoester-Derivat (ce) von Cumarin-substituierten Allylidenmalonat, von denen beide Konformere sehr effizient sichtbares Licht absorbieren trans: epsilon(489)=50.300 M^(-1) cm^(-1); cis: epsilon(437)=18.600 M^(-1) cm^(-1)). Andere photophysikalische Eigenschaften umfassen u.a. hohe thermische und photochemische Stabilität. Letztere wurde über ein Experiment nachgewiesen, bei dem die lichtinduzierte Isomerisierung alternierend durchgeführt wurde und selbst bei über 250 Zyklen keine signifikate Abnahme der Absorption beobachtet werden konnte. Des Weiteren konnte die Reaktion mit Quantenausbeuten von 39% (trans) und 42% (cis) induziert werden, wobei im photostationären Gleichgewicht auch hohe Isomerenverhältnisse mit bis zu 80% (trans) und 96% (cis) akkumuliert werden konnten. Die Geschwindigkeit der Reaktion wurde mit Hilfe der Ultakurzzeit-Spektroskopie untersucht. Die Dynamik im Zeitbereich von ps-ns zeigte, dass die trans/cis-Isomerisierung unterhalb von 0,5 ns und die umgekehrte Reaktion noch viel schneller (wenige ps) abgeschlossen ist. Durch die Untersuchungen in dieser Arbeit an den BIST-Verbindungen und ceCAM sind viele vorteilhafte, photophysikalische Eigenschaften charakterisiert worden, wodurch sie als verbesserte Alternative zu den bisher bekannten photolabilen Schutzgruppen oder Photoschaltern anzusehen sind.
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in early childhood. Despite recent advances in the treatment regimes of rhabdomyosarcoma, the 5-year survival is still alarmingly low for the more aggressive metastasizing alveolar rhabdomyosarcoma subtype. Novel treatment strategies are needed in order to increase the overall survival rate. Hallmarks of cancer include evade cell death induction and evade immune system surveillance. This is mediated in part by up-regulation of inhibitor of apoptosis (IAP) proteins. With the development of Smac mimetic compounds mimicking the endogenous IAP antagonist Smac, this tumor evasion mechanism became exploitable.
In this PhD thesis, a combinatory approach for a putative treatment option of RMS will be presented. Here, the Smac mimetic compound BV6 will be used as a pre-treatment of RMS cells. This leads to a sensitizing effect within the tumor cells, increasing the killing efficacy of natural killer (NK) cells.
Subtoxic concentrations of BV6 were chosen to sensitize RMS cells. To remodel the solid tumor characteristics of RMS, a multicellular RMS tumor spheroid culture model was used.
In both tumor spheroids and conventional monolayer cell culture BV6 induced the degradation of IAP proteins (cIAP1, cIAP2, in spheroids XIAP). Further, BV6 led to the activation of both, the canonical and non-canonical NF-κB signaling pathways.
This was demonstrated by an increased IκBα and p65 phosphorylation, and nuclear translocation of p-p65, indicative for an active canonical NF-κB signaling. On the other side, cIAP degradation led to the stabilization and accumulation of NIK and downstream partial degradation of p100 to p52 and its nuclear translocation, indicating non-canonical NF-κB signaling pathway activity. A bulk RNA sequencing approach of BV6 treated RH30 cells validated the NF-κB signaling involvement and identified 182 differentially expressed genes. Among the interesting target genes are NFKBIA (IκBα),BIRC3 (cIAP2), NFKB2 (p100), CCL5 and SSTR2. SSTR2 was thoroughly validated as being up-regulated on a transcriptional and on protein level. Here, SSTR2A, one of the two alternative splicing variants, is up-regulated and opens a hypothetical targeted treatment strategy, as SSTR2 expression is not associated with RMS, but rather described with neuroendocrine tumor entities. In addition, CCL5 was thoroughly validated as a BV6 induced target. Again, the up-regulated mRNA transcription was validated by an increased translation and by increased secretion of CCL5. As CCL5 being associated as pro-migratory and activating of NK cells, CRISPR/Cas9 mediated CCL5 knock-out studies were performed to evaluate the influence of CCL5 within a BV6 pre-treatment and NK cell co-cultivation setting. It was shown that CCL5 knock-out does not rescue BV6 pre-treated RMS spheroids from NK cell attack and killing.
The previous mentioned transcriptional activity by BV6 stimulation was NIK mediated as knock-down of NIK reduced the mRNA transcription of several interesting genes.
However, NIK mediated down-stream signaling had no influence on the BV6 induced sensitizing effect towards NK cell mediated attack. A NIK knock-down had no rescue effect upon BV6 pre-treatment and NK cell co-treatment.
As cIAP proteins are present in receptor bound complexes, e.g. complex I at the TNF receptor 1 (TNFR1), a putative involvement of death receptors in general was evaluated.
Indeed, BV6 treatment of RMS cells could increase the surface presentation of DR5, a death receptor ligating TRAIL. Functionally, co-treatment of BV6 with TRAIL led to an additive cell death inducting effect. However, within the NK cell co-cultivation setting, addition of a neutralizing TRAIL anitbody could not rescue BV6 pre-treated RMS spheroids from NK cell killing. A similar effect was observed when neutralizing TNFα by adding Enbrel during the NK cell co-cultivation. BV6 sensitization of RMS spheroids seems to be independent of death receptors.
In addition to activating NF-κB, BV6 as a Smac mimetic is supposed to be able to release caspases bound by IAP proteins. Indeed, BV6 pre-treatment of RMS spheroids and co-cultivation with NK cells could cleave and thereby activate the executioner caspase-3. Further, treatment with a pan-caspase inhibitor, zVAD.fmk, could reduce the BV6 mediated sensitizing effect towards NK cell attack in RD spheroids.
Taken together, BV6 does induce a thoroughly validated NF-κB signaling pathway, leading to a NIK mediated transcriptional signature change. However, the NF-κB activation might not be responsible for the observed sensitization. Further, BV6 in combination with NK cells led to a seemingly death receptor independent, caspase dependent cell death induction of RMS spheroids. Although the mechanism remains partially con-cealed, a therapeutic benefit by combining a cell death sensitizing compound, i.e. BV6, with cytotoxic lymphocytes is evident.
Chromosomal translocations (CTs) are a genetic hallmark of cancer. They could be identified as recurrent genetic aberrations in hemato-malignancies and solid tumors. More than 40% of all "cancer genes" were identified in recurrent CTs. Most of these CTs result in the production of oncofusion proteins of which many have been studied over the past decades. They influence signaling pathways and/or alter gene expression. However, a precise mechanism for how these CTs arise and occur in a nearly identical fashion in individuals remains to be elucidated. Here, we performed experiments that explain the onset of CTs: proximity of genes able to produce prematurely terminated transcripts, which leads to the production of transspliced fusion RNAs, and finally, the induction of DNA double-strand breaks which are subsequently repaired via EJ repair pathways. Under these conditions, balanced chromosomal translocations could be specifically induced.
The multistep-processes leading to the formation of tumors have been extensively studied in the past decades, leading to the identification of “hallmarks of cancer”. They are characteristic changes in biological processes that discriminate tumor cells from healthy cells. Increasing knowledge on the molecular structures associated with tumorigenesis allowed their specific inhibition in targeted anti-cancer therapy. However, successful targeted anti-cancer therapy is only available for a limited subset of diseases, so the continuous investigation of tumorigenic mechanisms is required to tackle the immense diversity of neoplastic entities.
AVEN and FUSE binding protein 1 (FUBP1) display the ability to regulate apoptosis and cell cycle progression. Thus, the proteins are associated with hallmarks of cancer (resisting cell death and uncontrolled proliferation). Indeed, aberrant expression of AVEN and FUBP1 could be demonstrated in multiple cancers. In contrast, there is only little knowledge on the physiological function of AVEN and FUBP1. The lack of knowledge results in part from the embryonic lethality of the homozygous knockout of Aven and Fubp1 in mouse models, limiting the gain of information by analyzing these animals.
In this study, I generated conditional Aven and Fubp1 knockout mice to investigate their physiological function.
By analyzing reporter mice expressing β-galactosidase under the control of the endogenous Aven promoter, I identified Aven promoter activity to be both tissue- and cell type-specific and dependent on the developmental stage. Detecting apoptotic cell death by immunohistochemistry did not reveal increased apoptosis in Aven knockout mice, suggesting a functional role of AVEN besides apoptosis inhibition during embryogenesis.
Basing on the significant Aven promoter activity detected in the adult brain and in the mammary gland, I generated and characterized conditional Aven knockout mice with Aven deletion restricted to cells within the brain or the mammary gland. AVEN depletion in these tissues was not embryonic lethal and the affected tissues displayed a normal histology.
Since aberrant Aven expression had been associated with hematologic malignancies, I also analyzed mice with an Aven knockout in the hematopoietic system. Depletion of AVEN in the blood cells had no effect on hematopoietic stem and progenitor cell frequencies. Consequently, AVEN seems to be dispensable for the maintenance and differentiation of stem, progenitor and mature blood cells, at least as far as the expression of particular differentiation markers was concerned.
As loss of AVEN in the analyzed tissues did not affect the viability of mice and did not produce any other obvious phenotype, the exact role of AVEN that is essential for embryo survival remains to be identified.
To study the oncogenic potential of AVEN, I investigated the role of AVEN in a mouse model for breast carcinogenesis. While AVEN expression seemed to be increased in breast tumors, tumor onset and progression were not altered in mice with depleted AVEN expression in the mammary gland. Consistently, Aven knockout tumor cells were neither less proliferative nor more prone to undergo apoptosis than Aven wildtype tumor cells. Cell culture experiments demonstrated that AVEN expression is upregulated by estrogen. Knockdown of AVEN in the breast cancer cell line MCF-7 slightly increased UV irradiation-induced apoptosis and accelerated metabolism. So while AVEN does not promote development or progression of breast tumors, enhanced AVEN expression in ER+ breast cancers might contribute to chemotherapy resistance.
To study the physiological role of FUBP1, I generated a conditional Fubp1 knockout mouse model. While the insertion of loxP sites into the Fubp1 locus was occasionally embryonic lethal, some mice with a cell type-specific deletion of Fubp1 in hematopoietic cells or EPO receptor expressing cells were born alive. In these mice, frequencies of hematopoietic stem and progenitor cells as well as erythrocytes were unaltered. These results conflict with previous publications. However, compensating mechanisms might be responsible for the discrepancies between the observed phenotypes and reported FUBP1 function.
In cell culture studies, I could demonstrate that the previously reported upstream regulation of FUBP1 by TAL1 depended on an intact GATA motif in the FUBP1 promoter and that binding of GATA1 to the FUBP1 promoter increased during erythropoiesis.
To identify new FUBP1 target genes with relevance for erythropoiesis, I performed differential gene expression analysis in cells with wildtype and depleted FUBP1 expression. RNA-sequencing and PCR-arrays revealed only moderate differences in the expression of genes that are components of the EPO receptor signaling pathway as well as genes associated with apoptosis and proliferation of hematopoietic cells. By regulating the transcription of these genes, FUBP1 could contribute to efficient erythropoiesis.
Impact of pectin dietary supplementation on experimental food allergy via gut microbiota modulation
(2023)
In recent years, dietary fibers gained focus in regard of their immune-modulatory effects and the potentially beneficial effect on allergies. The dietary fiber and prebiotic pectin is able to promote growth and activity of beneficial bacteria and thereby induce modulation of different immune responses. However, structurally different types of pectin might promote different immune-modulatory responses and to date the optimal pectin type for induction of beneficial health effects is not identified. Furthermore, it is still unclear, whether pectins provide a beneficial effect on certain allergies, such as food allergy.
Having this in consideration, this study examined the immune-modulatory effects of structurally different pectins on naive as well as peach allergic mice. Furhtermore, the impact of dietary pectin supplementation on composition and diversity of the murine gut microbiota was determined.
This study showed that dietary pectin intervention was able to suppress allergy-related Th2 responses considering humoral and cellular immune responses. Only apple-derived high-methoxyl pectin revealed an impact on total IgA levels and affected the microbial richness. Furthermore, it is not known whether the effects observed with the two pectins are caused by modulations of the bacterial composition or induced at least partly by direct interaction with the immune cells. Further studies are required to fully understand the mechanisms underlying the immune-modulatory capacities of different pectins.
Finally, the obtained results generated evidence that dietary pectin intervention can beneficially modulate the immune response in healthy mice and – at least partially – suppress allergy-related immune responses in a model of food allergy, depending on the structural characteristics of the used pectin.
Polyketides are highly valuable natural products, which are widely used as pharmaceuticals due to their beneficial characteristics, comprising antibacterial, antifungal, immunosuppressive, and antitumor properties, among others. Their biosynthesis is performed by large and complex multiproteins, the polyketide synthases (PKSs). This study solely focuses on the class of type I PKSs, which arrange all their enzymatic domains on one or more polypeptides. Despite their high medical value, little is known about mechanistic details in PKSs.
One central domain is the acyl transferase (AT), which is present in all PKSs and channels small acyl substrates into the enzyme. More precisely, the AT loads the substrates onto the essential acyl carrier protein (ACP), which subsequently shuttles the substrates and all intermediates for condensation and modification to additional domains to build the final polyketide.
Some PKSs use their domains several times during biosynthesis and work iteratively – these are called iterative PKSs. Others feature several sets of domains, each being used only once during biosynthesis – these PKSs are called modular PKSs. All PKSs or PKS modules consist of minimum three essential domains to connect the acyl substrates. Three modifying domains are optional and can enlarge the minimal set. According to the domain composition, the acyl substrate is fully reduced, partly reduced, or not reduced at all. This variation of modifying domains accounts for the huge structural and therefore functional variety of polyketides.
Even though the structure of fatty acids is not exactly reminiscent of polyketides, their biosynthetic pathways are closely related. Fatty acid biosynthesis is carried out by fatty acid synthases (FASs), which share many similarities with PKSs. Both megasynthases feature the same domains, performing the same reactions to connect and modify small acyl substrates. In contrast to PKSs, FASs always contain one full set of modifying domains which is used iteratively, leading to fully reduced fatty acids.
The present thesis extensively analyzes the AT of different PKSs in its substrate selectivity, AT-ACP domain-domain interaction, and enzymatic kinetic properties. The following key findings are revealed through comparison: 1.) ATs of PKSs appear slower than the ones of FASs, which may reflect the different scopes of biosynthetic pathways. Fatty acids as essential compounds in all organisms are needed in high amounts for physiological functions, whereas polyketides as secondary metabolites only require basal concentrations to take effect. 2.) The slower ATs from modular PKSs do not load non-native substrates even in absence of the native substrates. This is different to the faster ATs from iterative PKSs and FASs, which indicates high substrate specificity solely for the ATs from modular PKSs and emphasizes their role as gatekeepers in polyketide synthesis. 3.) The substrate selectivity can emerge in either the first or the second step of the AT-mediated ACP loading and is not assured by a hydrolytic proofreading function.
Moreover, a mutational study on the AT-ACP interaction in the modular PKS 6-deoxyerythronolide B synthase (DEBS) shows that single surface point mutations can influence AT-mediated reactions in a complex manner. Data reveals high enzyme kinetic plasticity of the AT-ACP interaction, which was also recently demonstrated for the interaction in a type II FAS.
Based on these findings, the mammalian FAS is engineered towards a modular PKS-like as- sembly line with the long-term goal to rationally synthesize new products. Basically, three important aspects need to be considered: 1.) AT’s loading needs to be splitted in specific loading of a priming substrate by a priming AT and in specific loading of an elongation substrate by an elongation AT. 2.) FAS-based elongation modules need to be designed with varying domain compositions for introducing functional groups in the product. 3.) Covalent and non-covalent linkers need to be designed for connection of priming and elongation modules.
This study focuses on the first aspect, splitting loading of priming and elongation substrates. An elongation substrate-specific AT is installed in the mammalian FAS via domain swapping. Since ATs from modular PKSs were proven to be substrate specific, these are used to exchange the mammalian FAS AT. This work demonstrates that it is extremely challenging to create stable and functional chimeras, but first essential steps are taken. Proper domain boundaries for AT swapping are established and a stable chimera with 70 % wild type AT activity is created. However, this chimera is only of limited value for application in an elongation module due to the intrinsic slow turnover rate of the wild type AT. Using another PKS AT, a stable elongation module is designed and analyzed in its activity in combination with a priming module. These experiments demonstrate that the loading of priming substrates are successfully suppressed in the elongation module, but nonetheless only minor turnover rates are detected in the assembly line.
...
Bacteria are true artists of survival, which rapidly adapt to environmental changes like pH shifts, temperature changes and different salinities. Upon osmotic shock, bacteria are able to counteract the loss of water by the uptake of potassium ions. In many bacteria, this is accomplished by the major K+ uptake system KtrAB. The system consists of the K+-translocating channel subunit KtrB, which forms a dimer in the membrane, and the cytoplasmic regulatory RCK subunit KtrA, which binds non-covalently to KtrB as an octameric ring. This unique architecture differs strongly from other RCK-gated K+ channels like MthK or GsuK, in which covalently tethered cytoplasmic RCK domains regulate a single tetrameric pore. As a consequence, an adapted gating mechanism is required: The activation of KtrAB depends on the binding of ATP and Mg2+ to KtrA, while ADP binding at the same site results in inactivation, mediated by conformational rearrangements. However, it is still poorly understood how the nucleotides are exchanged and how the resulting conformational changes in KtrA control gating in KtrB is still poorly understood.
Here,I present a 2.5-Å cryo-EM structure of ADP-bound, inactive KtrAB, which for the first time resolves the N termini of both KtrBs. They are located at the interface of KtrA and KtrB, forming a strong interaction network with both subunits. In combination with functional and EPR data we show that the N termini, surrounded by a lipidic environment, play a crucial role in the activation of the KtrAB system. We are proposing an allosteric network, in which an interaction of the N termini with the membrane facilitates MgATP-triggered conformational changes, leading to the active, conductive state.
Chronic inflammation is considered to be a cause of the autoimmune diseases such as rheumatoid arthritis, Alzheimer’s disease, multiple sclerosis, etc. The search for effective compounds with anti-inflammatory properties to combat these diseases is still ongoing. Natural compound narciclasine, derived from plants of Narcissus species, demonstrated its anti-inflammatory activity in in vivo arthritis models. Further investigation of narciclasine’s anti-inflammatory activity together with its impact on the interaction between leukocytes and endothelial cells was the main focus of this PhD thesis.
Narciclasine reduced the infiltration of monocytes and neutrophils to the abdomen and the concentration of the pro-inflammatory cytokines TNF, IL-6 and IL-1β. Together with this, it reduced acute visceral pain caused by zymosan injection. Narciclasine interfered with leukocyte-endothelial cell interaction in both in vivo and in vitro models. In vivo microscopy revealed that the compound reduced rolling, adhesion and transmigration of leukocytes in the vessels of an injured murine cremaster muscle. This observation was confirmed in the in vitro models for adhesion and transmigration where narciclasine reduced the level of leukocyte’s interaction with HUVECs. Narciclasine demonstrated profound anti-inflammatory properties based on its interference with leukocyte-endothelium interaction by downregulation of endothelial cell adhesion molecules expression (ICAM-1, VCAM-1, E-selectin, CX3CL1) and shutdown of NF-κB pathway. All these effects were a result of the TNF receptor 1 protein translation blocking by narciclasine.
In this work the ability of the compound to reduce visceral pain, downregulate the expression of the endothelial cell adhesion molecules and to interfere with the interaction between leukocytes and endothelial cells was demonstrated for narciclasine for the first time. Obtained results open a promising insight into the understanding of narciclasine’s anti-inflammatory properties and justify further investigation of its potential for treatment of inflammatory diseases.
Electron microscopy (EM) demarcates itself from other structural biology techniques by its applicability to a large range of biological objects that spans from whole cells to individual macromolecules. In single-particle cryo-EM, frozen-hydrated samples, prepared by vitrification with liquid ethane, retain macromolecules in a medium that approximates their natural aqueous environment and that, in this way, preserves high-resolution structural information. Nonetheless, the sensitivity of biological specimens to the high-energy electron beam introduces restrictions on the total dose that can be used during imaging while avoiding significant radiation damage. Consequently, the signal-to-noise ratio attained in each individual image is very low, and structures with high-resolution detail must be recovered by averaging thousands of projections in random orientations. This is achieved through the use of image processing algorithms capable of aligning and classifying particle images through the evaluation of cross-correlation functions between each particle and a reference.
In recent years, several innovations took place in the field of single-particle cryo-EM, among which the development of direct electron detectors must be highlighted. Direct electron detectors have a better detective quantum efficiency (DQE) than both photographic film and CCD cameras, and offer a fast readout, compatible with the acquisition of movie stacks. Additionally, new image processing software has become available, with more sophisticated algorithms and designed to take advantage of the specific characteristics of the movies produced with direct electron detectors. These technological advances in both hardware and software catalyzed a revolution in single-particle cryo-EM, which is now routinely used for the determination of near-atomic structures. As a result, the range of macromolecules accessible to cryo-EM has increased drastically, as targets that were unsuitable before for imaging due to their small dimensions can now be adequately visualized and refined to high-resolution.
During my doctoral work, I have used single-particle cryo-EM to structurally characterize challenging membrane proteins, with a strong emphasis on protein complexes from aerobic respiratory chains. In chapter I of this thesis, I present my results on the bovine respirasome, a mitochondrial supercomplex composed of complexes I, III and IV. Chapter II is dedicated to the analysis of the structure of alternative complex III (ACIII) from Rhodothermus marinus, a bacterial quinol:cytochrome c/HiPIP oxidoreductase unrelated to the canonical cytochrome bc1 complex (complex III). In addition, in chapter III I describe the structure of KimA, a high-affinity potassium transporter that drives the transport of its substrate by using the energy stored in the form of a proton gradient. These three membrane proteins, with molecular weights ranging from 140 kDa to 1.7 MDa, illustrate the possibilities and limitations faced in single-particle cryo-EM.
The aerobic respiratory chain is responsible for the generation of a transmembrane difference of electrochemical potential that is then used by ATP synthase for the production of ATP or for driving solute transport over the membrane. They catalyze the transfer of electrons from a substrate, such as NADH or succinate, to molecular oxygen and use the chemical energy released in these redox reactions to drive the translocation of protons, or in some cases sodium ions, to the intermembrane space in mitochondria or the periplasm in bacteria.
In mitochondria, the respiratory chain is composed of four complexes: complex I (NADH:ubiquinone oxidoreductase), complex II (succinate dehydrogenase), complex III (cytochrome bc1 complex) and complex IV (cytochrome c oxidase). While it was for a long time believed that these complexes existed as single entities in the membrane, the use of milder procedures for protein purification and analysis revealed that respiratory complexes associate into well-ordered structures, known as supercomplexes. These have been proposed to offer different structural and functional advantages that are still controversial, including substrate channeling, stabilization of individual complexes and reduction of reactive oxygen species (ROS) production. The most thoroughly studied respiratory supercomplex has been the respirasome, conserved in higher eukaryotes and composed of one copy of complex I, a complex III dimer and one complex IV. By single-particle cryo-EM analysis, I retrieved a 9 Å map of the respirasome from Bos taurus, which allowed the accurate docking of atomic models of the three component complexes. The structure shows that complex III associates to the concave side of the membrane arm of complex I, while complex IV is located between the end of the complex I hydrophobic arm and complex III. Several defined protein-protein contacts are observed between the component complexes, which are mediated predominantly by supernumerary subunits and close to the membrane surfaces. The interactions established between complex I and complex III are extensive and may support the argument that the association of complex I into supercomplexes is required for the stabilization or even the biogenesis of this complex.
...
The transcriptional regulator RcsB controls the expression of a minimum of 20 different genes having diverse functionalities and biosynthetic operons in the family of Enterobacteriaceae. While in the heterodimeric complex with the co activator RcsA, the RcsAB box consensus is recognized, DNA binding sites for RcsB without RcsA have also been identified. The conformation of RcsB might therefore be modulated upon interaction with various co activators, resulting in recognition of different DNA targets. In this study the interaction of RcsB with some of these DNA targets have been analysed by a diverse array of techniques including gel shift assay and SPR. The solution structure of the C-terminal DNA-binding domain of RcsB from Erwinia amylovora spanning amino acid residues 129-215 has been solved in this study by heteronuclear NMR spectroscopy. The C-terminal domain is composed of four α-helices where the two central helices of the H-T-H motif are similar to the structures of the regulatory proteins GerE, NarL and TraR. The DNA-binding activity of the C-terminal domain alone is established for the first time in this study and was specified by fluorescence spectroscopy, SPR and NMR titration experiments. The molecular interaction between the individual RcsB domains was analysed by cross-linking experiments and heteronuclear NMR spectroscopy and the amino acid residues of the C-terminal domain involved in this interaction were identified precisely. Another important part of this project was the cell-free production of different Trp analogue labelled RcsB protein. RcsB protein was produced in quite a good yield with different Trp analogue having spectrally enhanced properties. The isolated RcsB alloproteins proved to be ideal for protein interaction studies by fluorescence spectroscopy and the very first evidence of an oligomerization of RcsB due to molecular association has been put forth from these studies. The phosphorylated state of the RcsB protein was mimicked by a beryllofluoride complex in order to study its role in transcriptional regulation. It was found that RcsB alone could bind to DNA targets upon this modification by the beryllofluoride complex. Thus the phosphorylation of the protein that involves the Asp 56 residue induces a structural change of the protein followed probably by a domain movement also, so that the C-terminal domain having the H-T-H DNA binding motif that was previously eclipsed by the N-terminal domain is relieved of this constraint.
Structural biology often employs a combination of experimental and computational approaches to unravel the structure-function paradigm of biological macromolecules. This thesis aims to approach this combination by the application of Pulsed Electron-Electron Double Resonance (PELDOR/DEER) spectroscopy and structural modelling. In this respect, PELDOR spectroscopy in combination with site-directed spin labelling (SDSL) of proteins is frequently used to gain distance restraints in the range from 1.8 to 8 nm. The inter-spin distance and the flexibility of the spin labelled protein domains are encoded in the oscillation and the dampening of the PELDOR signal. The intrinsic flexibility of the commonly used MTSSL (1-Oxyl-2,2,5,5-tetramethylpyrroline-3-methyl) spin label itself can be an obstacle for structural modelling if the flexibility of the label is large compared to the flexibility of the protein domains. In this thesis the investigation of two multi-domain proteins by the 4-pulse PELDOR sequence is presented. At first, the N-terminal polypeptide transport-associated (POTRA) domains of anaOmp85, a rigid three domain protein, giving well-defined PELDOR distance restraints, is investigated. The experimental restraints are used for structure refinement of the X-ray structure and reveal a strong impact of the intrinsic flexibility of MTSSL on the accuracy of structural refinement. The second example, K48-linked diubiquitin, is a highly flexible multi-domain protein on which the flexibility of MTSSL is of minor impact on structural modelling. In this case, the distance restraints are utilized to determine conformational ensembles. Due to the high intrinsic flexibility already characterizing diubiquitin the recently developed 7-pulse Carr-Purcell (CP) PELDOR sequence was applied to investigate longer ubiquitin chains. This sequence enables to measure dipolar oscillations with an extended time window, allowing a good separation between inter- and intramolecular contributions even for long distance and broad conformational distributions, thereby providing an increased accuracy of the obtained distance distributions.
Pretubulysin (PT), a biosynthetic precursor of the myxobacterial compound tubulysin D, was recently identified as a novel microtubule-targeting agent (MTA) causing microtubule destabilization. MTAs are the most frequently used chemotherapeutic drugs. They are well studied regarding their direct cytotoxic effects against various tumors as well as for their anti-angiogenic and vascular-disrupting action addressing endothelial cells of the tumor vasculature. However, the impact of MTAs on endothelial cells of the non-tumor vasculature has been largely neglected, although tumor cell interactions with the healthy endothelium play a crucial role in the process of cancer metastasis. Besides their use as potent anti-cancer drugs, some MTAs such as colchicine are traditionally used or recommended for the therapy of inflammatory diseases. Here, too, the role of endothelial cells has been largely neglected, although the endothelium is crucially involved in regulating the process of inflammation.
In the present study, the impact of PT on tumor-endothelial cell interactions was therefore analyzed in vitro to gain insights into the mechanism underlying its anti-metastatic effect that was recently confirmed in vivo. In the second part of this work, the influence of PT and other MTAs, namely the microtubule-destabilizing compounds vincristine (VIN) and colchicine (COL) and the microtubule-stabilizing drug paclitaxel (PAC), on leukocyte-endothelial cell interactions was investigated in vitro and in vivo (only PT). It is important to mention that in all in vitro experiments solely endothelial cells and not tumor cells or leukocytes were treated with the MTAs to strictly focus on the role of the endothelium in the action of these compounds.
The impact of PT on tumor-endothelial cell interactions was analyzed in vitro by cell adhesion and transendothelial migration assays as well as immunocytochemistry using the breast cancer cell line MDA-MB-231 and primary human umbilical vein endothelial cells (HUVECs). The treatment of HUVECs with PT increased the adhesion of MDA cells onto the endothelial monolayer, whereas their transendothelial migration was reduced by the compound. Thereafter, the influence of PT on the endothelial cell adhesion molecules (CAMs) E-selectin, N-cadherin, ICAM-1, VCAM-1 and galectin-3 and on the CXCL12/CXCR4 chemokine system was examined, since they might be involved in the PT-triggered tumor cell adhesion. Interestingly, although PT induced the upregulation of ICAM-1, VCAM-1, N-cadherin and CXCL12, cell adhesion assays using neutralizing antibodies or the CXCL12 inhibitor AMD3100 revealed that all these molecules were dispensable for the PT-evoked tumor cell adhesion. As PT induces the formation of interendothelial gaps and MDA cells might adhere onto components of the underlying extracellular matrix (ECM), the precise location of MDA cells attached to the PT-treated endothelial monolayer was investigated. Instead of a direct interaction between tumor and endothelial cells, this work showed that MDA cells preferred to adhere to the ECM component collagen that was exposed within PT-triggered endothelial gaps. Both the PT-evoked increase in tumor cell adhesion onto and the decrease in trans-endothelial migration were completely abolished when β1-integrins were blocked on MDA cells. Similar results were obtained when endothelial cells were treated with VIN and COL but not PAC, indicating that the observed effects of PT depend on its microtubule-destabilizing activity.
The impact of PT, VIN, COL and PAC on leukocyte-endothelial cell interactions was analyzed in vivo (only PT) by intravital microscopy of the mouse cremaster muscle and in vitro by cell adhesion assays using the monocyte-like cell line THP-1 and TNFα-activated human dermal microvascular endothelial cells (HMEC-1). While PT did not affect the rolling of leukocytes on the endothelium, their firm adhesion onto and transmigration through the activated endothelium was reduced by PT in vivo. In accordance, the treatment of HMEC-1 with PT, VIN and COL decreased the TNFα-induced adhesion of THP-1 cells onto the endothelial monolayer, whereas PAC had no influence on this process. Thereafter, the influence of PT, VIN, COL and PAC on endothelial ICAM-1 and VCAM-1 was examined, since these molecules are substantially involved in the firm adhesion of leukocytes onto the endothelium. The cell surface protein expression of ICAM-1 and VCAM-1 was reduced by PT, VIN and COL in activated endothelial cells, whereas PAC did only slightly affect the TNFα-induced upregulation of VCAM-1. As the pro-inflammatory transcription factor NFκB plays a crucial role in the TNFα-induced expression of these CAMs, the impact of the MTAs on the NFκB promotor activity was investigated. While PT, VIN and COL decreased the activation of NFκB in activated endothelial cells, PAC did not affect this process. However, in contrast to the strong effects regarding the cell surface protein expression of ICAM-1 and VCAM-1, the effects of PT, VIN and COL on the NFκB activity was rather low. Thus, the used MTAs might also affect other relevant signaling pathways and/or the intracellular transport of CAMs might be influenced by the impact of the MTAs on the microtubule network.
Taken together, the current study provides – at least in part – an explanation for the anti-metastatic potential of PT and gives first insights into the use of PT and VIN as anti-inflammatory drugs. Moreover, this work highlights the endothelium as an attractive target for the development of new anti-cancer and anti-inflammatory drugs.
Investigation of co-translational protein folding using cryo-EM and solid-state NMR enhanced by DNP
(2020)
Die zelluläre Proteinbiosynthese findet am Peptidyltransferase-Zentrum innerhalb der großen ribosomalen Untereinheit statt. Die neu synthetisierte Polypeptidkette passiert den ribosomalen Exit-Tunnel, der 80-100 Å lang und 10-20 Å breit ist. Proteinfaltung findet kotranslational statt, während die Peptidkette durch den ribosomalen Tunnel geschleust wird. Zu welchem Ausmaß die Proteine ihre native Struktur noch am Ribosom gebunden annehmen, steht im Fokus aktueller Studien. Verschiedene Methoden, die naszierende Proteinkette am Ribosom zu arretieren und die Faltung des Proteins untersuchen zu können, wurden entwickelt. Zur Herstellung von Ribosom naszierenden Proteinkomplexen (RNCs) in vivo werden Arrestierungspeptide (APs) verwendet. Ein oft genutztes AP ist die 17 Aminosäuren lange SecM Sequenz des E. coli Sekretionsmonitors, das C-Terminal an das zu untersuchende Protein kloniert werden kann und dadurch die Peptidkette am Ribosom behält. RNCs wurden mittels verschiedener Methoden untersucht, einschließlich Proteolyse-Experimenten, enzymatischen Aktivitätsmessungen, FRET, Cryo-EM und NMR-Spektroskopie. Alle Methoden zeigten auf, dass sich die Proteine kotranslational falten und auch am Ribosom eine funktionale Struktur annehmen können. Außerdem konnte eine Peptidkette eine α-Helix innerhalb des Ribosoms ausbilden. Ebenso wurden nicht-native kompakte Strukturen innerhalb der Vestibule detektiert.
Die Translation ist ein nicht-uniformer Prozess und der genetische Code degeneriert mit bis zu sechs Codons, die eine einzelne Aminosäure kodieren. Die Verteilung dieser synonymen Codons ist nicht zufällig und sie werden mit verschiedenen Frequenzen innerhalb eines ORFs verwendet. Codons mit einer höheren tRNA Häufigkeit werden schneller eingebaut als Codons, die seltener verwendet werden. Diese seltenen Codons sind häufig zwischen Proteindomänen oder Sekundärstrukturelementen platziert und könnten daher zur Separierung von Faltungsevents dienen. Dass der Austausch von synonymen Codons nicht ohne Folgen ist, zeigten verschiedene Studien. Buhr et al. (2016) zeigte, dass der synonyme Austausch die Translationsgeschwindigkeit, aber auch die Proteinkonformation des bovinen Augenlinsenproteins γB crystallin (GBC) beeinflusst. Während die unmodifizierte Gensequenz aus B. taurus in E. coli langsamer translatiert wurde und zu einem vollständig reduzierten GBC Protein (U) führte, wurde die harmonisierte Genvariante, die der Codon-Verwendung in E. coli angepasst war, schneller exprimiert und resultierte in einem teilweise oxidierten GBC Protein (H). Dieser Befund war der Ausgangspunkt für diese Doktorarbeit.
Die gemessenen Oxidationsunterschiede basieren auf der unterschiedlichen Translationsgeschwindigkeit der beiden Gensequenzen. Die N-terminale Domäne (NTD) des Zweidomänen-Proteins GBC enthält sechs der insgesamt sieben Cysteinreste. Nur in dieser Domäne wurde Oxidation detektiert und die drei Cysteine Cys18, Cys22 und Cys78 bilden eine Ansammlung mit einem Abstand von 5.4-6.4 Å. Um zu untersuchen, ob die Unterschiede bereits nach der Translation der NTD ausgebildet werden, wurde ein Ein-Domänen-Konstrukt hergestellt. Dieses Konstrukt beinhaltete die Aminosäuren 1-82, aber nicht den Peptidlinker, der beide Domänen verbindet. Allerdings wurden bei der Translation der ersten 70 Aminosäuren die meisten Translationspausen detektiert. Das 2D 1H-15N HSQC wies anhand der unterschiedlichen chemischen Verschiebung der Signale auf eine gefaltete Proteinstruktur hin. Daher konnte sich die NTD ohne Beteiligung der CTD eigenständig falten. Zugabe von DTT zu beiden Proteinvarianten U und H führte zu keinem messbaren Effekt. Im Gegensatz zu dem Volllängen-Protein, in dem die Variante H teilweise oxidiert war, war die NTD der Variante H vollständig reduziert.
Zusätzlich sollte geklärt werden, ob auch mögliche Disulfidbrücken im Inneren des Ribosoms ausgebildet werden können. Dann könnte in beiden Genvarianten eine anfängliche Disulfidbrücke ausgebildet werden und durch die unterschiedliche Translationsgeschwindigkeit die Disulfidbrücke in der langsamen Genvariante im E. coli Zytosol reduziert werden, während diese in der schneller translatierten Variante von der CTD geschützt wird. Um zu untersuchen, ob in der Tat Disulfidbrücken im ribosomalen Tunnel ausgebildet werden können, wurden GBC-Fragmente mittels der SecM Sequenz an das Ribosom arretiert und diese RNCs mittels theoretischer Simulation, Festkörper-NMR, Massenspektrometrie und Cryo-EM gemessen.
Theoretische Simulation mittels flexible-mecanno zeigten, dass der ribosomale Tunnel groß genug für die Ausbildung verschiedenster Disulfidbrücken ist. In einem U32SecM Konstrukt, das vier Cysteine und die SecM Sequenz beinhaltet, konnten alle theoretisch möglichen Disulfidbrücken gebildet werden.
...
This PhD thesis is dedicated to the extension of the portfolio of nuclear magnetic resonance (NMR) methods to characterize ribonucleic acids (RNAs). Only within the last few decades it has been realized that the cellular role of RNA goes well beyond the central dogma of molecular biology. In fact, RNA takes part in numerous cellular processes, executes numerous functions and acts either as a single player or in larger complexes, mostly RNA-protein complexes (RNPs) such as the ribosome or the spliceosome. This versatility in RNA function is coupled to a structural variety and the ability to adopt multiple long-lived and intricate conformations. Due to this high molecular complexity special demands are placed on the methods that are required for RNA structural characterization. With the ability to capture dynamics at atomic resolution and to measure under close to native conditions, NMR spectroscopy is undoubtedly a prime method for this purpose.
A general introduction to the current state of research, selected achievements as well as challenges in the field of NMR spectroscopy on RNA is given in Chapter I. This thesis is further composed of three independent chapters covering the three separate projects, which form the main body of work within the course of this thesis.
The imino group found in two of the four RNA nucleobases is generally considered to be the most powerful reporter group in the process of the NMR spectroscopic characterization of RNA. Its resonance assignment provides key information for a rapid determination of the RNA’s secondary structure. This is possible, since the imino proton can only be detected, if it is protected from rapid solvent exchange through hydrogen bonding interactions or, in rare cases, steric shielding. Consequently, information on flexible regions of RNA that are not protected against solvent exchange cannot be derived using this NMR spy. It is a key finding of the thesis that nucleobase interactions can also be mapped through the amino groups, as they similarly take part in base pairing or RNA-ligand interactions. Notably, solvent exchange of the amino protons is always slower compared to the imino proton. Thus, 1H,15N resonances of the amino group can be detected even for dynamic regions of RNA. Moreover, focusing on characterizing amino groups of RNA nucleobases increases the number of available reporters as amino groups are present in three out of four RNA nucleobases.
However, there is a reason that up to work conducted in this thesis, amino groups have not been used for monitoring RNA nucleobases: the rate of the C-NH2 bond rotation is most often close to the chemical shift differences of the two non-identical amino proton resonances, in particular for guanosines and adenosines, amino resonances regularly remain elusive in NMR spectra. Therefore, we developed experiments that excite double quantum (DQ) coherences of the two amino group protons and that further utilize 13C-detection. Results on these experiments are discussed in Chapter II and show that the rotational exchange can be avoided by evolving double quantum instead of single quantum (SQ) coherence in the indirect dimension of a 13C-detected C(N)H-HDQC experiment. The new experiment enables the detection of a full set of sharp amino resonances. The advantages of this experiment are immediately apparent when comparing the number of observable imino resonances in a classic 1H,15N-HSQC spectrum with the number of amino resonances obtained in the 13C-detected C(N)H-HDQC spectrum of the same RNA.
Furthermore, based on the newly available resonance assignment of amino groups, we developed a 13C-detected “amino”-NOESY experiment to obtain precious additional structural restraints. The 13C-detected “amino”-NOESY experiment enables the observation of NOE contacts that are not accessible using other 1H-detected NOESY experiment. Among these new NOE contacts are valuable, inter-residual correlations, which are otherwise scarce in RNA due to the proton deficiency of its nucleobases. We showed that the newly obtained NOE contacts are especially important in the structure determination of RNAs with only few NOE restraints. Under such circumstances, the inclusion of the newly obtained amino NOE contacts lead to a significant improvement in the root-mean-square deviation (RMSD) of the three-dimensional structure of the 34 nts GTP class II aptamer. Together the novel 13C-detected NMR experiments developed within this PhD project provide a valuable alternative for the imino-based characterization of nucleobase interactions.
...
This dissertation contains two chapters. Each chapter covers a unique topic within RNA sci-ence and is divided in two sub sections, part A and B. Each chapter contains an introduction.
Chapter 1 gives an insight into challenges encountered during sample design and preparation for single molecule Förster energy transfer (smFRET) spectroscopy and offers a solution via a newly establishedestablished workflow to obtain accurate smFRET constructs. Following this workflow, a FRET network could be generated, which allowed a detailed structural dynamics study on H/ACA RNP during catalysis with smFRET spectroscopy. This led to detailed mech-anistic insights into H/ACA RNPs dynamics during catalysis.
Chapter 2 deals with RNA synthetic biology whereby a novel eclectic design strategy for RNA of interest (ROI) release platform is presented, which allows to release a diverse ROI se-quences with single nucleotide precision triggered by an external stimulus. This design strat-egy was used to establish a ROI release system and its powerful performance in in vitro and in vivo applications was shown.
This dissertation contains two chapters. Each chapter covers a unique topic within RNA science and is divided in two sub sections, part A and B. Each chapter contains an introduction.
Chapter 1 gives an insight into challenges encountered during sample design and preparation for single molecule Förster energy transfer (smFRET) spectroscopy and offers a solution via a newly establishedestablished workflow to obtain accurate smFRET constructs. Following this workflow, a FRET network could be generated, which allowed a detailed structural dynamics study on H/ACA RNP during catalysis with smFRET spectroscopy. This led to detailed mechanistic insights into H/ACA RNPs dynamics during catalysis.
Chapter 2 deals with RNA synthetic biology whereby a novel eclectic design strategy for RNA of interest (ROI) release platform is presented, which allows to release a diverse ROI sequences with single nucleotide precision triggered by an external stimulus. This design strategy was used to establish a ROI release system and its powerful performance in in vitro and in vivo applications was shown.
The enzyme 5-lipoxygenase (5-LO) occupies a central role in the biosynthesis of inflammatory leukotrienes and thus takes part in the pathogenesis of related diseases. Its occurrence is mainly restricted to cells of the immune system including granulocytes, monocytes/macrophages or B-lymphocytes and can be induced by cell differentiation of myeloid cells after treatment with differentiating agents, such as DMSO, retinoic acid or the combination of TGFβ/1,25(OH)2D3. The latter contribute to the highest level of induction of mRNA and protein expression. Its cell specific occurrence is at least partly due to DNA methylation in cells that do not exhibit 5-LO activity and genetic regulation is further dependent on histone acetylation. 5-LO expression is controlled by transcription factors binding to the promoter sequence of the ALOX5 gene that induce basal promoter activity, as well as promoter independent effects including transcript initiation and elongation, which are mostly attributed to TGFβ/1,25(OH)2D3 signaling. The ALOX5 gene resembles a typical housekeeping gene, hence lacks TATA- or CAAT-boxes for transcriptional regulation, but displays a high GC-content with eight GC-boxes, five of which are arranged in tandem, that provide binding sites for transcription factors Sp1, Sp3 and Egr-1.
The proximal ALOX5 promoter is furthermore a target for additional factors, such as TGFβ effector proteins SMADs or the vitamin D receptor and possesses additional consensus sequences for transcriptional regulators, including NF-κB or PU.1. However, as yet no actual binding of these proteins to the promoter sequence was demonstrated and an unbiased screening for identifying further ALOX5 promoter interacting proteins, which might have impact on 5-LO expression, is still lacking. For this purpose, the present study focused on the identification of significantly interacting proteins, employing DNA-affinity enrichment coupled to label-free quantitative proteomics, spanning a sequence of about 270 base pairs of the proximal ALOX5 promoter. For the elucidation of potential cell specific differences in protein patterns and compositions, DNA pulldowns were performed by using oligonucleotide stretches comprising the core promoter sequence including the 5-fold GC-box, which were incubated with different cell lines and differentiation states of myeloid, as well as B-lymphocytic lineages. In order to compare different mass spectrometric quantification strategies that would allow for identification of interactors, dimethyl labeling and label-free techniques were used. Since the label-free approach outperformed the label-based one in initial experiments, it was established as standard quantification strategy in all DNA pulldowns performed. The pulldowns of myeloid cell lines in both undifferentiated and differentiated state and B-lymphocytes resulted in a cell-unspecific protein pattern whose composition was similar, regardless of cell lineage. Additionally, further DNA sequences comprising either a vitamin D response element or a SMAD binding element were investigated in the promyelocytic model cell line HL-60 in both undifferentiated and differentiated state. The identified proteins confirmed known interaction partners and furthermore revealed novel potential regulators of the 5-LO promoter. Out of these, the most prominently identified and promising proteins included transcription factors of the KLF- and CCAAT/enhancer binding protein-family. In this context, KLF5 and KLF13 are both involved in the regulation of inflammatory processes, the former additionally being an effector protein of TGFβ-signaling, whose functional characterization is of utmost interest in terms of regulation of 5-LO expression. Further protein characterization will be inevitable for the CCAAT/enhancer binding proteins C/EBPα, C/EBPβ and C/EBPε. These transcription factors are involved in the regulation of inflammatory processes and heterodimers thereof (C/EBPα/β) are known to control TGFβ/1,25(OH)2D3-mediated effects of the CD14 gene.
Several of the identified proteins of the pulldowns containing the tandem GC-box represented interactors of G-quadruplex DNA, including the helicases BLM and DHX36, the ribonucleoproteins hnRNP D and hnRNP K and transcription factor MAZ. Since G-quadruplexes form in G-rich DNA sequences as secondary DNA structures and exhibit substantial regulatory effects on the transcription of their target genes, the potential formation thereof in the ALOX5 core promoter sequence was investigated in a second project. Out of the proteins mentioned above, MAZ is shown to exert resolving effects on G4-DNA and synergistically induce Sp1-dependent gene activation of oncogene h-RAS, which displays analogous promoter characteristics to the ALOX5 gene. A DNA stretch comprising the tandem GC-box was used for elucidating the potential of secondary DNA structure formation. Intriguingly, both immune-based and spectroscopic methods provided clear evidence for the in vitro G-quadruplex formation of the proximal promoter sequence for the first time. In order to provide additional information on a possible regulatory effect of existing G-quadruplex structures on 5-LO transcription, differentiated HL-60 cells were subsequently treated with two distinct G4-DNA stabilizing agents. A porphyrin analogon (TMPyP4) did not exhibit any effects on 5-LO mRNA and protein expression after cell treatment. A second G4-DNA stabilizing agent (pyridostatin) on the other hand revealed significant reduction on 5-LO protein expression after cellular treatment. These mixed results render further experiments inevitable, in order to provide a clear assertion as to whether 5-LO expression is regulated by G-quadruplex structures or not.
Altogether, this study enlarges the knowledge of ALOX5 proximal promoter interacting proteins by corroborating the binding of already known transcription factors and identifying novel interactors. It yields essential groundwork for subsequent functional studies of proteins involved in 5-LO transcription and introduces G-quadruplexes as a new potential mechanism in ALOX5 gene regulation.
Mechanism of the MHC I chaperone TAPBPR and its role in promoting UGGT1-mediated quality control
(2022)
Information about the health status of most nucleated cells is provided through peptides presented on major histocompatibility complex I (pMHC I) on the cell surface. T cell receptors of CD8+ T cells constantly monitor these complexes and allow the immune system to detect and eliminate infected or cancerous cells. Antigenic peptides displayed on MHC I are typically derived from the cellular proteome and are translocated into the lumen of the endoplasmic reticulum (ER) by the ATP-binding cassette (ABC) transporter associated with antigen processing (TAP), which is part of the peptide-loading complex (PLC). In a process called peptide editing, the MHC I-dedicated chaperone tapasin (Tsn) selects peptides for their ability to form stable complexes with MHC I. While initial peptide loading is catalyzed in the confines of the PLC, the second quality control is mediated by TAPBPR, operating in the peptide-depleted cis-Golgi network. TAPBPR was shown to have a more fine-tuning effect on the presented peptide repertoire rather than initial peptide selection. The fundamental mechanism of peptide editing was illuminated by two crystal structures of TAPBPR in complex with peptide-receptive MHC I. Notably, one of these structures reported a structural element that inserted into the peptidebinding pocket. The so-called scoop loop was assumed to be involved in mediating peptide exchange but the underlying mechanism remained undefined. Additionally, latest results suggested that TAPBPR mediates the interaction of the glucosyltransferase UGGT1 with peptide-receptive MHC. To expand the current knowledge of quality control processes in the antigen presentation pathway, the contribution of the scoop loop in peptide editing and the role of TAPBPR in UGGT1-mediated quality control needs to be elucidated. In the first part of this study, TAPBPR proteins with various loop lengths were designed to scrutinize the contribution of the scoop loop in chaperoning peptidereceptive MHC I. In a light-driven approach, the ability of TAPBPR variants to form stable complexes with peptide-free MHC I was tested. These results demonstrated that in a peptide-depleted environment, the scoop loop is of critical importance for TAPBPR to chaperone intrinsically unstable, peptidereceptive MHC I clients. Moreover, fluorescence polarization-based assays allowed the pursuit of peptide exchange in different, native-like environments. Peptide displacement activities of TAPBPR variants illustrated that catalyzed peptide editing is primarily induced by structural elements outside the scoop loop. In a peptide-depleted environment, the scoop loop occupies the position of the peptide C-terminus and acts as an internal peptide surrogate. By combining complex formation and fluorescence polarization experiments, the scoop loop of TAPBPR was shown to be critically important in stabilizing empty MHC I and functions as an internal peptide selector. In the second part of this study, a novel in-vitro glucosylation assay was established to examine the role of TAPBPR in UGGT1-catalyzed re-glucosylation of TAPBPR-bound MHC I clients. Therefore, a peptide-free MHC I-TAPBPR complex with defined glycan species was designed which served as physiological substrate for UGGT1. By subjecting the recombinantly expressed HLA-A*68:02- TAPBPR complex and UGGT1 proteins to the new in-vitro system, UGGT1 was shown to catalyze the transfer of a glucose residue to the N-linked glycan of TAPBPR-bound Man9GlcNAc2-HLA-A*68:02. Moreover, a high-affinity, photocleavable peptide was applied to dissociate the MHC I-chaperone complex. However, in the absence of TAPBPR, no glucosyltransferase activity was observed. Generation of peptide-free MHC I through UV illumination also showed no activity, and only the addition of TAPBPR could restore UGGT1-mediated reglucosylation of the empty MHC I. Independent of the peptide status of HLAA*68:02, the combination of protein glycoengineering and LC-MS analysis implicated that UGGT1 exclusively acts on TAPBPR-chaperoned HLA-A*68:02. The newly established system provided insights into the function of TAPBPR during UGGT1-catalyzed re-glucosylation activity and quality control of MHC I. Taken together, the scoop loop allows TAPBPR to function as MHC I chaperone through stabilizing peptide-receptive MHC I. In a peptide-depleted environment, the loop structure serves as an internal peptide surrogate and can only be dislodged by a high-affinity peptide. Based on these findings, TAPBPR fulfills a dual function in the second level of quality control. On the one hand, TAPBPR functions as peptide editor, shaping the repertoire of presented peptides. On the other hand, TAPBPR mediates peptide-receptive MHC I clients to the folding sensor UGGT1. Here, TAPBPR is essential to promote UGGT1-catalyzed reglucosylation of the N-linked glycan, giving MHC I a second chance to be loaded with an optimal peptide cargo in the peptide loading complex.
Zika virus (ZIKV) is a member of the Flaviviridae family that received public attention and scientific interest after the outbreak in French Polynesia (2013-2014) and the epidemic in the Americas (2015-2016). Even though only 20% of infected people exhibit clinical manifestations and they are predominantly flu-like symptoms, these events unveiled neurological complications associated with ZIKV infection, such as the Guillain-Barré syndrome in adults and microcephaly in newborns. Lacking a preventive vaccine and a specific antiviral therapy against ZIKV allied to the fact that this pathogen is a re-emerging virus, uncovering and comprehending novel virus-host interactions is crucial to the identification of new antiviral targets and the development of innovative antiviral approaches. Previous research work uncovered that the Chinese hamster ovary (CHO) cells do not support ZIKV infection.459 As this cell line does not express endogenous epidermal growth factor receptor (EGFR), this study aimed to investigate whether EGFR and EGFR-dependent signaling are relevant for the ZIKV life cycle in vitro.
In the first part of the study, viral infection was investigated in CHO cells and compared to A549 cells, a highly ZIKV permissive cell line. After performing binding and entry assays, ZIKV entry, but not the attachment, was significantly decreased in CHO cells in comparison to A549 cells. Additionally, in A549-EGFR KO cells, ZIKV entry was diminished relatively to the off-target control. These results show the clear impact that the absence of EGFR has on viral entry, implicating EGFR during this process. Even though EGFR overexpression in CHO cells could not render these cells permissive to ZIKV infection, as demonstrated by the lack of viral infection after electroporation with in vitro transcribed capped ZIKV-Renilla luciferase RNA, it was possible to rescue ZIKV entry. These findings suggest that there are additional elements, which are not expressed in CHO cells, required for viral replication.
Furthermore, the impact of ZIKV infection on EGFR mRNA and protein levels as well as on the EGFR subcellular localization and distribution was evaluated. The relative number of EGFR specific transcripts continuously increased with ZIKV infection, whereas the EGFR protein level diminished at later times of infection. Moreover, changes in the subcellular localization of EGFR and its colocalization with the early endosomal marker EEA1 in ZIKV-infected cells revealed that ZIKV triggers EGFR internalization. The relevance of EGFR in the ZIKV entry process was further corroborated by the observation of EGFR internalization at 30 min post-infection (mpi) and to less extent at 60 mpi, which concurs with the expected time of ZIKV entry into the host cells.
In the remaining part of the study, the influence of ZIKV infection in EGFR-dependent signaling as well as the contribution of EGFR and EGFR signaling for viral infection were studied. Activation of EGFR and the MAPK/ERK signaling cascade was detected as early as 5 mpi and ceased within 30 mpi in ZIKV-infected cells. Taking into account that EGFR internalization was observed at 30 mpi in infected cells, the activation of EGFR and ERK and subsequent dephosphorylation within this period go along with this previous observation. Vice-versa, inhibition of the activation of EGFR and the MAPK/ERK pathway declines ZIKV infection. On the one hand, inhibition of EGFR activation by Erlotinib affected ZIKV entry, as a consequence of impaired EGFR internalization. On the other hand, Raf and MEK inhibitors reduced ZIKV infection without disturbing viral replication or viral entry. These data suggest that the activation of the MAPK/ERK signaling cascade is necessary for a step of the viral life cycle before the onset of genome replication and morphogenesis and after viral entry. The importance of EGFR signaling was additionally investigated by the determination of EGFR half-life in ZIKV-infected cells upon EGF stimulation. While the EGFR half-life was similar in uninfected and Uganda-infected cells, a delay in EGFR degradation was observed in French Polynesia-infected cells. This observation might indicate an extended usurpation of the EGFR signaling since EGFR seems to still be active in the endosomes. Moreover, disruption of lipid rafts by MβCD, a cholesterol-depleting agent, hampered ZIKV entry. In uninfected cells, MβCD treatment led to the activation of EGFR, but at the same time prevented EGFR internalization, indicating that EGFR activation exclusively is not sufficient for an efficient ZIKV entry and further supporting the importance of EGFR internalization during the ZIKV entry process.
Taken together, this study uncovers EGFR as a relevant host factor in the early stages of ZIKV infection, providing novel insights into the ZIKV entry process. Since numerous monoclonal antibodies and substances that target EGFR are licensed, repurposing these compounds might be a helpful tool for the establishment of an antiviral therapy in case of ZIKV re-emergence.
The p38α mitogen-activated protein kinase (MAPK) is activated through stress stimuli such as heat shock or hypoxia. In the nucleus, p38α modulates the activity of other kinases and transcription factors, a process that regulates the expression of specific target genes, most importantly pro-inflammatory cytokines. Dysregulation of p38α therefore plays a major role in the development of inflammatory diseases such as rheumatoid arthritis. Despite many years of intensive research, no p38 small-molecule inhibitors have been approved yet. Several inhibitor design strategies have been reported, leading to >100-fold selective compounds for α/β over the γ and δ isoforms. Achieving such a selectivity among the two structurally most related α and β isoforms, however, remains a challenging task. Targeting an inactive DFG-out conformation offers another strategy for the development of potent kinase inhibitors (type-II), exemplified by the BCR/ABL-inhibitor Imatinib. Achieving selectivity with type-II binders is challenging, because many kinases can adopt an inactive DFG-out conformation. This is exemplified by the p38 type-II inhibitor BIRB-796, which exhibits picomolar on-target affinity but only a poor kinome-wide selectivity. A potent and selective type-II chemical probe for p38α/β was still lacking at the start of this thesis.
The promising hit VPC-00628, was chosen for a combinatorial synthetic approach to develop a type-II chemical probe. The studies covered the optimization of the hinge-binding head group, the hydrophobic region I and the DFG-out deep pocket of the lead compound VPC-00628. Selectivity for the p38α and p38β isoforms was monitored during the optimization process, which identified several inhibitors with favorable isoform selectivity, providing valuable insights into the potential of isoform-selective inhibitor design for p38. A potent and highly selective p38 MAPK probe (SR-318) was discovered, which showed IC50 values in the low nanomolar range in HEK293T cells. An unusual P-loop conformation induced upon binding of SR-318 to p38α contributed most likely to the impressive selectivity profile within the kinome that surpassed both the parent compound and BIRB-796. A negative control compound, SR-321, was developed, to distinguish between on-target effects and non-specific effects due to cross-reactivity with other cellular proteins. Studies of the metabolic stability in human liver microsomes revealed a high stability of the compounds, with only a small amount of metabolites formed over several hours. Compound SR-318 also exhibited a good in vitro efficacy, quantitatively reducing the LPS-stimulated TNF-α release in whole blood. Taken together, SR-318 is a highly potent and selective type-II p38α/β chemical probe, which will help to gain a better understanding of the catalytic and non-catalytic functions of these key signaling kinases in physiology and pathology.
The next studies focused on the exploration of the highly dynamic allosteric back pocket of p38 MAPK, and allosteric BIRB-796 derived compounds for targeting the αC- and DFG-out pockets were synthesized. Kinase activities of allosteric pyrazole-urea fragments were analyzed against a comprehensive set of 47 diverse kinases by differential scanning fluorimetry (DSF), revealing that BIRB-796 off-targets remain a problem when targeting this back-pocket binding motif. Revisiting the recently published compound MCP-081, which combines the allosteric part of BIRB-796 with the active-site directed part of VPC-00628, showed that it displays a clean selectivity profile in our kinase panel. Because the potency of MCP-081 was slightly reduced compared with VPC-00628 and the allosteric tert-butyl pyrazole moiety seemed suboptimal, a set of VPC-00628 derivatives for targeting the αC-out pocket region was synthesized. Through structure-guided extension of the terminal amide of VPC-00628 toward this allosteric site, the potent and selective compound SR-43 was developed, which showed excellent cellular activity on p38 MAPK in NanoBRETTM assays (IC50 [p38α/β] = 14.0 ± 0.1/ 16.8 ± 0.1 nM). SR-43 showed a dose-dependent inhibition of activating phosphorylation of p38 in HCT-15 cells as well as inhibition of phosphorylation of p38 downstream substrates MK2 and Hsp27. In addition, SR-43 induced an anti-inflammatory response by blocking TNF-α release in whole blood and displayed a high metabolic stability. Selectivity profiling of SR-43 revealed a narrow selectivity for additional targets such as the discoidin domain receptor kinases (DDR1/2). DDR kinases play a central role in fibrotic disorders, such as renal and pulmonale fibrosis, atherosclerosis and different forms of cancer. Since selective and potent inhibitors for these important therapeutic targets are largely lacking and the existing inhibitors are of low scaffold diversity, the next study focused on the optimization of SR-43 toward DDR1/2 kinase inhibition. The synthetic work covered the optimization of the hinge-binding head group and the allosteric part of SR-43 toward DDR1/2 kinase inhibition. These studies provided novel insights into the P-loop folding process of p38 MAPK and how targeting of non-conserved amino acids affects inhibitor selectivity. Importantly, they led to the development of a selective dual DDR/p38 inhibitor probe, SR-302, with picomolar affinity for DDR2. SR-302 was efficient in vitro and showed a destabilizing effect on the surface adhesion protein E-cadherin in epithelial cells. In summary, SR-302 and its negative control SR-301 provide a valuable tool set for studying the phenotypic effects of DDR1/2 signaling, e.g., in cancer cell lines.
Ubiquitination is regarded as one of the key post-translational modifications in nearly all biological processes, endowed with numerous layers of complexity. Deubiquitinating enzymes (DUBs) dynamically counterbalance ubiquitination events by deconjugating ubiquitin signals from substrates. Dysregulation of the ubiquitin code and its negative regulators drive various pathologies, such as neurological disorders and cancer.
The DUB ubiquitin-specific peptidase 22 (USP22) is well-known for its essential role in the human Spt-Ada-Gcn5 acetyltransferase (SAGA) complex, mediating the removal of monoubiquitination events from Histone 2A and 2B (H2A and -B), thereby regulating gene transcription. In cancer, USP22 was initially described as a part of an 11-gene expression signature profile, predicting tumor metastasis, reoccurrence and death after therapy in a wide range of tumor cells. However, novel roles for USP22 have emerged recently, accrediting USP22 essential roles in regulating tumor development as well as apoptotic cell death signaling.
One of the hallmarks of cancer is the evasion of cell death, especially apoptosis, a form of programmed cell death (PCD). Necroptosis, a regulated form of necrosis, is regarded as an attractive therapeutic strategy to overcome apoptosis-resistance in tumor cells, although a profound understanding of the exact signaling cascade still remains elusive. Nevertheless, several ubiquitination and deubiquitination events are described in fine-tuning necroptotic signaling.
In this study, we describe a novel role for USP22 in regulating necroptotic cell death signaling in human tumor cell lines. USP22 depletion significantly delayed TNFa/Smac mimetic/zVAD.fmk (TBZ)-induced necroptosis, without affecting TNFa-induced nuclear factor-kappa B (NF-KB) signaling or TNFa-mediated extrinsic apoptosis. Intriguingly, re-expression of USP22 wildtype in the USP22 knockout background could re-sensitize HT-29 cells to TBZ-induced necroptosis, whereas re-constitution with the catalytic inactive mutant USP22 Cys185Ser did not rescue susceptibility to TBZ-induced necroptosis, confirming the USP22 DUB-function a pivotal role in regulating necroptotic cell death. USP22 depletion facilitated ubiquitination and unexpectedly also phosphorylation of Receptor-interacting protein kinase 3 (RIPK3) during necroptosis induction, as shown by Tandem Ubiquitin Binding Entities (TUBE) pulldowns and in vivo (de)ubiquitination immunoprecipitations. To substantiate our findings, we performed mass-spectrometric ubiquitin remnant profiling and identified the three novel USP22-regulated RIPK3 ubiquitination sites Lysine (K) 42, K351 and K518 upon TBZ-induced necroptosis. Further assessment of these ubiquitination sites unraveled, that mutation of K518 in RIPK3 reduced necroptosis-associated RIPK3 ubiquitination and additionally affected RIPK3 phosphorylation upon necroptosis induction. At the same time, genetic knock-in of RIPK3 K518R sensitizes tumor cells to TNFa-induced necroptotic cell death and amplified necrosome formation.
In summary we identified USP22 as a new regulator of TBZ-induced necroptosis in various human tumor cell lines and further unraveled the distinctive role of DUBs and (de)ubiquitination events in controlling programmed cell death signaling.
The innate immune system is the first line of host defense that senses invading pathogens by various surveillance mechanisms, involving pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs). Furthermore, in response to stress, tissue injury or ischemia, cells release endogenous danger-associated molecular patterns (DAMPs) which activate PRRs in order to prompt an effective immune response. Activation of PRRs by DAMPs initiates signaling transduction pathways which drive sterile inflammation by the production of pro-inflammatory effector molecules. Biglycan, a class I small leucine-rich proteoglycan (SLRP), is proteolytically released from the extracellular matrix (ECM) in response to tissue stress and injury or de novo synthesized by activated macrophages. In its soluble form, biglycan operates as an ECM-derived DAMP and triggers a potent inflammatory response by engaging TLR2 and TLR4 on immune cells. By selective utilization of TLR2/4 and the TLR adaptor molecules adaptor molecule myeloid differentiation primary response gene 88 (MyD88) or TIR domain-containing adaptor-inducing interferon-β (TRIF) biglycan differentially regulates the production of TLR downstream mediators or inflammatory molecules. In this way, biglycan triggers the activation of mitogen-activated protein kinase (MAPK) p38, extracellular signal-regulated kinase (Erk) and nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) in a primarily MyD88-dependent manner. In contrast, biglycan induces the expression of (C–C motif) ligand (CCL)5 and chemokine (C-X-C motif) ligand (CXCL)10 over TLR4/TRIF, heat shock protein 70 (HSP70) production over TLR2 and the synthesis of tumor necrosis factor (TNF)-α, CCL2 and CCL20 by utilizing TLR2/4/MyD88. As a consequence, biglycan promotes the recruitment of immune cells such as neutrophils, T cells, B cells and macrophages into the inflamed tissue. Research over the past years showed that biglycan-induced inflammation is involved in the pathogenesis of various inflammatory diseases such as lupus nephritis (LN), sepsis and renal ischemia/reperfusion injury (IRI), whereby genetic deletion of biglycan or TLR2/4 alleviated disease outcome. Unfortunately, the selective interaction of biglycan to TLRs and TLR adaptors complicates the identification of an efficient pharmacological target in biglycan-mediated inflammation. Yet, the necessity of possible co-receptors in biglycan signaling such as cluster of differentiation 14 (CD14) which was found in a high molecular complex with biglycan was not addressed so far.
In the first part of the present study, by utilizing primary peritoneal murine macrophages we demonstrated that the biglycan-induced expression and synthesis of TNF-α and CCL2 via TLR2/4/MyD88, CCL5 through TLR4/TRIF and HSP70 over TLR2 is blunted in CD14 deficient mice, proving that CD14 is essential in TLR2- and TLR4-mediated biglycan signaling. Pre-incubation of macrophages with an anti-CD14 antibody significantly reduced the protein levels of TNF-α, CCL2, CCL5 and HSP70. In line with these data, pharmacological inhibition of CD14 alleviated the transcriptional activation of NF-κB by biglycan in HEK-Blue cells expressing hTLR2/CD14 as well as hTLR4/CD14/MD2 supporting CD14-dependency for biglycan/TLR2/4 signaling. Western blot analysis of phosphorylated p38, p44/42 and NF-κB in WT and CD14 deficient mice revealed that activation of biglycan-mediated TLR downstream signaling is CD14-dependent. Accordingly, biglycan-induced activation and nuclear translocation of p38, p44/42 and NF-κB was blocked in Cd14-/- mice as analyzed by confocal microscopy. Co-immunoprecipitation studies combined with microscale thermophoresis analysis showed that biglycan is in complex with CD14 in macrophages and in vitro binds directly with high affinity to CD14, thereby sustaining the concept that CD14 is a novel co-receptor in biglycan-mediated inflammation. Additionally, we provided proof-of-principle of our concept in an in vivo mouse model of renal IRI. Transient overexpression of biglycan in WT mice exacerbated the expression and production of TNF-α, CCL2, CCL5 and HSP70 in a CD14-dependent manner. Interestingly, pLIVE or pLIVE-hBGN-injected Cd14-/- mice displayed lower chemo- and cytokine levels in reperfused kidneys as compared to respective WT controls during renal IRI (30 h), indicating a renoprotective effect by CD14 deficiency. Flow cytometry analysis of kidney homogenates underlined the pivotal effect of CD14 in biglycan signaling as biglycan-mediated infiltration of CD11b- and F4/80-positive renal macrophages was abolished in Cd14-/- mice. Additionally, pLIVE or pLIVE-hBGN-injected CD14 deficient mice displayed lower numbers of renal CD11b- and F4/80-positive cells during renal IRI compared to WT mice. Analysis of F4/80- and CD38-positive cells isolated from mononuclear cell extracts from kidney homogenates of pLIVE or pLIVE-hBGN-injected WT and Cd14-/- mice revealed that biglycan triggers the polarization of pro-inflammatory M1 macrophages in a CD14-dependent manner. In line with this, Cd14-/- mice, either injected with pLIVE or pLIVE-hBGN, showed less F4/80- and CD38-positive cells during renal IRI than the respective WT control. As a corroboration of our data PAS-stained renal sections of pLIVE- or pLIVE-hBGN-injected WT or Cd14-/- mice uncovered that biglycan worsens tubular damage in IRI-subjected mice via CD14. At the same time, tubular damage was significantly reduced in IRI-subjected Cd14-/- mice as compared to WT mice. In correlation with these data, serum creatine levels were increased in pLIVE-hBGN-injected WT mice during renal IRI. In contrast, serum creatine levels were significantly less increased in pLIVE- or pLIVE-hBGN-injected Cd14-/- mice than in WT littermate controls. In conclusion we demonstrated that CD14 is a new high affinity ligand for biglycan-mediated pro-inflammatory signaling over TLR2 and TLR4 in macrophages. In vivo, soluble biglycan triggers the expression of various inflammatory mediators by utilizing the co-receptor CD14. Ablation of CD14 abolishes biglycan-induced renal macrophage infiltration and M1 macrophage polarization as well as overall kidney function by reduced tubular damage and serum creatinine levels. Therefore, this study identifies CD14 as a promising therapeutic target to ameliorate biglycan-induced inflammation.
...
G-protein coupled receptors (GPCRs) are a predominant class of cell-surface receptors in eukaryotic life. They are responsible for the perception of a broad range of ligands and involved in a multitude of physiological functions. GPCRs are therefore of crucial interest for biological and pharmaceutical research. Molecular analysis and functional characterisation of GPCRs is frequently hampered by challenges in efficient large-scale production, non-destructive purification and long-term stability. Cell-free protein synthesis (CFPS) provides new production platforms for GPCRs by extracting the protein synthesis machinery of the cell in an open system that allows target-oriented modulations of the synthesis process and direct access to the nascent polypeptide chain. CFPS is fast, reliable and highly adaptable. Unfortunately, highly productive cell-free synthesis of GPCRs is often opposed by low product quality. This thesis was aimed to adapt and improve some of the new possibilities for the cell-free production of GPCRs in high yield and quality for structural and pharmaceutical analysis. An E. coli based CFPS system was applied to synthesise various turkey and human Beta-adrenergic receptor (Beta1AR) derivatives as well as human Endothelin receptors type A and B (ETA and ETB) constructs. Both receptor families are important drug targets and pharmacologically addressed in the treatment of several cardiovascular diseases. CF-synthesis was mainly performed in presence of nanodiscs (ND), which are reconstituted high density lipoprotein particles forming discoidal bilayer patches with a diameter varyring from 6 to approx. 15 nm. The supplementation of ND in the CF-synthesis reaction caused the co-translational solubilisation of the freshly synthesised GPCRs. The fraction of the solubilised GPCR that was correctly folded was analysed by the competence to bind its ligand alprenolol or Endothelin-1, respectively. Both the solubilisation efficiency and the ability to fold in a ligand binding competent state was strongly affected by the lipid composition of the supplied ND. Best results were generally achieved with lipids having phosphoglycerol headgroups and unsaturated fatty acid chains with 18 carbon atoms. Furthermore, thermostabilisation by introduction of point mutations had a large positive impact on the folding efficiency of both Beta1AR and ETB receptor. Formation of a conserved disulphide bridge in the extracellular region was additionally found to be crucial for the function of the ETB receptor. Disulphide bridge formation could be enhanced by applying a glutathione-based redox system in the CFPS. Further improvements in the quality of ETB receptor could be made by the enrichment of heat-shock chaperones in the CF-reaction. Depending on the receptor type and DNA-template, roughly 10 – 30 nmol (350 – 1500 µg) of protein could be synthesised in 1 ml of CF-reaction mixture. After the applied optimisation steps, the fractions of correctly folded receptor could be improved by several orders of magnitude and were finally in between 35% for the thermostabilised turkey Beta1AR, 9% for the thermostabilised ETB receptor, 6.5% for the non-stabilised ETB receptor, 1 - 5% for non-stabilised turkey Beta1AR and for human Beta1AR isoforms and 0.1% for ETA receptor. Therefore, between 2 and 120 µg of GPCR could be synthesised in a ligand binding competent form, depending on the receptor and its modifications. Correctly folded turkey Beta1AR and ETB receptors were thermostable at 30°C and could be stored at 4°C for several weeks after purification. Yields of the thermostabilised turkey Beta1AR were sufficient to purify the receptor in a two-step process by ligand-binding chromatography to obtain pure and correctly folded receptor in the lipid bilayer of a ND. Furthermore, a lipid dependent ligand screen could be demonstrated with the turkey Beta1AR and significant alterations in binding affinities to currently in-use pharmaceuticals were found. The established protocols are therefore suitable and highly competetive for a variety of applications such as screening of GPCR ligands, analysis of lipid effects on GPCR function or for the systematical biochemical characterisation of GPCRs. Most promising for future approaches appears to address the suspected bottlenecks of intial insertion of the GPCR-polypeptide chain in the ND bilayer and the thermal stability of the receptors. Nevertheless, the estabilised protocols for the analysed targets in this thesis are already highly competitive to previously published production protocols either in cell-based or cell-free systems with regard to yield of functional protein, speediness and costs. Moreover, the direct accessibility and other general characteristics of cell-free synthesis open a large variety of possible applications and this work can therefore contribute to the molecular characterisation of this important receptor type and to the development of new pharmaceuticals.
Structure-function relationships in substrate binding protein dependent secondary transporters
(2023)
This work provides new insights into the relevance of SBP dependent secondary transport systems, especially in the thus far under-researched subgroup of TAXI transporters. Importantly, we identified and characterized the TAXI transport system TAXIPm-PQM from Proteus mirabilis. We demonstrated that, in contrast to previously characterized SBP dependent secondary transport systems, TAXIPm-PQM is a proton coupled system and transports the C5-dicarboxylate α- ketoglutarate. Since initially the transport of α-ketoglutarate could only be demonstrated in vivo but not in vitro using established protocols (Mulligan et al. 2009), we investigated in detail the differences between the in vivo and in vitro assay. This resulted in a bioinformatic analysis of TRAP and TAXI signal peptides, which strongly implied that TAXIPm-P requires a transmembrane anchor to allow for transport. We then provided TAXIPm-P surface tethered to the membrane in in vitro transport assays and confirmed the prediction of our bioinformatic analysis that TAXIPm-PQM deploys a membrane-anchored instead of a soluble SBP. Furthermore, the TAXI transport system TAXIMh-PQM from Marinobacter hydrocarbonoclasticus transports fumarate only if both membrane domains Q and M are present. For further characterization, Michaelis-Menten kinetics and affinities were determined for both TAXI transport systems TAXIPm-PQM from Proteus mirabilis and TAXIMh-PQM from Marinobacter hydrocarbonoclasticus. In addition, nanobodies were selected for the membrane domain TAXIPm-QM from Proteus mirabilis to stabilize different conformations which can serve in subsequent structural elucidation studies. Furthermore, the TRAP SBP TRAPHi-SiaP from Haemophilus influenzae was shown to interact not only with its corresponding membrane domain TRAPHi-SiaQM but with at least one additional transporter. It was thereby excluded that TRAPHi- SiaP transfers N-acetylneuraminic acid to the only native E. coli TRAP transporter TRAPEc-YiaMNO and suggested to rather interact with a SBP dependent ABC transport system as this protein family represents the largest SBP dependent protein group in E. coli (Moussatova et al. 2008).
Natural products are valuable sources for biologically active compounds, which can be utilized as pharmaceuticals. Thereby, the synthesis is based purely on biosynthetic grounds often conducted by so-called megaenzymes. One major biosynthetic pathway is the acetate pathway including polyketide and fatty acid synthesis, which encompass one of the largest classes of chemically diverse natural products. These have medicinal relevance due to their antibacterial, antifungal, anthelmintic, immunosuppressive and antitumor properties.
Due to the high structural and functional similarity between polyketide synthases and type I animal fatty acid synthases (FASs), FAS can serve as a paradigm for the whole class of multifunctional enzymes. To fully exploit the biosynthetic potential of FASs, a good access to the enzyme is of essential importance. In this regard, Escherichia coli remains an unchallenged heterologous host due to low culturing costs, particularly fast mutagenesis cycles and relatively easy handling. Surprisingly, no sufficient expression strategy for an animal FAS in E. coli has yet been reported, as it turned out that the only approach was not reproducible.
We commenced our analysis with searching for an appropriate FAS homolog that fulfills our requirements of high protein quality, sufficient yield and ensured functionality. After extensive screening of different variants, culturing conditions and co-expression strategies, we identified the murine FAS (mFAS) as our protein of choice. The established purification strategy using tags at both termini led to a reproducible and sufficient access to the protein in excellent quality. The enzyme was further biochemically characterized including an enzyme kinetic investigation of fatty acid synthesis and an examination whether different acyl-CoA substrates can serve as priming units. This adds mFAS to our repertoire of manageable megaenzymes paving the way to exploit the catalytic efficiency in regards of microbial custom-compound synthesis.
With a strong focus on deepening our understanding of the working mode of such megaenzymes, rather than analyzing respective biosynthetic products, we have addressed the question whether mFAS itself can be engineered towards PKSs or whether properties of mFAS can be exploited to engineer PKSs. This approach was conducted on three levels of complexity from function of individual domains via organization of domains to form modules to the interplay of two modules in bimodular constructs.
Fatty acid synthesis begins with the loading of acyl moieties onto the FAS, which is conducted by a domain called malonyl-/acetyltransferase (MAT). This domain was in-depth characterized due to its important role of choosing the substrates that are built in the final compound. Our analysis comprised structural and functional aspects providing crystal structures of two different acyl-bound states and kinetic parameters for the hydrolysis and transacylation reaction using twelve exemplary CoA-esters. For this purpose, we have successfully established a continuous fluorometric assay using the α-ketoglutarate dehydrogenase as a coupled enzyme, which converts the liberated coenzyme A into Nicotinamide adenine dinucleotide. These data revealed an extensive substrate ambiguity of the MAT domain, which had not been reported to that extent before. Further, we could demonstrate that the fold fulfills both criteria for the evolvability of an enzyme by expressing MAT in different structural arrangements (robustness) and by altering the substrate ambiguity within a mutagenesis study (plasticity). Taken these aspects together, we are persuaded that the MAT domain can serve as a versatile tool for PKSs engineering in potential FAS/PKS hybrid systems.
On the higher level of complexity, we investigated the architectural variability of the mFAS fold, which constitutes a fundamental basis for a broader biosynthetic application. We could rebuild all four module types occurring in typical modular PKSs confirming a high degree of modularity within the fold. Not only structural, but also functional integrity of these modules was validated by using triacetic acid lactone formation and ketoreductase activity. Especially the latter analysis, made it possible to quantify effects of the engineering within the processing part by respective enzyme kinetic parameters. Expanding our focus beyond a singular module, we have utilized the mFAS fold for designing up to 380 kDa large bimodular constructs. In this approach, a loading didomain was attached N-terminally containing an additional MAT and acyl carrier protein (ACP) domain. Two constructs could be expressed and purified in excellent quality to investigate the influence of an altered overall architecture on fatty acid synthesis. By comparison with appropriate controls, a functional effect of the additional loading module could indeed be proven in the bimodular systems. Those constructs allow a comprehensive analysis of the underlying molecular mechanism in the future and serve as a potential model system to study the transition from iterative to vectorial polyketide synthesis in vitro.
Die Etablierung der Festphasensynthese innerhalb der letzten Jahrzehnte macht hoch modifizierte Oligonukleotide verfügbar. Damit werden Methoden wie Einzelmolekül-aufgelöstes Tracking möglich, um beispielsweise den Weg einer einzelnen RNA von der Transkriptionsstelle im Nukleus bis zur Proteinbiosynthese im Cytoplasma verfolgen und kritische Stelle verstehen zu können. In den letzten Jahren entwickelten sich auch vermehrt Fragen zur lokalen Proteinsynthese. Dabei nimmt man besonders im Fall von polaren Zellen wie Neuronen an, dass die Proteinbiosynthese nicht global im Cytosol stattfindet, sondern es einen Transport der „ruhenden“ RNA bis zu dem Ort geben muss, an dem das entsprechende Protein lokal benötigt wird. In dieser vorliegenden Arbeit sollen nun in zwei Hauptprojekten molekulare Werkzeuge entwickelt werden, mit deren Hilfe oben genannte Fragestellungen in Zukunft beantwortet werden könnten. Im ersten Hauptprojekt wurde dazu eine neue Generation lichtaktivierbarer Molecular Beacons (von engl.: molekulare Leuchtfeuer) entwickelt. Dabei handelt es sich um Oligonukleotide, die komplementär zu einer intrazellulären RNA-Sequenz (Target-RNA) sind und mit Fluorophor und Fluoreszenz-Quencher modifiziert werden. Bei den lichtaktivierbaren Designs kann Fluoreszenz detektiert werden, wenn der Molecular Beacon an seine Targetsequenz gebunden und zusätzlich zuvor eine Lichtaktivierung stattgefunden hat. Im Gegensatz zu früheren Designs wurde bei diesem hier vorgestellten Molecular Beacon der Fluorophor mit Hilfe eines zweiten photoabspaltbaren Quenchers verbunden. Dadurch kann der Beacon an seine Targetsequenz binden, obwohl noch keine Lichtaktivierung stattgefunden hat. Fluoreszenz kann allerdings erst nach photoinduzierter Abspaltung des zusätzlichen Quenchers detektiert werden. In der vorliegenden Studie konnten dadurch extrem gute Signal-zu-Rausch-Verhältnisse von bis zu 170:1 erreicht werden. Zusätzlicher Vorteil dieses Designs ist die Tatsache, dass eine Vielzahl kommerziell erhältlicher Fluorophor-Quencher-Paare verwendet werden kann. Dabei ist es nicht relevant, ob der entsprechende Farbstoff co-synthetisch während der Festphasensynthese oder post-synthetisch durch die Modifikation funktioneller Gruppen angebracht wird. Nach anfänglichen in vitro Tests wurden die besten Molecular Beacons in vivo in der Zuckmücken-Art Chironomus tentans getestet. Dieser Organismus ist aufgrund seiner Polytänchromosomen, der sog. Balbiani Ringe, interessant. Dabei handelt es sich um ein Chromosom, das viele Chromatiden mit jeweils identischen Gensequenzen enthält. Diese Balbiani Ringe haben eine sehr charakteristische Struktur. Die Molecular Beacons wurden in den Zellkern injiziert und anschließend photoinduziert. Auch in den in vivo Messungen zeigte sich die Überlegenheit des neuen Design mit Signal-zu-Rausch-Verhältnissen von bis zu 80:1. Im zweiten Hauptprojekt war es das Ziel, lokale mikroRNA-Reifung in Neuronen nachzuweisen bzw. sichtbar zu machen. MikroRNA (kurz miRNA) ist einer der wichtigsten zellulären Werkzeuge, um Genregulation auf post-transkriptioneller Ebene zu ermöglichen. Für dieses Projekt wurde eine Sonde entwickelt, die den nativen miRNA-Vorläufer – die sog. prä-miRNA – nachbildet. Der enzymatische Reifungsprozess durch die RNase Dicer sollte durch Fluoreszenz nachweisbar sein. Dies gelang durch Modifikationen der Sequenz um die enzymatische Schnittstelle herum. Durch den Dicer-vermittelten, enzymatischen Verdau wurde ein Fluorophor von einem Quencher getrennt, wobei der fluoreszente Farbstoff an der reifen mikroRNA verblieb. Nach der Etablierung der in vitro Tests und Auswahl des optimalen Fluorophor-Quencher-Paars zeigte sich in einem Kontrollexperiment, dass bei Verwendung von neuronalen Ganglien aus Dicer-Knock-Out Mäusen kein Fluoreszenzanstieg zu beobachten war. Dieses Experiment bewies, dass bisher beobachtete Fluoreszenzanstiege Dicer-spezifisch waren. Im nächsten Schritt wurden in vivo Messungen durchgeführt. Es zeigte sich dabei, dass die sog. Patch Clamp Technik herkömmlichen Transfektionsmethoden überlegen war. Unter normalen Bedingungen zeigte sich sowohl im Soma als auch in den Dendriten ein Fluoreszenzanstieg. Durch Depolarisation des Neurons konnte dieser Effekt noch verstärkt werden, wobei das somatische Signal grundsätzlich als höher einzustufen war. Interessanterweise führte eine Blockade der NMDA-Rezeptoren auch bei gleichzeitiger Depolarisation zu einer verringerten Fluoreszenz. Dies lässt darauf schließen, dass die Reifung der untersuchten prä-miRNA in Dendriten von der Aktivität des NMDA-Rezeptors bzw. einem als Konsequenz ansteigenden Ca2+-Spiegels in der Zelle abhängig ist. In einem weiteren Experiment wurde nach „Beladung“ eines Neurons mit der prä-miRNA-Sonde Dendriten punktuell aktiviert. Dies konnte durch Licht-aktivierbares Glutamat erreicht werden. Im zentralen Nervensystem gilt Glutamat als der wichtigste aktivierende Neurotransmitter. Es konnte beobachtet werden, wie einerseits Fluoreszenz lokal an der aktivierten Stelle anstieg und gleichzeitig sog. dendritische Spines wuchsen. Zum Teil war auch ein Wachstum benachbarter Spines zu beobachten. Dabei handelt es sich um pilzförmige Aussackungen der Dendriten an Stellen, an denen Vernetzungen zu Synapsen anderer Neuronen existieren. Als Ergebnis kann geschlussfolgert werden, dass es eine lokale Reifung der untersuchten prä-miRNA durch Dicer in Dendriten gibt. Dieser Prozess kann sehr spezifisch und lokal durch die Aktivierung einzelner synaptischer Verbindungen initiiert werden.
In dieser Studie haben wir die Modulation von Arachidonsäure (AA)-Stoffwechselwegen während einer Wurminfektionen mit dem Fadenwurm Heligmosomoides polygyrus bakeri (Hpb) als angeborene regulatorische Strategie zur Modulation der Typ-2-Entzündung untersucht. Wir zeigten, dass Hpb in frühen Stadien der Infektion (Tag 7) die Produktion von regulatorischen Prostaglandinen (PGE2 und 6-keto PGF1-α, ein Abbauprodukt von PGI2) und COX-Metaboliten (12-HHT und TXB2) fördert, jedoch die Sekretion von entzündungsfördernden Mediatoren PGD2 und LTs (LTB4, cysLTs) unterdrückt. Die Hpb-gesteuerte Regulierung des AA-Stoffwechsels könnte eine Strategie zur Immunsuppression/ Immunevasion dieses Parasiten darstellen, die darauf abzielt, die vom Wirt ausgelösten Immunantworten des Typs-2 zu unterbinden und sowohl die Infiltration und Rekrutierung von Granulozyten als auch die Schleimproduktion zu begrenzen und auf diese Weise das Abtöten bzw. Ausscheiden der Larven zu verhindern.
Als Schwerpunkt der Arbeit, konnten wir ebenso zeigen, dass ein Larvenextrakt aus Heligmosomoides polygyrus bakeri (HpbE) den AA Stoffwechsel in myeloiden Zellen wie Makrophagen und Granulozyten moduliert, indem die Synthese von 5-LOX in Richtung COX-Metaboliten verschoben wird. Die Behandlung von murinen und humanen Makrophagen mit HpbE induzierte die Synthese von regulatorischen Prostaglandinen (PGE2) und Prostaglandinen, die an der Wundheilung und Blutgerinnung beteiligt sind (12-HHT, TXB2), wohingegen die Produktion von entzündungsfördernden Lipidmediatoren (LTs, PGD2) unterdrückt wurde. Weiter induzierte HpbE in humanen und murinen Makrophagen die Synthese der Typ-2 hemmenden Mediatoren IL-10 und IL-1β und modulierte die Produktion von Zytokinen, die an der Regulierung von M2-Polarisierung und der Typ-2-Entzündung (IL-12, IL-28, IL-27 und TNF-α) in humanen Makrophagen beteiligt sind. Ähnlich zu der HpbE-vermittelten Eicosanoid-Umprogrammierung in Makrophagen, veränderte HpbE den AA-Stoffwechsel humaner Granulozyten und zeigt eine Verschiebung von LOX- in Richtung COX-Metabolismus. Außerdem kann HpbE direkt auf humane Granulozyten wirken und die Chemotaxis von Granulozyten effizienter hemmen als zur Asthmabehandlung verwendete Standardarzneimittel, indem es die Expression von LT synthetisierenden Enzymen (LTA4H und LTC4S) verringert und die Expression von chemotaktischen Rezeptoren (CCR3 und CRTH2) herunterreguliert.
Darüber hinaus, konnten wir die Mechanismen identifizieren, die der HpbE-gesteuerten Eicosanoid-Umprogrammierung in Makrophagen zugrunde liegen. Hpb Produkte induzierten die Aktivierung von p38 MAPK, welche COX und die Transkriptionsfaktoren HIF-1α und NFκβ aktiviert und die Produktion von Prostaglandinen (PGE2 and TXB2) sowie der Typ-2 unterdrückenden Zytokine IL-10 and IL-1β fördert. Der der Induktion des COX-Signalwegs zugrunde liegende Upstream-Mechanismus umfasste mehrere PPRs (TLR2, Dectin-1/2). Diese Rezeptoren waren allerdings nicht an der HpbE-gesteuerten Induktion von IL-10 beteiligt. Die Mechanismen der Modulation des 5-LOX-Signalweges muss noch in zukünftigen Studien weiter erforscht werden.
Das therapeutische Potential von HpbE oder HpbE-behandelten Makrophagen wurde in einem Maus Model mit HDM-induzierter allergischer Atemwegsentzündung in vivo gezeigt. Eine intranasale Behandlung mit HpbE vor HDM-Sensibilisierung und -Provokation führte zu einer Umprogrammierung des AA-Stoffwechsels und verhinderte die Allergie-induzierte Eosinophilie, Zellinfiltration, Atemwegsentzündung und Schleimproduktion. Die Modulation der Typ-2-Entzündung durch HpbE wurde vor allem durch COX-2-Metabolite vermittelt, die von HpbE-stimulierten Makrophagen freigesetzt wurden. Dies zeigte sich insbesondere darin, dass der Transfer von HpbE-stimulierten Wildtyp- aber nicht COX-2-defizienten Makrophagen vor Provokation die Granulozyten Rekrutierung und Typ-2-Entzündung während der HDM-induzierten Allergie in vivo abschwächte.
Mittels eines Maus Models für die allergische Atemwegsentzündung in unterschiedlichen Altersstufen (Neugeboren, Jungtier und Erwachsen) zeigte dieses Forschungsprojekt, dass das Alter der Sensibilisierung eine Schlüsselrolle bei der Produktion von LTs, der Expression von LT-Synthese Enzymen sowie von Faktoren, die zu strukturellen Veränderungen in den Atemwegen führen, spielt. Hier haben wir auch festgestellt, dass der Mechanismus hinter der LT-Produktion und dem Atemwegs-Remodeling im Epithel von ausgewachsenen sensibilisierten Mäusen die Aktivierung der Faktoren sPLA2X, TGM2 und Wnt5a beinhaltet.
Des Weiteren zeigte unsere Studie, dass eine Wechselwirkung zwischen entzündetem Atemwegsepithel und Alveolar-ähnlichen Makrophagen die Synthese von LTs fördern kann. Der vorgeschlagene Mechanismus startet mit der Sekretion von Wnt5a durch das entzündete Atemwegsepithel, welches die Expression von TGM2 in Makrophagen aktiviert und die Produktion von entzündungsfördernden LTs induziert, wodurch die Rolle der Makrophagen in entzündeten Atemwegen bei Erwachsenen weiter unterstützt wird. Die Relevanz der entdeckten Kaskade konnte auch in Geweben von Patienten mit chronischer Rhinosinusitis und Nasenpolypen (CRSwNP) bestätigt werden. Hohe Konzentrationen von LT Enzymen (5-LO, LTC4S LTA4H), sPLA2-X, TGM2 und Wnt5a wurden in humanen Nasenpolyp Geweben beobachtet, und hohe Konzentrationen von CysLTs wurden in Nasenpolyp Sekreten dieser Patienten gemessen. Dies lässt vermuten, dass die Expression von Atemwegs Remodeling-Faktoren, LT-Synthese Enzymen und die LT Synthese steroidresistent sind. Daher könnte diese entzündliche Kaskade ein alternatives therapeutisches Ziel für die Behandlung von Asthma darstellen, speziell bei Patienten mit steroidresistenten Formen von Atemwegsentzündungen.
Basierend auf den möglichen therapeutischen Anwendungen von HpbE haben wir begonnen, an der Charakterisierung der im HpbE vorhandenen immunmodulatorischen Wirkstoffe zu arbeiten. Glutamatdehydrogenase (GDH) und Ferritin wurden als potenzielle immunmodulatorische Komponenten von HpbE identifiziert. Es ist jedoch weitere Arbeit erforderlich, um diese in HpbE vorhandenen Proteine rekombinant herzustellen und den Wirkungsmechanismus im Bezug auf die Typ-2-Entzündung weiter aufzuklären.
At the beginning of the 1980s, an increased frequency of immune deficiency was discovered in a population of homosexual men, which is nowadays known as the Acquired Immune Deficiency Syndrome (AIDS). A few years later, the retro virus Human Immunodeficiency Virus 1(HIV-1) has been discovered as the cause of AIDS. Since the beginning of the pandemic, more that 74 million people have become infected and more than 32 million people died. In 2018, it was estimated that 38 million people where living with HIV-1 of which 24.5 million had access to Highly Active Antiretroviral Therapy (HAART), which blocks viral replication and prevents the progression towards AIDS. In the most cases an HIV-1 infection leads to the patient’s death within a few years Without HAART.
Taken together, this thesis shows that hematopoietic stem and progenitor cells harbor the prerequisites and characteristics to form an HIV-1 reservoir in vivo. The subsets of HSCs, MPPs and CD34+CD38+ progenitors harbor CD4 & CXCR4 double-positive cells as well as a lower amount of CD4 & CCR5 doublepositive cells. In addition, the susceptibility to X4-tropic HIV-1 is shown in vitro. Susceptibility to R5-tropic HIV-1 is only seen to a very low amount for CD34+CD38+ progenitors. The results also show that transduced HSPCs are capable to pass on integrated viral genomes via proliferation and differentiation during in vitro colony formation. More over the experiments provide evidence that this can take place for long time span as the outcome of the replating assays shows. Ex vivo analysis of HSPCs isolated from PLHIV also suggests that these cells are susceptible to HIV-1. Proviral DNA detection using a nested PCR showed infection of Lin- cells of a single donor with an R5-tropic subtype B HIV-1 clone. However, the assay could not detect infection of CD34+ cells. The
received results of this thesis are in agreement with previously published results. Albeit the obvious susceptibility to HIV-1 and existing reports of viral survival within HSPCs for several years, the low frequency of detected in vivo infected HSPCs could be related to the cytopathic effects of HIV-1 during replication resulting in cell death of potentially infected CD34+ cells. Other reasons could be associated with assay sensitivity or the small number of available patient samples. This makes hematopoietic stem and progenitor cells a target, which can be infected by HIV-1. The role and the clinical relevance of hematopoietic stem and progenitor cells in contribution to the latent viral HIV-1 reservoir within an HIV-1 infected patient needs to be further analyzed.
Der Hirntumor Glioblastom (GBM) ist aufgrund seines infiltrativen Wachstums, der hohen intra- und intertumoralen Heterogenität, der hohen Therapieresistenz als auch aufgrund der sogenannten gliomartigen Stammzellen sehr schwer zu behandeln und führt fast immer zu Rezidiven. Da es in den letzten Jahrzehnten kaum Fortschritte in der Behandlung des GBMs gab, bis auf die Therapie mit Tumortherapiefeldern, wird weiterhin nach alternativen Zelltodtherapien geforscht, wie zum Beispiel dem Autophagie-abhängigen Zelltod. Der Autophagie-abhängige Zelltod ist durch einen erhöhten autophagischen Flux gekennzeichnet und obwohl die Autophagie, als auch selektive Formen wie die Lysophagie und Mitophagie, normalerweise als überlebensfördernde Mechanismen gelten, konnten viele Studien eine duale Rolle in der Tumorentstehung, -progression und -behandlung aufzeigen, die vor allem vom Tumortyp und stadium abhängt. Um die zugrunde liegenden Mechanismen des durch Medikamente induzierten Autophagie-abhängigen Zelltods im GBM weiter zu entschlüsseln, habe ich in meiner Dissertation verschiedene Substanzen untersucht, die einen Autophagie-abhängigen Zelltod induzieren.
In einer zuvor in unserem Labor durchgeführten Studie konnte gezeigt werden, dass das Antipsychotikum Pimozid (PIMO) und der Opioidrezeptor-Antagonist Loperamid (LOP) einen Autophagie-abhängigen Zelltod in GBM Zellen induzieren können. Darauf aufbauend habe ich die Fähigkeit zur Induktion des Autophagie-abhängigen Zelltods in weiteren Zellmodellen validiert. Dies bestätigte einen erhöhten autophagischen Flux nach PIMO und LOP Behandlung, während der Zelltod als auch der autophagische Flux in Autophagie-defizienten Zellen reduziert war. In weiteren Versuchen konnte ich die Involvierung der LC3-assoziierten Phagozytose (LAP), ein Signalweg der auf die Funktion einiger autophagischer Proteine angewiesen ist, ausschließen. Weiterhin konnte ich eine massive Störung des Cholesterin- und Lipidstoffwechsels beobachten. Unter anderem akkumulierte Cholesterin in den Lysosomen gefolgt von massiven Schäden des lysosomalen Kompartiments und der Permeabiliserung der lysosomalen Membran. Dies trug einerseits zur Aktivierung überlebensfördernder Lysophagie als auch der Zell-schädigenden „Bulk“-Autophagie bei. Letztendlich konnte aber die erhöhte Lysophagie die Zellen nicht vor dem Zelltod retten und die Zellen starben einen Autophagie-abhängigen lysosomalen Zelltod. Da die Eignung von LOP als Therapie für das GBM aufgrund der fehlenden Blut-Hirn-Schranken Permeabilität und von dem Antipsychotikum PIMO aufgrund teils schwerer Nebenwirkungen eingeschränkt ist, habe ich mich im weiteren Verlauf meiner Dissertation mit einer Substanz mit einem anderen Wirkmechanismus beschäftigt.
Der Eisenchelator und oxidative Phosphorylierungs (OXPHOS) Inhibitor VLX600 wurde zuvor berichtet mitochondriale Dysfunktion und Zelltod in Kolonkarzinomzellen zu induzieren. Allerdings hat meines Wissens nach bisher noch keine Studie die therapeutische Eignung von VLX600 für das GBM untersucht. Hier zeige ich eine neuartige Autophagie-abhängige Zelltod-induzierende Fähigkeit von VLX600 für GBM Zellen, da der Zelltod signifikant in Autophagie-defizienten Zellen aber nicht durch Caspase-Inhibitoren gehemmt wurde und der autophagische Flux erhöht war. Darüber hinaus konnte ich die Hemmung der OXPHOS und die Induktion von mitochondrialem Stress in GBM Zellen bestätigen und weiterhin aufzeigen, dass VLX600 nicht nur die mitochondriale Homöostase stört, sondern auch zu einer BNIP3-BNIP3L-abhängigen Mitophagie führt, die wahrscheinlich durch HIF1A reguliert wird aber keinen erkennbaren Nettoeffekt auf den von VLX600 induzierten Zelltod hat. Demnach induziert VLX600 letale „Bulk“-Autophagie in den hier verwendeten Zellmodellen. Darüber hinaus konnte ich zeigen, dass die Eisenchelatierung durch VLX600 eine große Rolle für den von VLX600-induzierten Zelltod spielt aber auch für die Mitophagie Induktion, Histon Lysin Methylierung und den ribosomalen Stress. Letztendlich ist es wahrscheinlich ein Zusammenspiel all dieser Faktoren, die zur Zelltodinduktion durch VLX600 führen und interessanterweise werden Eisenchelatoren bereits in präklinischen und klinischen Studien für Krebstherapien untersucht. Dabei könnten gewisse metabolische Eigenschaften verschiedener Tumorzellen die Sensitivität von Wirkstoffen, die auf den Metabolismus wirken wie VLX600, beeinflussen was in zukünftigen Studien beachtet werden sollte um den bestmöglichsten Therapieerfolg zu erzielen. Zusammenfassend unterstützt meine Dissertation die duale Rolle der Autophagie, die stark vom jeweiligen Kontext abhängt und befürwortet die weitere Forschung von Substanzen, die einen Autophagie-abhängigen Zelltod induzieren, für das GBM.
Photolabile protecting groups (PPGs, cages, photocages) are molecules which can block the activity of a functional group and be removed by irradiation of light of an appropriate wavelength. One of the goals of this work was to design new photolabile protecting groups, based on a literature known one. The far-UV absorbing diethylamino benzyl (DEAMb) photocage, developed by Wang et al., was selected as structural basis for this work. In order to trigger the uncaging reaction with longer wavelengths (≥365 nm), thus allowing also biological applications, its structure was optimized. This was done by elongating the π-orbital conjugation using biphenyl derivatives instead of a single aromatic moiety. The photocage was loaded with glutamic acid as the leaving group.
The highest bathochromic shift was shown by compounds, which had the smallest sterical hindrance imposed on the second aromatic ring. The absorption spectrum was more redshifted if the second aromatic ring contained an electron withdrawing group. However, the stronger the substituents electron withdrawing strength was, the lower the uncaging quantum yield was. It was rationalized, that this is due to a decreased excited state electron density at the benzylic carbon of the DEAMb core which is necessary to trigger bond dissociation. This has been confirmed using TDDFT (time-dependent density functional theory) computations done by Jan von Cosel, Konstantin Falahati and Carsten Hamerla (from the group of Irene Burghardt). The best uncaging quantum yield was 42% for m-phenyl substituted DEAMb, while if a strong electron withdrawing group was present (nitro group), there was no photoactivity at all.
In order to achieve a better π-orbital conjugation of the non-coplanar biphenyl derivatives, a C-C bond was introduced between the benzylic carbon and the second aromatic ring. The resulting planar compounds belong to the fluorene class. The computational data predicted the photochemical meta effect to some extent to be preserved in these molecules. A set of fluorene derivatives was synthesized and photochemically characterized. The molar absorption coefficients of all prepared fluorene derivatives were higher than for any of the biphenyl derivatives. Quantum yields of the acetate release ranged between 3-42%, thus being as good as the best glutamic acid releasing biphenyl compounds. The highest uncaging cross section of the acetate release from the prepared fluorene derivatives was above 5000 M^-1 cm^-1. This value proves the high potential of the new fluorene based photocages developed in this work. Furthermore, release of hydroxide ion from fluorenol could be shown along with generation of, presumably, fluorenyl cation. These intriguing results paves a way for further exploration of fluorene based photocages for the release of bad leaving groups.
The second part of this work describes the custom synthesis of 13C labeled compounds for the VIPER (VIbrationally Promoted Electronic Resonance) project. In the VIPER pulse sequence, a molecule is vibrationally excited by a narrow band IR-pump pulse. The following Vis-pump pulse will promote the vibrationally pre-excited molecules to an electronically excited state. This Vis-pump pulse is offresonant for the not vibrationally pre-selected species and only resonant with the molecules, which are already pre-excited by the IR-pump pulse. Since the IR absorption bands usually are well resolved, a selective excitation of one molecule in an ensemble of similar ones is possible in the IR frequency range. Isotopologues and isotopomers are an extreme case of molecules which are near identical and differ only by isotopic composition or position. As a result in solution and at room temperature they have an identical UV-Vis absorption spectrum but different IR spectrum. This allows vibrational excitation of only one isotopologue (or isotopomer).
Isotopic labels were introduced in known photocages: 7-diethylamino coumarin (DEACM) and para-hydroxy phenacyl (pHP). The position for isotopic label incorporation in these molecules was guided by computations done by Jan von Cosel and Carsten Neumann. To allow control of the photoreactions in an ultrafast timescale, an IR active leaving group was used. The uncaging behavior of the prepared molecules in steady state was tested using chromatography (HPLC) and spectroscopy (1H NMR, FTIR and UV-Vis). The VIPER experiments were performed by Daniela Kern-Michler, Carsten Neumann, Nicole Mielke and Luuk van Wilderen (from the group of Jens Bredenbeck). A selective uncaging of only the vibrationally pre-excited molecules could be achieved.
Bei ca. 95% der chronisch myeloischen Leukämie (CML) und 20-30% der akuten lymphatischen Leukämie (ALL) des Erwachsenen liegt eine reziproke Chromosomentranslokation t(9;22)(q34;q11) vor, in deren Rahmen das BCR (Breakpoint Cluster Region) Gen auf Chromosom 22 mit dem ABL (Abelson-Leukämie-Virus) Gen auf Chromosom 9 fusioniert. Auf Chromosom 22 gibt es zwei verschiedene Bruchpunkte, die somit zur Bildung von unterschiedlichen Fusionsgenen führen. Bei der CML findet man den sogenannten „großen“ Bruchpunkt (M-bcr), während bei der Ph+ ALL der sogenannte „kleine“ Bruchpunkt (m-bcr) vorkommt. Das hybride Fusionsgen auf Chromosom 22q+ (Philadelphia-Chromosom) kodiert für das jeweilige BCR/ABL Protein, während das Fusionsgen auf Chromosom 9q+ für das reziproke ABL/BCR Protein kodiert. Das ABL-Protein ist eine Nicht-Rezeptor Tyrosinkinase, die eine wichtige Rolle in der Signaltransduktion und der Regulation des Zellwachstums spielt. Im BCR/ABL Fusionsprotein wird die Kinase-Aktivität von ABL, die im Normalfall streng reguliert ist, durch die Fusion mit BCR konstitutiv aktiv. Dadurch kommt es zur Deregulierung intrazellulärer Signalwege, welche die maligne Transformation hämatopoetischer Zellen verursacht. Eine zielgerichtete Inhibierung von BCR/ABL mittels ABL-Kinase-Inhibitoren induziert Apoptose in BCR/ABL transformierten Zellen, was eine komplette Remission im größten Teil Ph+ Leukämie Patienten zur Folge hat.
Formulation scientists have developed a toolkit of strategies that can improve the solubility and subsequent bioavailability of poorly soluble candidates. Amorphous formulations are especially appealing due to the significant improvement in solubility the amorphous form can provide, but must be stabilized for effective performance (Timpe, 2007).
2. The Importance of Drug Polymer Interactions in Precipitation Inhibition
Polymeric “precipitation inhibitors” have seen widespread usage in the literature (Warren, 2010). The precipitation inhibition effect of polymers on precipitations is related to interference with nucleation and crystal growth (Xu, 2013). Many techniques have been reported in the literature to predict these interactions, however, they are not suitable to screening due to API and time resources required, which are not amenable to early stage pharmaceutical development.
3. Mesoporous Silica: An Emerging Formulation Technology
Mesoporous silicon dioxide has emerged in recent years as a new option for stabilizing the amorphous form. Upon impregnation of the silica with a concentrated drug solution, the drug can be molecularly adsorbed and locally and sterically confined, preventing recrystallization (Ditzinger, 2018). Upon administration of mesoporous silica formulations to the body the amorphous formulation generates supersaturation which must be stabilized using precipitation inhibitors (Guzman, 2007).
4. Co-incorporation: A New Method to Combine Precipitation Inhibitors with Mesoporous Silica
There has been no systematic study of how best to incorporate precipitation inhibitors into mesoporous silica formulations. The current standard practice involves combining inhibitors in a physical mixture with the drug-loaded silica, either by pestle and mortar or overhead stirring. Due to the lack of a defined protocol, there is uncertainty about how reliably the precipitation inhibitor is combined with the drug-loaded silica on a batch to batch basis. In this work, a novel co-incorporated formulation of glibenclamide and the precipitation inhibitor, HPMCAS, onto mesoporous silica was described. By co-incorporating the precipitation inhibitor, the formulation significantly outperformed the commonly applied simple physical blend due to the formation of drug-polymer interactions in the solid state.
5. In Silico Pharmaceutics: A New Method to Select Precipitation Inhibitors for Mesoporous Silica
An approach that can incorporate understanding of the drug-polymer interactions with a quick and efficient screening process would be very useful. The COnductor like Screening MOdel for Real Solvents (COSMO-RS) is a quantum mechanical theory, which can be used to derive thermodynamic properties of interest. (Klamt, 1993, 1995, 2003). We proposed excess mixing enthalpies of drug and polymer could be calculated using the COSMO-RS theory. This new approach was applied to screen precipitation inhibitors for three model compounds, all of which showed a strong positive correlation between the rank assigned based on the calculated free enthalpy of mixing and the overall formulation performance.
6. Conclusion
This body of work aimed to improve the processes underpinning the design and development of mesoporous silica with precipitation inhibitors. Firstly, this involved two extensive literature reviews in the area of solubility enhancement formulation technologies and precipitation inhibition. Secondly, a mechanistic rational and experimental approach was developed to improve the formulation of precipitation inhibitors with mesoporous silica, the “co-incorporation” approach significantly improved process efficiency and formulation performance. Finally, combining insights from the aforementioned review, and learnings from the mechanistic analysis of the “co-incorporation” approach, an in silico screening protocol was developed to calculate the enthalpy of interaction between drug and polymer, to identify the most optimal precipitation inhibitor for a given formulation.
Die Entwicklung von neuartigen, funktionellen Materialien ist eine komplexe Aufgabe, da die Gesamteffizienz der zu entwickelnden Materialien von einer Vielzahl von Faktoren abhängt. Während die auf einer molekularen Ebene durchgeführte Funktionalisierung via chemischer Reaktionsführung genauso wichtig ist wie die makromolekulare Anordnung, kann die Frage nach einer geeigneten Verbesserung von gegenwärtigen Materialien nicht nur auf einer dieser beiden Ebenen beantwortet werden. Die in dieser Arbeit präsentierten Ergebnisse basieren auf der mirkoskopischen aber auch markoskopischen Betrachtung von neuartigen, funktionellen Nanomaterialien und den daraus gewonnenen Erkenntnissen. Das übergeordnete Ziel ist dabei das Verständnis und die Charakterisierung von Ladungsseparationsprozessen und die daraus resultierende Erzeugung von elektrischen Strömen in organischen photovoltaischen Materialien.
Die relevanten Ladungsseparationsprozesse werden oft im Kontext der Dissoziation von Exzitonen, gebundenen Elektron-Loch Paaren, beschrieben, welche innerhalb der Donordomäne eines beliebigen Donor-Akzeptor-Materials erzeugt werden. Dabei ist der Prozess der Exzitonengenerierung abhängig von der Nanomorphologie des entsprechenden Materials, typischerweise so genannten Bulk-Heterojunctions. Dahingehend ist es notwendig, die Effekte von intermolekularen Wechselwirkungen sowohl mittels quantenmechanischer als auch dynamischer Methoden zu betrachten. Um alle relevanten Zeitskalen und Prozesse zu betrachten ist es weiterhin notwendig, auf sowohl eine deterministische Darstellung im Rahmen von quantendynamischen Methoden als auch statistischen Methoden zurückzugreifen.
Um die oft ultraschnellen und kohärenten Exzitonendissoziationsprozesse zu untersuchen wurde eine Kombination aus high-level ab initio Methoden und zeitabhängiger Dichtefunktionaltheorie (TDDFT) angewandt, um geeignete Modellhamiltonians zu parametrisieren, welche schließlich mittels der Multi-Configurational Time-Dependent Hartree (MCTDH) und der Multilayer (ML-MCTDH) variante propagiert wurden. Die MCTDH Methode hat sich als geeignete Methode erwiesen um eine voll quantendynamische Beschreibung von bis zu 100 Freiheitsgraden durchzuführen; die ML-MCTDH Methode erlaubt gar bis zu 1000 Freiheitsgrade quantendynamisch zu behandeln. Die Parametrisierung der Modellhamiltonians, auf welchen die quantendynamische Behandlung basiert, wurde dabei für kleine, jedoch repräsentative Fragmente durchgeführt. Die geeignete Wahl dieser Fragmente sollte sicherstellen, dass zum einen alle relevanten intermolekularen als auch intramolekularen Wechselwirkungen enthalten sind, jedoch gleichzeitig eine möglichst akkurate Beschreibung mittels high-level elektronenstrukturtheoretischer Methoden in gegebener Zeit möglich ist.
Mit Hilfe dieser Methodenkombination wurden zwei Arten von funktionellen organischen Materialien untersucht. Das erste untersuchte System ist ein neuartiges Donor-Akzeptor System, bestehend aus selbstorganisierenden Oligothiophen-Perylenediimid Dimeren, welche in der Gruppe von S. Haacke und S. Mery der Universität Straßburg synthetisiert und spektroskopisch untersucht wurden. Die quantendynamischen Simulationen an diesem System sollten die Ergebnisse der experimentellen, zeitaufgelösten pump-probe Spektroskopie validieren und die dürftige Effizienz im Hinblick auf eine effektive Ladungstrennung erklären. Dabei konnte gezeigt werden, dass nach der Exzitonendissoziation Elektron und Loch auf räumlich benachbarten Donor- und Akzeptorfragmenten lokalisiert werden, was schließlich zu einem Rekombinationsprozess führen wird. Das zweite untersuchte System ist eine Kombination von Poly(3-Hexylthiophen-2,5-diyl) (P3HT) als Elektronendonor und [6,6]-Phenyl-C61 Butansäure Methyl-Ester (PCBM) als Elektronenakzeptor, welches schon hinreichend stark in diversen theoretischen und experimentellen Studien untersucht wurde. Aufbauend auf einem Gittermodell, welches in unserer Gruppe entwickelt wurde, wurde das Modellsystem um Charge Transfer Exzitonen in der Donordomäne erweitert. Die Bedeutung von solchen Charge Transfer Exzitonen in regioregulären Oligothiophenaggregaten ist ein aktuelles Thema in der Wissenschaft, sowohl in experimentellen aber auch theoretischen Abhandlungen. Neben der theoretischen Beschreibung zur Entstehung solcher Charge Transfer Exzitonen liegt ein besonderes Augenmerk auf dem Einfluss dieser predissoziierten Elektron-Loch Paaren auf die Ladungsseparationsdynamik zwischen Donor und Akzeptor sowie die Generierung von freinen Ladungsträgern. Dieser Aspekt der Ladungsseparation in einem P3HT-PCBM System wurde in dieser Art und Weise in dieser Arbeit zum ersten mal untersucht.
Neben dem zuvor erwähnten Donor-Akzeptor System erster Generation der Universität Straßburg wurde eine zweite Variante dieses Systems entwickelt, welches sich bei bisherigen experimentellen Untersuchungen als wesentlich effizienter erwies. Der interessante Prozess der Ladungsseparation ist dabei allerdings auf einer Zeitskala von mehreren hundert Pikosekunden angesiedelt, sodass kinetische Monte Carlo Methoden verwendet werden mussten um diese Prozesse zu modellieren. Dazu wurde ein Fortran90 Code entwickelt, welcher den First Reaction Method Algorithmus verwendet und explizite Delokalisationsprozesse behandelt, welche in dieser Form in kommerziellen Programmpaketen nicht enthalten ist. In vorangehenden Arbeiten konnte gezeigt werden, dass die Delokalisation von Exzitonen zu einer effektiven Herabsetzung der energetischen Barriere der Ladungsseparation führt und somit die Effizienz zur Stromumwandlung gesteigert werden konnte. Erste Simulationen mit diesem Code an idealisierten und zufällig generierten Donor-Akzeptor Morphologien lieferten realistische Werte für makroskopische Observablen wie Ladungsträgermobilitäten. Weiterhin wurden Simulationen einer coarse-grained Struktur zur zweiten Generation des Donor-Akzeptor Systems durchgeführt, ebenfalls mit Hinblick zur Untersuchung der Ladungsträgermobilität.
Die vorliegende Dissertation stellt eine Methode zur Löslichkeitsbestimmung vor, die für die Anwendung im Rahmen von BCS-Biowaiver Monografien entwickelt wurde. Der Methode und dem dafür konzipierten Studienprotokoll liegt das Prinzip der „Minimallöslichkeit“ zugrunde. Damit lässt sich einfach, kosteneffizient und wissenschaftlich verlässlich feststellen, ob ein Arzneistoff „hochlöslich“ gemäß den BCS-Biowaiver Richtlinien der Gesundheitsbehörden FDA, EMA und WHO ist und sich dementsprechend generische Produkte des Arzneistoffs grundsätzlich für das BCS-Biowaiver Zulassungsverfahren eignen.
Dieses Verfahren für die Zulassung von Generika erlaubt die Beurteilung der Bioäquivalenz eines festen generischen Arzneimittels zur peroralen Anwendung auf Basis von in vitro-Freisetzungsuntersuchungen anstatt von in vivo-Studien wie z.B. pharmakokinetischen Studien am Menschen und erleichtert dadurch eine Marktzulassung sowohl durch Zeit- als auch Kosteneinsparung. Die Anwendung des Verfahrens ist von Vorteil, um die Verfügbarkeit von qualitativ hochwertigen, generischen (und damit kostengünstigen) Arzneimitteln zu erhöhen. Dies ist besonders wünschenswert für die Verfügbarkeit von gemäß der Weltgesundheitsorganisation essenziellen Arzneistoffen und unter denen gerade von solchen, die zur Bekämpfung von Krankheiten mit nur wenigen und/oder teuren therapeutischen Alternativen benötigt werden.
Entstanden ist die Löslichkeitsbestimmungsmethode im Rahmen von zwei Projekten, die beide zu diesem Ziel einer guten globalen Gesundheitsversorgung beitragen: die Erstellung der Biowaiver Monografien von Proguanilhydrochlorid (ein Malaria-Prophylaktikum) und Cefalexinmonohydrat (ein Antibiotikum aus der Gruppe der Cephalosporine) setzt die Publikationsreihe „Biowaiver Monograph Series“ der FIP Focus Group „Bioclassification/Biowaiver“ fort. Jede Monografie gibt eine umfassende wissenschaftliche Empfehlung zur Eignung eines Wirkstoffs der WHO „Model List of Essential Medicines“ und seiner generischen Produkte für das BCS-Biowaiver Verfahren hinsichtlich aller regulatorisch geforderten Aspekte ab. Proguanilhydrochlorid (BCS Klasse III – „hochlöslich“ und nicht „hoch permeabel“) und Cefalexinmonohydrat (BCS Klasse I – „hochlöslich“ und „hoch permeabel“) sind beide für dieses Zulassungsverfahren geeignet.
Im Zuge des anderen Projektes wurde die Löslichkeit und anschließend die BCS Klasse von Wirkstoffen bestimmt, die der 16. und 17. Version der WHO „Model List of Essential Medicines“ neu hinzugefügt wurden. Neun von 16 untersuchten Wirkstoffen, die in feste, perorale Arzneimittel formuliert werden können, sind im Hinblick auf ihre BCS Klasse für das eine Zulassung per BCS-Biowaiver geeignet. Eine umfangreichere Empfehlung könnte im Rahmen einer Biowaiver Monografie gegeben werden.
Die experimentelle Bestimmung der Löslichkeit über einen pH-Wert-Bereich von 1-6,8 war essenzieller Bestandteil beider Projekte, da Literaturdaten zur Löslichkeit der Wirkstoffe nicht oder nur unvollständig vorlagen. Die entwickelte Methode basiert auf einer im Kleinmaßstab angesetzten „Shake-Flask“-Methode zur Bestimmung der thermodynamischen Löslichkeit, wird jedoch in einem Zeitrahmen von 24 Stunden durchgeführt. Sie nutzt die höchste Dosis der Wirkstoffe als Substanzmenge, um zu bestimmen, ob dieser „hochlöslich“ gemäß den BCS-Biowaiver Richtlinien ist oder nicht. Die Methode bzw. das dazugehörige Studienprotokoll beinhalten Empfehlungen zu den einzelnen Schritten der Durchführung, der Auswahl der Medien und Herausforderungen wie Präzipitation (Fallbeispiel: Proguanilhydrochlorid) und Zersetzungsreaktionen (Fallbeispiel: Cefalexinmonohydrat). Löslichkeitsdaten, die mit dieser Methode erhoben werden, können für eine Zulassung per BCS-Biowaiver bei den Gesundheitsbehörden eingereicht werden, aber auch für ein Vorab-Screening genutzt werden, dass „hochlösliche“ Arzneistoffe aus einer Vielzahl von Substanzen herauszufiltern soll, um nähere Untersuchungen im Rahmen einer Biowaiver Monografie anzuschließen.
Paramyxo- and pneumoviruses include many pathogens with great relevance for human and animal health. To identify common host factors involved in the Paramyxo- and Pneumoviridae life cycle as a basis for new insights in the biology of these viruses and the development of rationally designed therapeutics, genome scale siRNA screens with wild-type measles, mumps, and respiratory syncytial viruses in A549 cells, a human lung adenocarcinoma cell line, were performed. A comparative bioinformatics analysis yielded different members of the coatomer complex I, the translation factors ABCE1 and eIF3A, and several RNA binding proteins as cellular proteins with proviral activity for all three viruses. The strongest common hit, ABCE1, an ATP-binding cassette transporter member, was chosen for further study. We found that ABCE1 supports replication of all three viruses, confirming its importance for both virus families. While viral protein kinetics showed that ABCE1 knockdown resulted in a drastic decrease of MeV protein expression, viral mRNA kinetics are not directly affected by a reduction of ABCE1.
The impact of ABCE1 on viral and global cellular translation was investigated using both 35S metabolic labelling and non radioactive fluorescent protein labelling. ABCE1 knockdown strongly inhibited the production of MeV proteins, while only modestly affecting global cellular protein synthesis and showed that ABCE1 is specifically required for efficient viral, but not general cellular, protein synthesis, indicating that paramyxoand pneumoviral mRNAs may exploit specific translation mechanisms.
In a second approach the efficacy of the small-molecule polymerase inhibitor ERDRP-0519 against MeV was assessed in squirrel monkeys. Animals treated with the drug experienced less severe clinical disease compared to untreated controls, and this effect correlated with the onset of drug treatment.
We observed a reduction of levels of PBMC-associated viremia and virus release in the upper airways, illustrating effective inhibition of virus replication by the drug treatment. ERDRP-0519 drug treatment also alleviated MeV-induced immunosuppression. In addition to providing proof-of-concept for the support of MeV eradication efforts by preventing disease and transmission with a small-molecule polymerase inhibitor, this dissertation provides a novel perspective on cellular proteins that impact the replication of MeV, MuV and HRSV and highlights the role of ABCE1 as host factor that is required for efficient paramyxo- and pneumovirus translation.
Leukemia is a cancer of the blood and bone marrow characterized by an uncontrolled proliferation and accumulation of abnormal white blood cells. Leukemia can be classified based on the course of the disease (acute or chronic) and the blood cell type involved (myeloid or lymphocytic), leading to four main subtypes: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML). Leukemia represents 2.5% of all new cancer cases per year, and survival rates in some leukemias remain low at 40%.
The bone marrow microenvironment (BMM) is a system within the bone marrow comprising cellular and acellular components, all of which play a major role in hematopoiesis, providing the physical space where hematopoietic stem cells (HSCs) reside. The BMM interacts with HSCs, offering a “niche” for those cells and in case of leukemia, the BMM has a supportive role in disease maintenance and progression by supporting Leukemia stem cells (LSCs). One of the components of the BMM are calcium ions. Calcium is the most abundant mineral in the body, a key component of bones and is released by parathyroid hormone (PTH) induced bone remodeling. Calcium ions play a role in the localization, engraftment and adhesion of normal HSC to extracellular matrix (ECM) proteins in the BMM via the calcium sensing receptor (CaSR), thereby maintaining normal hematopoiesis. In addition of a major regulator of calcium homeostasis, CaSR contribute to the development of different cancers, functioning as either tumor suppressor or oncogene, depending on the involved tissue. However, the role of CaSR and its associated pathways in the local BMM for the development of leukemia is poorly understood. We hypothesized that calcium ions released from bone, subject to a fine balance between osteoblasts and osteoclasts, and/or CaSR, contribute to development, progression and response to therapy.
We have shown that the local calcium concentration forms a gradient in the bone marrow niche and in mice with CML is similarly low as in control mice, but significantly higher in mice suffering from BCR ABL1 driven B ALL or MLL AF9 driven AML. Similarly, the calcium concentration in the human BMM was found to be higher in AML than in other leukemias. Regarding the function of calcium in leukemia cells, we found that AML and CML cells respond differently to calcium exposure, with AML cells exhibiting regulation of cellular processes such as adhesion to the ECM protein fibronectin and migration toward CXCL 12, whereas CML cells remained mostly unaltered. Using genetic deletion or overexpression of CaSR in murine models of leukemia, we observed that CaSR acts as tumor suppressor in BCR-ABL1 driven CML and B ALL and as oncogene in AML.
Focusing on AML, our data shows that deficiency of CaSR on LICs leads, on one hand to increased apoptosis, and on the other hand to reduced cell cycle, reactive oxygen species (ROS) production and DNA damage in vivo, which may explain the observed prolongation of survival of mice. Complementary, in vitro experiments demonstrated that cells overexpressing CaSR have a distinct, cancer promoting phenotype compared to wildtype cells. Overexpression of CaSR led to an increase in proliferation, cell cycle, ROS production, DNA damage and reduced apoptosis. We have identified CaSR mediated pathways in AML and shown that CaSR enhances leukemia progression by activating MAPK/ERK and Wnt β catenin signaling. In addition, the CaSR interacting protein filamin A (FLNA) was shown to contribute to aggressive disease in vitro and in vivo. Furthermore, the mechanism underlying the role of CaSR in AML pathogenesis and possible regulation of LSCs was studied. Our findings demonstrated that CaSR ablation reduces myeloid progenitor function and proved that CaSR is required for maintenance of LSC pool by regulating its frequency and function. Further supporting the role of CaSR in LSC maintenance, genes associated with AML stemness and self renewal capacity were upregulated when CaSR was overexpressed and downregulated when CaSR was depleted. Given the role of CaSR in AML, the CaSR antagonist NPS 2143 was tested in vivo. The combination treatment of NPS 2143 with the standard of care, ara C, significantly reduced the tumor burden and prolonged the survival of mice with AML in syngeneic and xenotransplantation experiments. Based on the finding that CaSR functions as a tumor suppressor in CML, treatment of mice with the CaSR agonist cinacalcet in combination with imatinib prolonged survival of mice with CML compared to treatment with the mice given vehicle.
Our results suggest that calcium ions stemming from the calcium-rich BMM via CaSR strongly and differentially influence leukemia progression. As an adjunct to existing treatment therapies, targeting of CaSR with specific pharmacologic antagonists may prolong survival of patients with AML.
G-protein-coupled receptors (GPCRs) from the largest family of receptors in the human body. They contain seven transmembrane helices. There are roughly 800-900 GPCR genes expressed in humans encoded by 4-5% of the human genome. These receptors are the most important signal transducers and play a crucial role in cell physiology and pathology, by using various extracellular stimuli to start complex intracellular signaling. GPCRs interact with a wide variety of stimuli from small molecules (photons, ions, amines) to large molecules (peptides, small proteins), and trigger downstream cascade effects by interacting with G-proteins, GPCR kinases, and ß-arrestin. Because of their crucial roles in many cellular functions, GPCRs are the most important drug targets for the pharmaceutical industry. Approximately 30% of the clinically approved drugs available in the market are against GPCRs. In this work achieved successful expression and purification of GPCRs from class-C and class-A families. Combined with biochemical experiments, DNP-ssNMR, and molecular simulation helped to decipher the mechanism of crosstalk between the allosteric modulator, and the orthosteric binding sites of the peptide receptor. The main findings and major highlights of this dissertation are outlined in the following paragraphs.
The calcium-sensing receptor (CaSR) belongs to the GPCR class-C family and contains a large extracellular domain. This receptor regulates Ca2+ homeostasis in blood and its absorption in the kidney and bone. To understand the molecular and structural mechanisms of these receptors their cDNAs were cloned into the pPICZ and pOET1 vectors to express them in Pichia pastoris and in Sf9 insect cells respectively. The CaSR was successfully expressed heterologously in Pichia pastoris and in the insect cell with high yield. The purified receptor purified in LMNG shows no aggregation in a monomeric state. Further optimization was performed to use it for cryo-EM sample preparation and structure determination. In 2nd part of the thesis, different mini G (mini Gs, mini Gi, mini Gqs, and mini Gsi) DNA constructs were made and expressed in E. coli. It's challenging to obtain active GPCR structures due to the instability of G-protein or G-protein-bound receptors. In this work, all mini-G proteins and chimera mini-G-protein-maltose binding protein (MBP) were cloned and expressed in E. coli and purified with a His-trap column with high purity.
In the last part of the thesis, to decipher the mechanism of allosteric modulation of orthosteric binding sites in the bradykinin receptor was produced and characterized in insect cells. Angiotensin I converting enzyme inhibitors (ACEIs), are very important drugs and are widely used for the treatment of hypertension, congestive heart failure, and diabetic neuropathy. These drugs target primarily the catalytic zinc center of the ACE. It has been shown that enalaprilat, a well-known ACEI, binds to a proposed zinc-binding site on hB1R and even directly activates the receptor. To obtain information on the influence of ACEIs on the receptor-peptide complex, and to have a better understanding of the molecular mechanism and structural plasticity of the bradykinin receptor and PAM, we used the three commercially available ACEIs captopril, enalaprilat, and lisinopril for our studies. An important result of this thesis is that though enalaprilat, captopril, and lisinopril all have similar functional properties in humans, each one regulates the orthosteric binding site of hB1R in a unique way. These findings provide atomic insights into the allosteric modulation of the bradykinin receptor. This study along with the effects of ACEI on the binding sites of receptors also deciphers the effects of the Zn2+ as well as the crosstalk between zinc binding sites and ACEI compounds. The binding of allosteric modulators induces distinct endogenous binding, which might aid in creating new possibilities in the pharmaceutical field.
Computational oral absorption models, in particular PBBM models, provide a powerful tool for researchers and pharmaceutical scientists in drug discovery and formulation development, as they mimic and can describe the physiologically processes relevant to the oral absorption. PBBM models provide in vivo context to in vitro data experiments and allow for a dynamic understanding of in vivo drug disposition that is not typically provided by data from standard in vitro assays. Investigations using these models permit informed decision-making, especially regarding to formulation strategies in drug development. PBBM models, but can also be used to investigate and provide insight into mechanisms responsible for complex phenomena such as food effect in drug absorption. Although there are obviously still some gaps regarding the in silico construction of the gastrointestinal environment, ongoing research in the area of oral drug absorption (e.g. the UNGAP, AGE-POP and InPharma projects) will increase knowledge and enable improvement of these models.
PBBM can nowadays provide an alternative approach to the development of in vitro–in vivo correlations. The case studies presented in this thesis demonstrate how PBBM can address a mechanistic understanding of the negative food effect and be used to set clinically relevant dissolution specification for zolpidem immediate release tablets. In both cases, we demonstrated the importance of integrating drug properties with physiological variables to mechanistically understand and observe the impact of these parameters on oral drug absorption.
Various complex physiological processes are initiated upon food consumption, which can enhance or reduce a drug’s dissolution, solubility, and permeability and thus lead to changes in drug absorption. With improvements in modeling and simulation software and design of in vitro studies, PBBM modeling of food effects may eventually serve as a surrogate for clinical food effect studies for new doses and formulations or drugs. Furthermore, the application of these models may be even more critical in case of compounds where execution of clinical studies in healthy volunteers would be difficult (e.g., oncology drugs).
In the fourth chapter we have demonstrated the establishment of the link between biopredictive in vitro dissolution testing (QC or biorelevant method) PBBM coupled with PD modeling opens the opportunity to set truly clinically relevant specifications for drug release. This approach can be extended to other drugs regardless of its classification according to the BCS.
With the increased adoption of PBBM, we expect that best practices in development and verification of these models will be established that can eventually inform a regulatory guidance. Therefore, the application of Physiologically Based Biopharmaceutical Modelling is an area with great potential to streamline late-stage drug development and impact on regulatory approval procedures.
Neuropathic pain, a form of chronic pain, is a steadily rising health problem due to health costs and increasing numbers of patients. Neuropathic pain conditions arise upon metabolic disorders, infections, chemotherapeutic treatment, trauma or nerve injury. Especially nerve injury induced neuropathic pain is characterized by spontaneous or ongoing pain due to neuroimmune interactions. Thereby, inflammatory mediators, released by the injured nerve, recruit to and activate immune cells at the site of injury. Those mediators further activate transient receptor potential vanilloid 1 (TRPV1), a known channel involved in pain perception, or bind to G-protein coupled receptors (GPCR) in peripheral nerve endings. The following activated second messenger signaling pathways lead to sensitization of TRPV1. One of those GPCRs is G2A.
The overall aim of this thesis was to investigate the role of G2A in nerve-injury induced neuropathic pain. For this, the common mouse model of nerve-injury induced neuropathic pain, the spared-nerve injury, was used. As measurements with dynamic plantar aesthesiometer showed, G2A-deficiency leads to reduced mechanical hypersensitivity. Upon analysis with FACS, ELISA and Luminex a reduced number of macrophages and neutrophils at the injured nerve, as well as less inflammatory mediators (TNFα, IL-6, VEGF) in G2A-deficient animals was observed. In dorsal root ganglia (DRGs) there was only a reduced number of macrophages and less IL-12 observed in G2A-deficient animals. Additionally, in wild-type mice, G2A agonist 9-HODE was elevated at the injured nerve, as a LC-MS/MS analysis showed.
To investigate the underlying pathways of G2A-9-HODE signaling, a proteom screen was performed. This screen revealed upregulation of multiple proteins involved in migration in wild-type macrophages. Additionally, Ca-Imaging and transwell migration assays showed that the G2A antagonist G2A11, had desensitizing effects on DRG neurons and inhibited macrophage migration.
Overall, the results suggest that loss of G2A has dual effects. On the one hand loss of G2A is antinociceptive. On the other hand, G2A-deficiency leads to reduced inflammation, suggesting G2A as promising target in treatment of neuropathic pain. Here, an antagonist had inhibitory effects on the migration and the sensitization.
An essential part of the animal survival strategy comprises the ability to control body movement and coordinate long-term navigational strategies, in order to maintain locomotion towards a nutrition source and stay in its vicinity. In the nematode Caenorhabditis elegans (C. elegans) this function is carried out by neuronal circuits, that vary their activity in response to diverse environmental condition.
This comprises different classes of neurons, acting together in a sensory, signaling and modulatory system to control body posture and induce behavioral responses. For this reason, one particular goal in the field of neuroscience research is to elucidate the mechanisms of how neuronal circuits integrate multiple sensory cues to navigate the environment. Aim of this study was to analyze the function of a neuronal network comprising the interneurons AVK, as well as the identification of signaling molecules, controlling body posture during food related locomotory behavior. This should be achieved by establishing optogenetic approaches, which provide a non inversive and temporally precise control of neuronal activity and drives the activation or silencing of individual neurons, to alter the neuronal basis of behavior. Animals exposed to food perform a dwelling-like behavior, characterized by a slowing of locomotion with a reduced crawling distance and an irregular movement, accompanied by a high frequency of pauses, reversals and directional changes. Upon food-removal, they initiate a local-search behavior with the same behavioral characteristics, but with a more pronounced sinusoidal movement. After a prolonged period of unsuccessful food finding, animals exhibited long runs with reduced pauses, reversals and turnings, increasing their maximal covered distance, indicated as dispersal behavior. Acute photoinhibition of AVK neurons, mediated by cell-specific expression of halorhodopsin (NpHR) caused the animals to perform a dwelling-like locomotory state with increased bending angles, as seen during local-search behavior. Thus, food-induced behavioral effects are mimicked by the optogenetic manipulation of AVK interneurons.
In this study, signaling molecules were ascertained by cell specific mRNA profiling of AVK neurons, mediating these behavioral responses. It was able to demonstrate, that flp-1, coding for a FMRFamidelike neuropeptide, is one of the genes with the highest distribution in AVK. In the absence of food, AVK neurons continuously release the FMRFamide-like neuropeptide FLP-1 to inhibit a subset of target motoneurons, leading the animals to maintain a low body curvature to promote dispersing behavior.
Conversely, if AVK was inhibited by NpHR or the presence of food, less FLP-1 was secreted to the body fluid, indicated by reduced intracellular fluorescence levels of mCherry-tagged FLP-1 proteins in the scavenger cells. The search of a FLP-1 receptor was successful by in vitro investigation on G protein-coupled receptors (GPCRs) and neuropeptide ligands, revealing NPR-6 to be activated by FLP-1 neuropeptides, but with a low potency. Expression pattern of the NPR-6 receptor indicated receptor localization in in the VC ventral cord and SMB head motoneurons, as well as in a subset of other neurons required for chemosensation and feeding. AVK interneurons are highly coupled to SMB head motoneurons, forming electrical synapses composed of the gap junction protein subunits UNC-7 and UNC-9. Elimination of SMB or gap junction genes using cell ablation and RNA interference, respectively, phenocopied effects of AVK inhibition on bending angles. Furthermore, this study was able to demonstrate that these neurons get inhibited during FLP-1 transmission to the NPR-6 receptor, which was required to mediate AVK effects on crawling behavior. Consequently, photoinhibition of AVK caused disinhibition of VC and SMB neurons, in order to enhance sinusoidal movement and to induce a local-search related locomotory behavior.
Thereby, FLP-1 neuropeptide transmission is the preferred used signaling pathway over direct gap junction coupling. Additional neuropeptides and receptors were identified to be essential downstream to AVK neurons to mediate effects on body curvature and locomotory behavior as well. The high-potency FRPR-7 receptor was shown to mediate FLP-1 peptide effects on undulatory motion during swimming in a liquid environment, rather than crawling locomotion on a solid surface. This result suggests that the receptor NPR-6 is required for FLP-1 peptide effects on bending and crawling locomotion, whereas conversely the receptor FRPR-7 is addressed by FLP-1 peptides to exclusively regulate swimming behavior. The FRPR-7 receptor is expressed in the AIM and NSM motoneurons, which are suggested to be the primary neuronal candidates mediating swimming behavior. Furthermore, this study provides evidence, that FRPR-7 acts in the DVC interneuron to control spontaneous reversal behavior, most probably by inhibitory FLP-1 signaling from the AVK neurons. Among other neuropeptides, the FMRFamide-like peptide FLP-26 binds with higher affinity to NPR-6 receptors than FLP-1 peptides. FLP-26 peptides are expressed in the SMB motoneurons, where they are able to further potentiate FLP-1 inhibitory effects by simultaneous binding to NPR-6.
...
Protein biosynthesis is a conserved process, essential for life. Proteins are assembled from single amino acids according to their genetic blueprint in the form of a messenger ribonucleic acid (mRNA). Peptide bond formation is catalyzed by ancient ribonucleic acid (RNA) residues within the supramolecular ribosomal complex, which is organized in two dynamic subunits (Ramakrishnan, 2014). Each subunit comprises large ribosomal RNA (rRNA) molecules and several dozens of peripheral proteins. mRNA translation has been divided into three phases, namely translation initiation, elongation and termination in biochemistry textbooks. During initiation, the ribosomal subunits assemble into a functional ribosome on an activated mRNA and acquire the first transfer RNA (tRNA), an adapter between the start codon on the mRNA and the N-terminal methionine of the protein (Hinnebusch and Lorsch, 2012). During elongation, the ribosome translocates along the mRNA exposing one codon after the other, and amino acids are delivered to the ribosome by the respective tRNAs, and attached to the nascent polypeptide chain. During termination, the polypeptide is released and the ribosome remains loaded with mRNA and tRNA at the end of the open reading frame for the translated gene (Hellen, 2018). Bacterial ribosomes are subsequently recycled by a specific ribosome recycling factor and the small ribosomal subunit is simultaneously consigned to initiation factors for a next round of translation – rendering bacterial translation as a cyclic process with an additional ribosome recycling phase. However, the process of ribosome recycling remained enigmatic in Eukarya and Archaea until the simultaneous discovery of the twin-ATPase ABCE1 as the major ribosome recycling factor. Strikingly, ABCE1 has initially been shown to participate in translation initiation (Nürenberg and Tampé, 2013). Thus, closing the translation cycle by revealing the detailed molecular mechanism of ABCE1 and its role for translation initiation are the two goals of this research.
Beyond the plenitude of well-studied translational GTPases, ABCE1 is the only essential factor energized by ATP, delivering the energy for ribosome splitting via two nucleotide-binding sites. Here, I define how allosterically coupled ATP binding and hydrolysis events in ABCE1 empower ribosome recycling. ATP occlusion in the low-turnover control site II promotes formation of the pre-splitting complex and facilitates ATP engagement in the high-turnover site I, which in turn drives the structural re- organization required for ribosome splitting. ATP hydrolysis and ensuing release of ABCE1 from the small subunit terminate the post-splitting complex. Thus, ABCE1 runs through an allosterically coupled cycle of closure and opening at both sites consistent with a processive clamp model. This study delineates the inner mechanics of ABCE1 and reveals why various ABCE1 mutants lead to defects in cell homeostasis, growth, and differentiation (Nürenberg-Goloub et al., 2018).
Additionally, a high-resolution cryo-electron microscopy (EM) structure of the archaeal post-splitting complex was obtained, revealing a central macromolecular assembly at the crossover of ribosome recycling and translation initiation. Conserved interactions between ABCE1 and the small ribosomal subunit resemble the eukaryotic complex (Heuer et al., 2017). The conformational state of ABCE1 at the post-splitting complex confirms the molecular mechanism of ribosome recycling uncovered in this study. Moving further along the reaction coordinate of cellular translation, I reconstitute the complete archaeal translation initiation pathway and show that essential archaeal initiation factors are recruited to the post-splitting complex by biochemical methods and cryo-EM structures at intermediate resolution. Thus, the archaeal translation cycle is closed, following its bacterial model and paving the way for a deeper understanding of protein biosynthesis.
The focus of this research was to understand the molecular mechanism that lies behind the insertion of tail-anchored membrane proteins into the ER membrane of yeast cells. State-of-art instruments such as LILBID, and Cryo-EM, combined with the introduction of direct electron detectors, were used to analyze the proteins that capture tail-anchored proteins near the ER membrane and help their releases from a chaperone, an ATPase named Get3. Get3 escorts TA proteins to the ER membrane, where both Get3 and the TA proteins interact sequentially to Get3 membrane bound receptors Get1 and Get2. Get1 and Get2 are homologs of mammalian WRB and CAML.
The native host was used to separately produce Get1, Get2, and the Get2/Get1 single chain constructs. The studies showed that when Get1 is expressed alone, Get1 does not seems to be located in the ER membrane but rather in microbodies like shape organelles (or peroxisome). Interestingly, Get1 seems to be located in the ER membrane when it is linked to Get2 as single chain construct.
The localization study of Get2/Get1 fused to GFP shows from the fluorescence intensity that Get2/Get1.GFP has a tube-like morphology or membrane-enclosed sacs (cisterna), implying that Get2/Get1 is actually targeted to the ER membrane and is likely functional. In other words, Get1 and Get2 stabilize each other in the ER membrane.
The expression of Get2/Get1 was found to be already optimum when expressed as single chain construct because the fluorescence counts did not improve when additives such as DMSO or histidine were added. However, when Get1 and Get2 are expressed separately, additives improve their protein production yield. In 1 liter culture, Get1 yield is increased by about 3 mg and Get2 by 1.8 mg. This can be explained by the space that Get1 and Get2 should occupy within the ER membrane as they must coexist with other membrane components to maintain the homeostasis of the cell. Hence, if there were no gain for single chain construct expression, it meant that Get2/Get1 was already well expressed on its own in ER membrane and has reached its optimum expression without the help of additives. The Get2/Get1 overexpression is more stable, tolerated and less toxic for the cells to express it at a high level.
DDM has proved to be the best detergent from the detergents tested to solubilize Get1, Get2, and Get2/Get1.
Thereafter, Get1, Get2 (data not shown), and Get2/Get1 were successfully purified in DDM micelles.
Furthermore, for the first time using LILBID, the actual study has shown that Get1 and Get2 are predominantly a heterotetramer (2xGet1 and 2xGet2) but higher oligomerization may exist as well.
Get3 binds to Get1 in a biphasic way with a specific strong binding of an affinity of 57 nM and the second of 740 nM nonspecific indicative of heterogeneity within the interaction between Get1 and Get3. This heterogeneity is caused by the presence of different conformation of either protein. However, in order to characterize a high-resolution structure model of a specific target one needs highly homogenous and identical molecules of the target protein or complex in solution. The homogeneity increases the chances of growing crystals during crystallography as the good homogeneity will likely generate a perfect packing of unit cells stack (also known as crystal lattice) in the three-dimensional spaces. The same truth goes for the single particles analysis Cryo-EM, especially for smaller complexes where having less or no conformation alterations of specific targets will enable the researcher to classify the particles in 2D and 3D, therefore improving the signal-to-noise-ratio that will ultimately lead to high-resolution structure determination.
Get1, Get2/Get1 and chimeric variants (tGet2/Get1, T4l.Get2/Get1, T4l.Get2.apocyte.Get1) were crystallized but none of the crystals could diffract due to heterogeneity.
This heterogeneity was not only occurring upon the binding of Get3 to its membrane receptors, but seems to be already present within the receptors themselves through possibly different conformation.
In this Ph.D. thesis, the heterogeneity of purified Get2 and Get1 as complex or individually in detergent is then, so far, the limiting factor for obtaining a high-resolution structure model of Get1 and Get2. As mentioned above, the heterogeneity observed was not due to the quality of the sample preparation but rather to the effect of different conformations that could have been native, or just because of the micelle used, as it was proven by the 3-D heterogeneity classification by Cryo-EM.
In general, crosslinking is one way to keep the integrity of protein complexes, however it appeared not to improve the sample quality when it was analyzed in micelles. Often the integrity of some membrane proteins is affected when they are solubilized and purified in detergents.
Finally, in this study, the structural map of Get2 and Get1 complex linked with chimeric protein T4 lysozyme and apocytochrome C b562RIL gene was obtained at 10 Å. However, this single chain construct has a density map corresponding to heterodimer species (one Get1 and Get2). Therefore, based on those data the tertiary structure of Get2/Get1 in micelle is poorly defined. It could be that the membrane extraction in DDM and the purification destabilizes the structure of the complex.
Die Zahl der gramnegativen Bakterien auf der WHO-Liste der Antibiotikaresistenzen hat in den letzten Jahrzehnten erheblich zugenommen. Schätzungen zufolge wird die Antibiotikaresistenz bis 2050 tödlicher sein als Krebs. Die äußere Membran gramnegativer Bakterien ist aufgrund ihres wichtigsten Strukturbestandteils, des Lipopolysaccharids (LPS), sehr anpassungsfähig an Umweltveränderungen. Das LPS macht gramnegative Bakterien von Natur aus resistent gegen viele Antibiotika und führt somit zu Antibiotikaresistenz. Der bakterielle ATP-bindende Kassettentransporter (ABC-Transporter) MsbA spielt eine entscheidende Rolle bei der Regulierung der bakteriellen Außenmembran, indem er das Kern-LPS durch ATP-Hydrolyse über die Innenmembran von gramnegativen Bakterien flockt. Darüber hinaus fungiert diese Floppase als Efflux-Pumpe, indem sie Medikamente durch die innere Membran transportiert, was sie zu einem interessanten Ziel für Medikamente macht. Vor kurzem wurden zwei verschiedene Klassen von MsbA-Inhibitoren entdeckt: (1) Tetrahydrobenzothiophene (TBT), die den LPS-Transport aufheben, und (2) Chinolinderivate, die sowohl die ATP-Hydrolyse als auch die LPS-Translokation blockieren. Darüber hinaus hat die Bestimmung der 3D-Struktur von MsbA durch Rontgen- und Kryo-EM mehrere interessante Zustände der Floppase ergeben. Die Kernspinresonanzspektroskopie ist eine hervorragende biophysikalische Methode zur Ergänzung der vorhandenen 3D-Strukturdaten. Insbesondere ermöglicht die Festkörper-NMR die Untersuchung von Membranproteinen in einer nativen Umgebung (z. B. in einer Lipiddoppelschicht). In der Vergangenheit hat unser Labor mithilfe der Festkörper-NMR einige detaillierte Mechanismen von MsbA aufgedeckt. Trotz der zahlreichen Fortschritte bei der Untersuchung der ABC-Transporterprotein-Superfamilie ist der spezifische Prozess der Substrattranslokation von MsbA noch immer unbekannt. Es wird angenommen, dass dieser Translokationsprozess über die Kopplungshelices (CHs) erfolgt, die sich zwischen der Transmembranregion (TMD) und der Nukleotidbindungsdomäne (NBD) befinden. Nukleotid-Bindungsdomäne (NBD). Zu diesem Zweck wird dem Zusammenspiel zwischen der TMD und der NBD über die CHs besondere Aufmerksamkeit gewidmet, mit dem Ziel, den Prozess der Substrattranslokation mithilfe von funktionellen Assays und Festkörper-NMR zu verstehen. Bei letzterem wurden spezifische Reporter in die CHs eingeführt, um Konformationsänderungen in 2D-spektroskopischen Daten zu verfolgen. Darüber hinaus wurde zeitaufgelöste NMR eingesetzt, um die Auswirkungen verschiedener Substrate in der TMD während der ATP-Hydrolyse in der NBD sichtbar zu machen. Die einzigartigen Reporter in den CHs haben Konformationsänderungen in bestimmten katalytischen Zuständen gezeigt. Darüber hinaus scheinen verschiedene Substrate die Kinetik der ATP-Hydrolyse zu beeinflussen. Die Ergebnisse zeigten, dass einige Substrate einen bevorzugten katalytischen Zustand innerhalb des ATP-Hydrolyse Zyklus aufweisen, der möglicherweise einen gekoppelten oder ungekoppelten Kinasemechanismus hat. Diese Ergebnisse könnten verschiedene Einblicke in die molekulare Struktur potenzieller neuer Antibiotika liefern.
This thesis primarily covers a systematic assessment of quantum chemical methods to predict accurate 19F NMR shifts for fluoroarenes and magnetic exchange coupling constant (J) in organic spin dimers which are basic building blocks for rational designing of organic magnetic materials.
One of the most important goals in chemistry is to design and synthesize molecules with optimum properties. This thesis is divided into two parts: the first part comprises of a systematic effort to find an inexpensive quantum chemical method to predict accurate 19F NMR chemical shifts (within an accuracy of 2 ppm) for perfluoraromatics. Essentially, these strenuous efforts have been devoted to find best DFT functional and basis set combination to predict accurate 19F shifts. In addition,the influence of geometrical parameters, solvents, chemical environment was also analyzed. Various correction approaches were tested to correct the calculated shifts. The influence of various functionals and basis sets was also analyzed on the correction efficiency of an individual scheme. All the NMR calculation methods already being used and correction approaches were verified to predict shifts of three different fluorine-substituted molecular sets. These structure sets include fluorobenzenes, substituted benzenes and fluorine substituted aromatic fused rings (e.g. fluorine substituted anthracene).
In the second part of this thesis, we investigated the accurate prediction of magnetic exchange couplings (J) for organic spin dimers using quantum chemical methods. We analyzed the performance of various DFT methods and various post-HF methods, such as the CASSCF, CASPT2, MSTDISD, DDCI1, DDCI2, DDCI3, and FCI to predict magnetic exchange couplings (J).
Overview of the Chapters:
Chapter 1, presents a brief theoretical introduction to the Schrödinger equation and its application in quantum mechanical calculations, the Hartree-Fock approximation, basis sets, electron correlation energy, and density functional theory (using pure and hybrid functionals).
In chapters 2 and 3, an introduction is given for quantum chemical approaches used to calculate NMR parameters and magnetic exchange coupling constants. We discuss an effective spin Hamiltonian, the Breit-Pauli Hamiltonian (BPH), chemical shielding tensor and total energy relationship, measuring of the NMR spectra, and different techniques to deal with gauge origin problem. In addition, the theoretical background of magnetic exchange coupling constant calculation for spin dimers, the Heisenberg-Dirac-van-Vleck Hamiltonian (HDVV) and the Noodelman's broken-symmetry approach for calculating J values are briefly discussed.
Chapter 4, presents a benchmark study of various DFT functionals and basis sets to calculate accurate C-F bond lengths and 19F chemical shifts. High-resolution NMR spectral data of complex molecules are often difficult to interpret. Great scientific efforts have been devoted to search for a computational approach to interpret experimental NMR data. Quantum chemical methods such as the CCSD(T) method offer high accuracy in calculation of NMR parameters but being computationally too demanding they cannot be applied to large chemical systems. On the other hand, density functional theory (DFT) is achieving a steady progress among diversity of computational techniques. An accuracy within 2 ppm deviation from the experimental values in 19F chemical shifts can be achieved if the NMR calculation is performed using accurate equilibrium geometries, GIAO is used to tackle gauge origin problem and electron correlation is properly treated by employing a high level of theory (e.g. CCSD (T)/cc-pVQZ). We found that the calculation of 19F shielding tensors with the density-functional theory does not provide any noticeable improvement over the HF method. Post-HF theory demands too much computational resources that makes them impossible to use for large systems [35] .
We found that a quantitative prediction of NMR shifts can be made as the errors introduced by theoretical methods are cancelled out while calculating shifts. Various benchmark studies in this thesis show that 19F chemical shifts calculated for perfluoraromatics with the M06-L, BHandH, BHandHLYP in combination with the 6-311+G (2d,p) basis set are within 4 ppm deviation from the experiments. Furthermore, we noted that NMR calculations on accurate
C-F (e.g. PBE/6-311G (d, p)) bond lengths does not show any improvement if the NMR calculation and optimization are performed at the same level of theory. A significant improvement can be achieved on calculated 19F NMR shifts, if some correction schemes are used.
In chapter 4 we discuss various correction schemes applied to correct the calculated 19F chemical shifts. A multi-standard approach (MSTD) was used to minimize the error that may occur due to the difference in the nature of the reference compound and test molecules [122]. We propose another approach to correct shielding constants which is the reference corrected approach. This approach makes a correction similar to the MSTD. We also tested a Linear Regression Correction Approach and we noted that this is the best approach amongst all. This is found to be less dependent on the theoretical method. We use conformation averaging corrections to correct the calculated shifts[126].
...
This work deals with the theoretical investigation of the vibrationally promoted electronic resonance (VIPER) experiment, the intramolecular energy transfer within a rhodamine-BODIPY antenna system initiated by two-photon excitation and a computational study of the photochemical mechanism of the uncaging of the [7-(dimethylamino)coumarin-4-yl]methyl (DEACM) class of photocages . In continuation to Jan von Cosel’s work, the setup for the theoretical investigation of the VIPER experiment has been extended to two-photon absorption (TPA) also including the first-order Herzberg-Teller (HT) effects which are dependent on changes with respect to nuclear coordinates.
The VIPER experiment constitutes an extended form of two-dimensional infrared (2DIR) spectroscopy with a sequence of infrared (IR) and ultraviolet (UV) or visible (vis) pulses. The molecular system under probe is excited initially by a narrow-band IR pump pulse and then electronically excited by an off-resonant UV/vis pulse. An IR probe pulse is applied afterwards to probe the system and record a 2DIR spectrum in combination with the first pulse. Since the lifetime of the vibrational excitation is very short, the electronic excitation by the UV/vis pulse is used to enlarge the lifetime of the excitation in the molecule and thus enable measurements on a longer timescale. Therefore, it becomes easier to study dynamical photochemical processes on long timescales. In the VIPER experiment with TPA, the UV/vis pulse is replaced by a near-infrared (NIR) pulse which offers an intrinsic 3D resolution, minimzed photodamage, a lower noise level and an increased penetration depth. This makes TPA highly attractive for biological systems among a wide range of other possible applications.
The computation of the vibrationally resolved electronic absorption spectra accounts for the Franck-Condon (FC) contributions which are independent of the nuclear framework as well as the HT effects which are dependent on the nuclear coordinates. The FC contributions are dominant for electronically-allowed transitions whereas HT contributions could be important for weakly-allowed or forbidden transitions. Laying emphasis on TPA, the test systems used belong to the category of two-photon active compounds. The initial candidate is dimethylaminonitrodibenzofuran (DMA-NDBF) which has been reported to be a two-photon only caging compound. The other system is a well-known laser dye, a rhodamine derivative of the commercially available rhodamine 101 (Rh101). Rhodamines are also recognized for their excellent TPA characteristics.
The findings for both the test systems show interesting contrasts. The one-photon absorption (OPA) and TPA spectrum together with vibronic couplings present the same lineshape in case of DMA- NDBF and also the HT effects have very weak contributions to the vibronic spectrum. Insignificant HT effects are quite typical for electronically allowed transitions. Overall, the NO2 bending mode exhibits the strongest change in the absorption spectrum upon vibrational pre-excitation, even stronger than in the case of different ring distortion modes that usually show a high VIPER activity. In the case of rhodamine, the vibronic OPA spectrum is pre-dominantly the FC spectrum and the HT couplings have a very weak contribution. The vibronic TPA spectrum is entirely dominated by the HT contributions and hence, the vibrationally resolved TPA spectrum of the rhodamine is a HT-only spectrum. Explanations towards this behaviour have been reported by Milojevich et al. which are holding the change in symmetry of the molecular orbital transitions from the ground to the excited state accountable. No significantly VIPER-active normal modes could be determined owing to the low magnitudes of their dimensionless displacements that are connected to the Huang-Rhys factors. Two ring distortion modes however have been probed but the intensity of their vibrational pre-excitation is observed to be very low.
The other part of this work is concerned with the estimation of the rate of the intramolecular energy transfer within rhodamine-BODIPY dyads. After the investigations on the prospective rhodamine derivatives, the Rho101 derivative shows the highest TPA activity. This linked together with the BODIPY derivative with styryl substituents through an acetylene bond has been probed theoretically as well as experimentally for the excitation energy transfer (EET).
Time-resolved spectroscopic measurements reveal an ultrafast energy transfer process on femtosecond timescales. The theoretical estimation of the EET rates through the Förster theory and the determination of the coupling between the donor and acceptor groups by the transition density cube (TDC) method falls short of the experimental results. Because of this disagreement, quantum dynamics simulations with the multi-layer multi-configuration time-dependent Hartree (ML-MCTDH) method have been performed on an adapted rhodamine-BODIPY molecular dyad which reveal that the energy transfer occurs through transient coherence whose mechanism cannot be described by Förster theory ...
The work of this thesis focuses on the targeting of G-quadruplexes (G4s), wherein several specific and potential ligands were designed, synthesized and characterized for its structural and biological activity. G4s are nucleic acid secondary structures that may form in single-stranded guanine (G)-rich sequences under physiological conditions. Four Guanines (Gs) bind via Hoogsteen-type hydrogen bonds base pairing to yield G-quartets, which in turn stack on top of each other to form the G4. G4s are highly polymorphic, both in terms of strand stoichiometry (forming both inter and intramolecular structures) and strand orientation/topology. The presence of K+ cations specifically supports G4 formation and stability. In the human genome G4 DNA motifs have been found in telomeres, G-rich micro and mini-satellites, up-stream to oncogene promoters and within the ribosomal DNA (rDNA). Human G4 DNA motifs are over-expressed in recombinogenic regions, which are associated with genomic damage in cancer cells.
In the present work, we focus on lead identification with specificity towards the c-MYC promoter G4s. Drug discovery is a highly time consuming and costly process. Lead identification and development are key steps in the drug discovery program. Studies have suggested that a large number of commercially available drugs exhibit deep structural similarity to the lead compounds from which they were developed. Quality lead identification in terms of compounds with high potency and selectivity, favorable physicochemical parameters and in vitro Absorption Distribution Metabolism and Excretion (ADME) parameters are the foremost requirements for the success of the drug discovery process. We herein describe the fragment-based drug design approach for the development of pyrrolidine-substituted 5-nitroindole derivatives as a new class of G4 ligands that exhibit high affinity and selectivity for the c-MYC promoter G-quadruplex. This chapter focuses on the methodology explored whilst finding a suitable hit and its optimization with fragment expansion strategies which undergo efficient G4 binding.
To target G4 DNA, screenings of numerous heterocycles have been reported including indoles, 7-azaindoles, 1H-indazol-3-yl, benzothiazole, imidazo[1,5-a]pyridine, 2,6- diaminopyrimidin-4-ol, 1H-pyrazolo[4,3 d]pyrimidin-7-amine, morpholino, bis-indoles, 2-hydroxynaphthalene-1,4-dione, 1,4-dihydroxyanthracene-9,10-dione, benzofuran and piperonal derived from several alkaloids. In this part of the thesis, we set out to identify new binders targeting the c-MYC G-quadruplex starting from the indole fragment. Several synthetic strategies are reported to optimize and generate best hits starting from 5-nitro indole derivatives by introducing the secondary cationic linked pyrrolidine side chain. Interestingly, all improved versions of G4-indole fragments 5, 7 and 12 contain this 5-nitro functionality, which may aid in the electrostatic binding and contributes to hydrogen binding interactions of the ligands to G4 DNA. In-silico drug design, biological and biophysical analyses illustrated that the substituted 5-nitro indoles scaffolds show preferential affinity towards the c-MYC promoter G-quadruplex compared to other G-quadruplexes and double stranded DNA. In vitro cellular studies confirm that the substituted indole scaffolds downregulate c-MYC expression in cancer cells and have the potential to induce cell cycle arrest in the G0/G1 phase. NMR analysis suggests that 5, 7, and 12 interacts in a fast exchange regime with the terminal G-quartets (5’ and 3’end) in a 2:1 stoichiometry.
To further optimize the fragment generated in chapter II, a novel series of triazole linked indole derivatives as a potential G quadruplex stabilizers have been described in chapter III. The potential ligands can be obtained through an efficient, convergent, synthetic route in moderate to good yields. The synthesized triazole linked indole derivatives are selective towards c- MYC G4-DNA vs. duplex-DNA. The planarity of the aromatic core and its ability to occupy more surface area by stacking over the G4 greatly affect the ability of the compounds to stabilize the G4. Further biophysical and biological studies revealed that the triazole linked nitro indoles are more promising than the amino indole derivatives.
Additionally, the importance of the nitro functional group has been justified by molecular docking studies, where hydrogen-bonding interactions were observed in between the nitro group and the G4 base pairs of the G-quadruplex. In biological findings, most of the synthesized triazole linked nitro indoles has found to be effective against human carcinoma (cervical) HeLa cell lines. Furthermore, western blot and cell cycle analysis confirms that the novel triazole linked 5-nitro indole derivatives (9b) could down-regulate c-MYC oncogene expression in cancer cells via stabilizing its promoter quadruplex structure, arresting cell cycle in G0/G1 phase. NMR analysis suggests that 9b interacts in slow exchange regime with the terminal G-quartets (5’ and 3’-end).
In chapter IV of the thesis, we have developed the synthetic strategies to generate more potent G4 ligands via Knoevenagel condensation. To investigate novel and selective G4 ligands for cancer chemotherapy, we designed and synthesized a series of azaindolin-2-one derivatives (11, 14, 15, 16 and 22) by attaching cationic pyrrolidine side chains and introducing a fluorine atom into the aromatic chromophore (Fig. 3). Fluorine atoms, with high electronegativity and small size, often exhibit unique properties in functional molecules. The electron-withdrawing effect of fluorine could reduce the electron density of the aromatic chromophore, which might favor a stronger interaction with the electron-rich π-system of the G-quartet. In addition, the introduction of fluorine atoms into small molecules might improve lipophilicity and thus the bioavailability. Fluorescent indicator displacement assay (FID) assays suggests that the synthesized azaindolin-2-one derivatives are selective towards c-MYC G4-DNA vs. duplex-DNA and showed potent anticancer activity against human carcinoma (cervical) HeLa cell lines. They down-regulate c-MYC expression in cancer cells via stabilizing its promoter quadruplex structure, arresting cell cycle in G0/G1 phase. Furthermore, NMR spectroscopy suggests that azaindolin-2-one conjugate interacts with terminal G-quartets as well as with the nearby G-rich tract (G13-G14-G15 and G8-G9-G10) of c-MYC quadruplex in intermediate exchange regime.
Standard cancer therapy research targets tumor cells while not considering the damage on the tumor microenvironment (TME) and its associated implications in impairing therapy response. Employing patients-derived organoids (PDOs) and matched stroma cells or a novel murine preclinical rectal cancer model of local radiotherapy, it was demonstrated that tumor cells-derived IL-1α polarizes cancer-associated fibroblasts towards an inflammatory (iCAFs) phenotype. While numerous studies in different tumor entities highlighted the molecular heterogeneity of CAFs, so far there are no clear findings on their functional heterogeneity and relevance in therapy resistance and response. The present study molecularly characterized iCAFs subpopulation among RCA patients as well as the preclinical mouse model and importantly unraveled the detailed molecular mechanism underlying their contribution to impair therapy response. Mechanistically, iCAFs were demonstrated to be characterized by an upregulation of nitric oxide synthase (iNOS) which triggered accumulation of reactive nitrogen species (RNS) and subsequently an oxidative DNA damage response (DDR). Such a baseline IL-1α-driven DNA damage further sensitized iCAFs to a p53-mediated therapy induced senescence (TIS) causing extensive extracellular matrix (ECM) changes and induction of senescence associated secretory phenotype (SASP) that favored tumor progression and hindered tumor cell death. Moreover, iCAFs reversibility and repolarization into more quiescent like phenotype was demonstrated upon IL-1 signaling inhibition by anakinra, a recombinant IL-1 receptor antagonist (IL1RA). Accordingly, treating mice with anakinra or specific deletion of Il1r1 in CAFs sensitized stroma-rich resistant tumors to chemoradiotherapy (CRT). Similarly, targeting CAFs senescence by senotherapy (venetoclax chemical) or employing Trp53 deficient mice reverted therapy resistance among non-responsive tumors in vivo by reducing ECM deposition and consequently favoring CD8+ T cells intratumoral infiltration posttherapy. Importantly, rectal cancer patients that do not completely respond to neoadjuvant therapy displayed an iCAFs senescence program post-CRT. Moreover, these patients presented a baseline increased CAFs content, a dominant iCAFs signature that correlated with poorer disease-free survival (DFS) and a significantly reduced circulating IL1RA serum levels. While reduced pretherapeutic IL1RN gene expression predicted poor prognosis among RCA patients, IL1RA serum levels were associated with rs4251961 (T/C) single nucleotide polymorphism (SNP) in the IL1RN gene. Finally, functional validation assays revealed that conditioned media of PDOs drove inflammatory polarization of fibroblasts and consequently rendered them sensitive to RNS-mediated DNA damage and TIS. Collectively, the study highlighted a crucial and novel role of a CAFs subset, iCAFs, in therapy resistance among RCA patients, shedding light on their functional relevance by identifying IL-1 signaling as an appealing target for their repolarization and successful targeting. Therefore, it makes sense to combine the newly demonstrated and thoroughly proven therapeutic approach of targeting IL-1 signaling in combination with conventional CRT and possibly immunotherapy. This might have a major impact on RCA therapy and be of immense relevance for other stroma-rich tumors.
The overall survival for patients with acute lymphoblastic leukemia (ALL) often is the function of age, in particular in 2019 analysis revealed that 5-year overall survival for patients older than 20 years remains below 35% (American Cancer Society, Cancer Facts &Figures 2019). Importantly, one of the major issues in ALL therapy is the ability of tumor cells to escape the treatment via the establishment of an immunosuppressive environment. The tumor microenvironment has gained tremendous importance in the past decade. This is largely based on the reasoning that, in order to devise better therapeutic strategies for patients, we need to gain better understanding into how malignant cells transform their microenvironment to promote growth, escape immune control and gain therapeutic resistance.
TAM receptors (TAMRs) are engaged in innate immune cells as a feed-back mechanism to terminate the immune response and promote the return to homeostasis (Rothlin et al. 2007). In the context of cancers, aberrant TAMR signaling was mainly explored concerning its pro-oncogenic function (Paolino and Penninger 2016). There are only limited data available suggesting the modulation of cancer immune response via TAMR signaling in highly immunogenic solid tumor models (Paolino et al. 2014; Ubil et al. 2018). So far, however, little is known about their potential indirect immune-modulatory function in hematological malignancies. Taking into account the pronounced importance of TAMR signaling in immune cells combined with the leukemic immune tolerance, the current study focused on the function of TAMR and their ligands in anti-leukemic immunity.
This work uncovers the mechanism of dampening anti-leukemic immune response via TAMR signaling on macrophages using the syngeneic BCR-ABL1 B-ALL mouse model. Using genetic depletion of GAS6 in the host environment or ablation of AXL and/or MERTK receptors in macrophages the bone marrow microenvironment could be rewired in order to achieve an efficient anti-leukemic immune response. In particular, the GAS6/AXL blockade triggers an effective NKand T- cell-dependent anti-leukemic response that results in prolonged survival. This finding specifically tackles the obstacle of inefficient bridging between innate and adaptive immune response typical for hematological malignancies in contrast to solid tumors (E. K. Curran, Godfrey, and Kline 2017).
Besides establishing the vital function of TAMR signaling in anti-leukemic immunity using murine models, the analysis of human blood plasma revealed that age-related immune dysregulation was manifested by significant GAS6 decrease and PROS1 upregulation among elderly donors (>60 y.o.) compared to controls (<25 y.o.). These data are indicative that TAMR signaling likely favors the age-dependent immune system decline, which in turn is associated with a poor survival rate of elderly patients diagnosed with leukemia.
In conclusion, using a preclinical ALL model here it was identified in vivo, that Axl significantly increases upon B-ALL challenge in Mph and NK cells. Therefore, AXL targeting, using the orally bioavailable selective inhibitor Bemcentinib, could serve as a powerful approach to revert early immunosuppression created by leukemia.
Taken together these data propose the AXL receptor as a novel immune checkpoint and attractive candidate for the development of a new therapeutic approach via unleashing the patient’s own immune system to combat leukemic cells.
An overexpression of the E3 ubiquitin ligase TRIM25 is implicated in several human cancers and frequently correlates with a poor prognosis and occurrence of therapy resistance in patients. Previous studies of our group have identified the mRNA encoding the pro-apoptotic caspase-2 as a direct target of the ubiquitous RNA binding protein human antigen R (HuR). The constitutive HuR binding observed in colon carcinoma cells negatively interferes with the translation of caspase-2 mainly through binding to the 5' untranslated region (UTR) of caspase-2 and thereby confers an increased survival of tumor cells. The main objective of this thesis was to unravel novel regulatory proteins critically involved in the control of caspase-2 translation and their impact on therapeutic drug resistance of human colon carcinoma cells. By employing RNA affinity chromatography in combination with mass-spectrometry, among several putative caspase-2 mRNA binding proteins, we have identified the tripartite motif-containing protein 25 (TRIM25) as novel caspase-2 translation regulatory protein in colon carcinoma cells. The constitutive TRIM25 binding to caspase-2 mRNA in two different human colorectal carcinoma cell lines was validated by ribonucleoprotein (RNP)-immunoprecipitation (RIP)-RT-PCR assay and by means of biotin-labeled RNA-pull-down assay. Since caspase-2 is a caspase which is particularly involved in the DNA-damage-induced apoptosis, I tested the functional relevance of negative caspase-2 regulation by TRIM25 for chemotherapeutic drug-induced cell death of different adenocarcinoma cells by RNA interference (RNAi)- mediated loss-of-function and gain-of-function approaches. In the first part of the thesis, I could demonstrate that transient silencing of TRIM25 caused a significant increase in caspase-2 protein levels without affecting the amount of corresponding mRNAs. Mechanistically, the TRIM25 silencing-triggered increase in caspase-2 was totally impaired by cycloheximide, indicating that the stimulatory effects on caspase-2 levels depend on protein synthesis. This finding was corroborated by RNP/polysomal fractionation, which revealed that the transient knockdown of TRIM25 caused a significant redistribution of caspase-2 transcripts from the fraction of RNP particles to that from translationally active polyribosomes.
The second part of my thesis aimed at the elucidation of the functional consequences of the negative caspase-2 regulation by TRIM25 for enhanced tumor cell survival. Thereby, I found that the siRNA-mediated knockdown of TRIM25 caused a significant increase in the chemotherapeutic drug-induced cleavage of caspase-3 and to elevations in cytoplasmic cytochrome c levels implicating that TRIM25 depletion did mainly affect the intrinsic apoptotic pathway. Concordantly, the ectopic expression of TRIM25 caused a reduction in caspase-2 protein levels, concomitant with an attenuated sensitivity of tumor cells to doxorubicin.
To test the functional impact of caspase-2 in the TRIM25 depletion-dependent sensitization to drug-induced apoptosis, I employed a siRNA-mediated knockdown of caspase-2. Interestingly, the strong induction of caspase-3 and -7 cleavage after doxorubicin treatment was fully impaired after the additional knockdown of caspase-2, indicating the sensitizing effects by TRIM25 knockdown depend on caspase-2.
Data from this thesis identified the TRIM25 as a novel RNA-binding protein of caspase-2 mRNA, which negatively interferes with the translation of caspase-2 and which functionally contributes to chemotherapeutic drug resistance of colon carcinoma cells. Interfering with the negative TRIM25-caspase-2 axis may represent a promising therapeutic avenue for sensitizing colorectal cancers to conventional anti-tumor therapies.
Oxidative stress is thought to be a driver for several diseases. However, many data to support this concept were obtained by the addition of extracellular H2O2 to cells. This does not reflect the dynamics of intracellular redox modifications. Cells actively control their redox-state, and increased formation of ROS is a response to cellular stress situations such as chronic inflammation.
In this study, it was shown that different types of ROS lead to different metabolic and transcriptomic responses of HUVECs. While 300 μM extracellular H2O2 led to substantial metabolic and transcriptomic changes, the effects of DAO-derived H2O2 and menadione were low to moderate, indicating that the source and the concentration of ROS are important in eliciting changes in metabolism and gene expression.
Specifically, it was identified that acute increases in ROS transiently inactivate the enzyme ω-amidase/NIT2 of the glutaminase II pathway, which supplies cells with anaplerotic α-ketoglutarate. The pathway has not been studied systematically because, as noted above, the major intermediate, KGM, is not commercially available. In the present study, an internal standard for targeted detection of KGM in cells and blood plasma/serum was used. Deletion of NIT2 by CRISPR/Cas9 significantly reduced α-ketoglutarate levels in HUVECs and elevated KGM levels. It appears that in cell culture conditions, hydrolysis of KGM to α-ketoglutarate is very efficient. Knockout of the glutamine transaminases significantly reduced methionine, suggesting that the glutaminase II pathway is an important source of amino acid replenishment.
Similar to genetic silencing of GLS1 [91,92], HUVECs lacking NIT2 showed reduced proliferation and angiogenic sprouting. Furthermore, our results indicate that, at least in HUVECs, the enzyme also locates in the mitochondria where it interacts with key enzymes of glutamine/glutamate/α-ketoglutarate metabolism.
The data of the present work indicate that the glutaminase II pathway is an underappreciated, redox-sensitive pathway for glutamine utilization in HUVECs. Genetic deletion of NIT2 has considerable physiological effects highlighting the importance of glutamine for ECs.
The health status of every nucleated cell in the human body is monitored through peptides presented by major histocompatibility complex class I (MHC I) to T-cell receptors of CD8+ T-cells. Thereby, the adaptive immune system ensures the recognition and elimination of infected or cancerous cells. MHC I molecules comprise the polymorphic heavy chain (hc) and the light chain β2-microglobulin (β2m). More than 13,000 allomorphs of the MHC I hc have been identified. All MHC I hcs associate with β2m but differ in their binding preferences for peptides, ensuring the presentation of a large peptide pool. After maturation of MHC I hc/β2m heterodimers in the endoplasmic reticulum (ER), most of the peptide-deficient MHC I molecules are recruited to the peptide-loading complex (PLC). There, they go through peptide loading and editing before they are released as stable peptide-MHC I (pMHC I) complexes and traffic to the cell surface for antigen presentation.
During the stringent quality control of MHC I peptide loading and editing within the PLC, the chaperone tapasin in conjunction with the oxidoreductase ERp57 stabilizes peptide-receptive MHC I molecules and alters the peptide cargo for high immunogenicity by catalyzing peptide-exchange. The tapasin-homologue TAP-binding protein related (TAPBPR) is involved in downstream quality control, editing the peptide repertoire of MHC I molecules that slipped through peptide proofreading by tapasin. Both chaperones were shown to adopt similar binding-modes for MHC I, suggesting related mechanisms of peptide editing. Nevertheless, the MHC I specific chaperones operate in different subcellular locations with differing assistance. While TAPBPR mediates peptide-exchange solely in the peptide-poor environment of the cis-Golgi and ER-Golgi intermediate compartment (ERGIC), tapasin functions mainly within the PLC together with ERp57 and the lectin-like chaperone calreticulin. Calreticulin with its lectin-, arm- and C-terminal domain contacts the MHC I heterodimer, ERp57 and the C-terminal domain of tapasin, respectively. Notably, the interaction site between calreticulin and tapasin has not yet been elucidated experimentally at molecular detail. The depletion of tapasin leads to a compromised immune response and a change in the pool of peptide cargo. The numerous MHC I allomorphs vary in their plasticity and their dependence on tapasin for the loading of optimal peptides. Moreover, the conformational plasticity of MHC I correlates with their dependence on tapasin. However, the molecular basis on how tapasin edits the various MHC I allomorphs and the structural features that are essential for peptide exchange catalysis at atomic resolution remained elusive.
In the first part of this thesis, the trimeric complex of tapasin–ERp57/calreticulin was analyzed. To this end, laser induced liquid bead ionization mass spectrometry (LILBID-MS) was performed as part of a collaboration and revealed the trimeric assembly for tapasin–ERp57 and calreticulin. Furthermore, additional to a wildtype construct of calreticulin, a second construct, lacking the acidic helix of calreticulin that was found to come to close contact with tapasin, was utilized for isothermal titration calorimetry (ITC). A micromolar affinity of wildtype calreticulin to tapasin–ERp57 was determined. Previous biochemical and NMR studies utilizing the P-domain of calreticulin and solely ERp57 provided a micromolar affinity for the complex of calreticulin and ERp57. In this study, no interaction of calreticulin lacking the acidic helix with tapasin–ERp57 could be measured by ITC. However, these results undergo with findings that calreticulin lacking the acidic helix impairs the function of the PLC. Most likely, the negatively charged acidic helix is located in a groove of tapasin, carrying a more positive charge. Taken together, the functional data demonstrates the importance of the acidic helix of calreticulin for assembly of the trimeric subunit of calreticulin/tapasin–ERp57.
In the main part of this study an MHC I–tapasin–ERp57 complex was structurally analyzed. Therefore, a photo-triggered approach was chosen to assemble the transient complex of MHC I–tapasin–ERp57. Various allomorphs were screened for complex formation with the tapasin–ERp57 heterodimer after photocleavage by size exclusion chromatography (SEC), resulting in mouse MHC I H2-Db as the suited allomorph. Microseed matrix screening was performed. Crystals diffracting X-rays to a resolution of 2.7 Å were obtained showing one tetrameric tapasin–ERp57–MHC I complex per asymmetric unit.
The MHC I-chaperone structure shows molecular rearrangements upon MHC I engagement and unveils structural features of tapasin, involved in peptide-exchange catalysis...
The focus of this thesis is the integral membrane protein Escherichia coli diacylglycerol kinase (DGK). It is located within the inner membrane, where it catalyzes the ATP-dependent phosphorylation of diacylglycerol (DAG) to phosphatic acid (PA). DGK is a unique enzyme, which does not share any sequence homology with typical kinases. In spite of its small size, it exhibits a notable complexity in structure and function. The aim of this thesis is the investigation of DGK’s structure and function at an atomic level directly within the native-like lipid bilayer using MAS NMR. This way, a deeper understanding of DGK’s catalytic mechanism should be obtained.
First, the preparation of DGK was optimized, leading to a sample, which provides well-resolved MAS NMR spectra. The high quality MAS NMR spectra formed the foundation for the second step, the resonance assignment of DGK’s backbone and side chains. The assignment was performed at high magnetic field (1H frequency 850 MHz). The sequential assignment of immobile domains was carried out using dipolar coupling based 3D experiments, NCACX, NCOCX and CONCA. The measurement time could be reduced by paramagnetic doping with Gd3+-DOTA in combination with an E-free probehead. The sequential assignment was mainly performed using a uniformly labelled sample (U-13C,15N-DGK). Residual ambiguities could be resolved by reverse labelling (U-13C,15N-DGK-I,L,V). Resonances could be assigned for 82% of the residues, from which 74% were completely assigned. For validation, ssFLYA was applied, which is a generally applicable algorithm for the automatic assignment of protein solid state NMR spectra. Its principal applicability for demanding systems as membrane proteins could be proven for the first time. Overall, ~90% of the manually obtained assignments could be confirmed by ssFLYA. For the completion of DGK’s assignment, J-coupling based 2D experiments, 1H-13C/15N HETCOR and 13C-13C TOBSY, were carried out to detect highly mobile residues. This way, residues of the two termini and the cytosolic loop, which were not detectable by dipolar coupling based experiments, could be assigned tentatively. Whereupon, peaks for arginine and lysine were assigned unambiguously to Arg9 and Lys12. Overall, ~84% of the residues could be assigned by the applied NMR strategy. Furthermore, a secondary structure analysis was carried out. It showed substantial similarities between wild-type DGK, its thermostable mutant determined both by MAS NMR and the crystal structure of wtDGK. However, there are few differences around the flexible regions most likely caused by the high mobility of these regions. During the assignment procedure, no systematic peak doublets or triplets were detected, indicating that the DGK trimer adopts a symmetric conformation. This is in contrast to the X-ray structure, which shows asymmetries between the three subunits. Especially, crystal packing may be a potential source for these structural asymmetries.
On the basis of the nearly complete assignment of DGK, the apo state was compared with the substrate bound states. Perturbations in peak position and intensity of the substrate bound states were analysed for all assigned residues in 3D and 2D spectra. The nucleotide-bound state was emulated by adenylylmethylenediphosphonate (AMP-PCP), a non-hydrolysable ATP analogue, whereas the DAG-bound state was mimicked by 1,2-dioctanoyl-sn-glycerol (DOG, chain length n = 8). Upon nucleotide binding, extensive chemical shift perturbations could be observed. These data provide evidence for a symmetric DGK trimer with all of its three active sites concurrently occupied. Additionally, it could be demonstrated that the nucleotide substrate induces a substantial conformational change. This most likely supports the enzyme in binding of the lipid substrate, indicating positive heteroallostery. In contrast, the overall alterations caused by DOG are very minor. They involve mainly changes in peak intensities. For DGK bound with either AMP-PCP+DOG or only AMP-PCP, a similar spectral fingerprint was observed. This implies that binding of the nucleotide seems to set the enzyme into a catalytic active state, triggering the actual phosphoryl transfer reaction.
The investigation of DGK’s remarkable stability and the cross-talk between its subunits forms the last part of this thesis. This demands for the identification of key intra- and interprotomer contacts, which are of structural or functional importance. For this purpose, 13C-13C DARR and 2D NCOCX spectra with long mixing times were recorded using high field MAS NMR. Additionally, DNP-enhanced 13C−15N TEDOR experiments were conducted on mixed labelled DGK trimers to enable the visualization of interprotomer contacts. With the applied NMR strategy, intra- (Arg32 - Trp25/ Glu28/ Ala29 and Trp112 - Ser61) and interprotomer (ArgNn,e - AspCg/ GluCd/ AsnCg) long-range interactions could be identified.
Uncontrolled constitutive activation of Wnt signaling is a hallmark of colorectal cancer (CRC), which is responsible for the initiation of the vast majority of CRC cases (Fearon and Vogelstein, 1990; Morin et al., 1997; Wood et al., 2007). Paneth cells support the small intestinal stem cells by providing them with the required niche factors and especially Wnt3. Although the normal colonic epithelium does not contain Paneth cells, Paneth cell metaplasia is frequently observed in human and mouse adenoma (Joo et al., 2009). The occurrence of Paneth cells suggests the presence of high levels of Wnt ligands with unknown function in the tumor microenvironment of Wnt-independent tumor cells. Tumor progression is recognized as result of evolving crosstalk between tumor cells and their surrounding non-transformed stromal cells (Hanahan and Weinberg, 2011; Wang et al., 2017). Although Wnt signaling has been intensively studied in colorectal cancer (CRC) cells (Zhan et al., 2017), it remains unclear whether Wnt activity in the tumor-associated stroma contributes to the tumor malignancy. The present thesis used the organoid 3D cell culture system, genetically modified mouse models as well as next generation sequencing technology to identify and characterise the role of Wnt signaling in the tumor microenvironment of CRC.
Uncaging approach, native membrane dynamics and lipidic cubic phases in biomolecular solid-state NMR
(2019)
It was previously shown for the Escherichia coli diacylglycerol kinase (DgkA) that enzyme-reactions at the membrane interface can be monitored by solid-state NMR. However, such studies can face problems due to limited accessibility of the active sites: Natural substrates for membrane enzymes, but also ligands for membrane proteins or lipid mediators, are either partitioning into the membrane and cannot be added easily, or if soluble exhibit accessibility restrictions, as they cannot freely pass through lipid bilayers. This situation complicates quantitative kinetic analysis of biochemical processes such as enzyme activity, ligand binding, but also oligomerization or folding reactions in the membrane or at its interface under MAS NMR conditions.
To overcome these limitations the feasibility and possible advantages of the uncaging approach as a new tool for biomolecular solid-state NMR to trigger reactions by light have been explored. DgkA’s enzymatic activity, exemplary of a biochemical process on the membrane interface, was thereby triggered in situ during MAS by light-induced release of its substrates that were rendered inactive with photolabile protecting groups. To be capable of uncaging sufficient amounts of substrate during MAS to follow the enzymatic reaction via 31P real-time NMR measurements, several illumination variants including an existing illumination setup to study retinal proteins under cryogenic conditions via DNP enhanced NMR were tested. As uncaging of micromole amounts of substrates requires a higher flux compared to initiation of a photocycle in retinal proteins, a new illumination setup was built with Bruker Biospin and Leoni Fibertech. It consists of a modified MAS probe and a suitable fiber bundle, allowing to efficiently couple light from high power LEDs into a sapphire rotor containing the sample, without disturbing the magnetic field homogeneity or sample rotation. By reducing the sample volume to the illuminated area up to 60 mM ATP were released by uncaging NPE ATP to initiate DgkA’s activity in several tested membrane mimetics. These mimetics included liposomes and bicelles, which are well established in the field of biomolecular solid state NMR as well as the optically transparent lipidic cubic phase of monoolein, widely used in membrane protein crystallography, but not yet well characterized as membrane mimetic under MAS conditions. A unique and powerful but compared to time and spatial resolution often underrepresented advantage of the uncaging approach for biophysical studies has been demonstrated by successful uncaging of a non-miscible lipid substrate to trigger DgkA’s kinase reaction: Initiation of processes that cannot easily be triggered by mixing. Examples of these are reactions involving highly hydrophobic, membrane partitioning compounds including lipid substrates, ligands or interaction partners, but also oligomerization or folding of biomacromolecules. The herein performed experiments therefore serve as a first demonstration of the uncaging approach’s feasibility and compatibility with a wide variety of membrane mimetics and give a first indication of its potential for a variety of biomolecular solid state NMR experiments.
As high accessibility for solutes has been a second focus for the choice of membrane mimetics, DgkA’s activity in the lipidic cubic phases of monoacylglycerols with its two continuous networks of water channels has been further characterized. Kinetic parameters obtained from 31P real time solid state NMR experiments revealed that DgkA’s activity is similar to activities obtained in swollen cubic phases in a bath solution with wider water channels. Diffusion of ATP in a non swollen cubic phase was however strongly reduced compared to ATP in solution as diffusion measurements showed. Therefore, saturation of the enzyme required distinctly higher ATP concentrations. These results thereby underline the advantage of a non invasive and label free method like NMR to directly gain information about enzymatic reactions of immobilized enzymes in porous materials. The obtained wealth of information from 31P real time NMR experiments and biochemical assays in different membrane mimetics in presence and absence of lipid substrates and activators also provided further insight into DgkA’s enzymatic activity. It confirms ATP binding and hydrolysis in the absence of a lipid substrate, in agreement with the proposed mode of substrate binding, and allowed to estimate the in vivo relevance of previously observed ATPase activity in liposomes.
Further exploration of the cubic phase as membrane mimetic for protein solid state NMR revealed its high stability under MAS at elevated temperatures and capacity to reconstitute sufficient amounts of DgkA. Unlike monoolein, DgkA was cross-polarizable in a cubic phase and exhibited similar dynamics compared to DgkA reconstituted into liposomes, allowing to acquire the herein shown dipolar coupling based 2D protein spectra. As lipidic cubic phases are not containing phospholipids, monoacylglycerols could be especially useful as membrane mimetics for 31P correlation spectra. Initial experiments under DNP conditions, where in liposomes line broadening causes severe overlap of phospholipid signals and unspecific cross polarization highlight this aspect.
In summary, herein reported results of the experiments performed with lipidic cubic phases demonstrate that they are robust and versatile membrane mimetics. They could be of advantage for a variety of solid-state NMR experiments where either optical transparency for efficient illumination is desired, accessibility for solutes and membrane components under MAS is required, or interference of phosphorous signals of other membrane mimetics must be avoided.
In the second chapter of this thesis 1H solid-state NMR as a label free method to probe membrane order and dynamics directly within a cellular and disease relevant context was used to observe the effects of soluble epoxide hydrolase (sEH) encoding gene knock-outs on membrane dynamics. Knock-out of the sEH encoding gene changed the overall membrane dynamics in the physiological temperature range of native membranes derived from mouse brains, making the bulk membrane more dynamic. To confirm that these effects are related to the enzymatic activity of sEH, substrates and products of sEH were added to evaluate their effects on membrane dynamics. 19,20 dihydroxydocosapentaenoic acid (DHDP), a product of sEH, partially reversed the knock out phenotype in a concentration dependent manner whereas the substrate 19,20 epoxydocosapentaenoic acid did not cause any effects. As both polyunsaturated fatty acids did not show differences in phase behavior in a simple phospholipid bilayer these results provide evidence that the previously observed concentration dependent DHDP induced relocation of cholesterol away from detergent resistant lipid raft fractions is associated with alteration of membrane dynamics. Therefore, also the effect of cholesterol removal via cyclodextrin on membrane dynamics was analyzed. Removal of cholesterol led to a similar temperature profile of wild type and knock out membranes thereby supporting the hypothesis that DHDP induced relocation of cholesterol is causing altered membrane dynamics. These alterations have been shown by the lead authors of the collaborative research project to induce relocation of various membrane proteins and are involved in the development of diabetic retinopathy. Furthermore, in this context inhibition of sEH has been shown to inhibit diabetic retinopathy and proposed as target for prevention of one of the leading causes of blindness in the developed world.
Bacteria constantly attempt to hold up ion gradients across their membranes to maintain their resting potential for routine cell function, while coping with sudden environmental changes. Under abrupt hyperosmotic conditions, as faced when invading a host, most bacteria restore their turgor pressure by taking up potassium ions to prevent death by plasmolysis. Here, the potassium transporter AB, or KtrAB for short, is a key player. KtrAB consists of the membrane-embedded KtrB dimer, which includes two pores organized in tandem, and a cytoplasmic, octameric KtrA ring, which regulates these two pores. The KtrB subunits alone were suggested to function as rather non-selective ion channels translocating potassium and sodium ions. The KtrA subunits confer transport velocity, K+ selectivity as well as Na+ and nucleotide dependency to the Ktr system. The nucleotide regulation by binding to KtrA is rather well characterized. In contrast, the regulatory role of Na+ remains elusive. Controversially discussed is how selective the ion translocation by KtrB is and how KtrA affects it. Although there are several functional and structural data available of KtrAB and its homolog TrkAH, the selectivity of the ion translocation was never thoroughly addressed. The functional characterization of whether KtrAB is a selective ion channel and how selectivity is achieved is in the focus of this thesis. Since selectivity is usually defined by the ion channels’ selectivity filter contained in the pore-forming domain, a particular attention was laid on the ion-translocating subunits KtrB.
KtrB belongs to the superfamily of K+ transporters (SKT). Each KtrB monomer consists of four covalently attached M1-P-M2 motifs, each motif is made of two transmembrane (TM or M) helices that are connected by a pore (P) helix. The four motifs, referred to as domains D1 to D4, are arranged in a pseudo-fourfold symmetry and together form the pore for potassium ion translocation. Each pore contains two structural features thought to be involved in ion selectivity and ion gating. These are the non-canonical selectivity filter and the intramembrane loop. The selectivity filter is localized at the extracellular side of the pore and mostly shaped by the backbone carbonyl groups of the loops connecting the P and M2 helices in each domain. In KtrB, each P-loop contains only one highly conserved glycine residue instead of the classical -TVGYG- signature sequence of a K+ channel. This simple constructed selectivity filter led to the hypothesis that KtrAB would only have low ion selectivity. The intramembrane loop is formed by broken helix D3M2 and is located directly under the selectivity filter. It consists mostly of polar residues and acts as a molecular gate restricting ion fluxes. The intramembrane loop has been shown to be regulated by nucleotide binding to KtrA. Additionally, it could directly or indirectly be affected by Na+ binding. Further, the loop might even be involved in ion selectivity because it presents a physical barrier inside the pore.
To address the ion selectivity of the Ktr system, first, the ion binding specificity of KtrB was investigated. Binding affinities of different cations to KtrB were determined using isothermal titration calorimetry (ITC). For this, KtrB from Vibrio alginolyticus was heterologously produced in and purified from Escherichia coli. 12 L of culture roughly yielded 4 to 8 mg of the functional KtrB dimer in detergent solution. ITC measurements were performed in two different buffers, one choline-Cl-based and one LiCl-based buffer. No differences in the affinity between Na+ (KD = 1.8 mM), K+ (KD = 2.9 mM), Rb+ (KD = 1.9 mM) or Cs+ (KD = 1.6 mM) were detected in the choline-Cl-based buffer; only Li+ did not bind. In contrast, ITC measurements in LiCl-based buffer revealed a significant preference for K+ (KD = 91 µM) over Rb+ (KD = 2.4 mM), Cs+ (KD = 1.7 mM) and particularly Na+ (for which no binding was observed). Similarly, the presence of low millimolar NaCl concentrations in the choline-Cl-based buffer led to a decreased KD value of 260 µM. Hence, small cations, which usually are present in the natural environment, seem to modulate the selectivity filter for a better binding of K+ ions providing K+ selectivity. In fact, the low binding affinities of the other ions could indicate that they do not even bind to the selectivity filter but to the cavity. However, ITC competition experiments showed that all four ions compete for the same or overlapping binding sites, with Rb+ and Cs+ even blocking K+ binding at concentrations 10-fold above their binding affinities. Importantly, at physiological NaCl concentrations of 200 mM, the apparent binding affinity for K+ to KtrB was still 3.5 mM. This suggested that Na+ can also bind to KtrB’s selectivity filter but with a comparably low binding affinity providing an unexpectedly high preference for K+ ions.
...
Nitric oxide (NO) is a potent mediator with pleiotropic functions such as inhibition of platelet aggregation, smooth muscle relaxation and regulation of neuronal transmission. These effects are mostly mediated by intracellular NO-sensitive guanylyl cyclases (GCs) which convert GTP into the second messenger, cGMP. This messenger in turn activates multiple downstream effectors such as cGMP-dependent protein kinases, cGMP-regulated ion channels and cGMPdependent phosphodiesterases. Mammalian NO-sensitive GCs are obligate heterodimers of an α and β subunit each. Given that these enzymes play a key role in cGMP-mediated pathways, one may anticipate that mechanisms other than allosteric activation via NO may exist to regulate the production and turnover of cGMP. In this thesis, novel aspects of the regulation of the most abundantly expressed GC heterodimer α1β1 are presented.
A possible mechanism of regulation that was tested here, is tyrosine phosphorylation. Using anti-phosphotyrosine antibodies, the phosphorylation of the β1 subunit was detected after incubation of β1-overexpressing COS-1 cells with protein tyrosine phosphatase (PTP) inhibitors such as pervanadate and bpV(phen). β1 phosphorylation on tyrosines was also observed in PC-12 cells which endogenously express GC and in rat aorta after inhibition of PTPs. Furthermore, hydrogen peroxide was found to be a physiological stimulus for the induction of reversible β1 tyrosine phosphorylation in intact cells. Using phenylalanine mutants of different tyrosines, residue 192 (Y192) of β1 was identified as the major phosphorylation site. Consistent with this finding, sequence analyses showed that Y192 forms part of a motif that resembles a preferential target site for Src-like kinases. When tyrosine-phosphorylated, this motif exposes a typical SH2 docking site for members of the Src kinase family.
Experiments with inhibitors of Src kinases, PP1 and PP2, clearly showed that phosphorylation of Y192 is Src-dependent. Preincubation of β1-expressing cells with these inhibitors significantly reduced the level of phosphorylated β1 after bpV(phen) treatment. Furthermore, co-expression of β1 with Src led to a strong phosphorylation of this subunit. Co-precipitation experiments showed that Src interacts with GC. Interestingly, kinases of the Src family are recruited to β1 via the SH2 domain upon phosphorylation of Y192. Together, these results indicate that Src kinases phosphorylate tyrosine 192 thereby creating a docking site for their own SH2 domains. Kinase bound to GC may then catalyze phosphorylation of GC or other downstream effectors. Inhibition of PTPs altered GC activity in two ways: it increased both the basal activity and the YC-1- and BAY 41-2272-stimulated activity two-fold, and it reduced the sensitivity of the enzyme towards NO. The detailed mechanism of action is still unknown, but experiments using the mutant β1[Y192F] demonstrated that residue 192 is not responsible for these effects.
Another major focus of this thesis was the identification of novel GC binding proteins. Using the yeast two-hybrid approach, the carboxy-terminal portion of a protein named AGAP1 (amino acid (aa) 399-804) was found to interact with the catalytic domain of α1 (aa 466-690) and with the regulatory domain of β1 (aa 1-348). Human AGAP1 is a multidomain protein of 804 amino acids with a calculated molecular mass of 89,1 kDa comprising an Arf-GAP (GAP:GTPase activating protein), a putative GTPase domain, two Ankyrin repeats and a PHdomain. Co-precipitation experiments using lysates from mammalian cells overexpressing both binding partners confirmed the interaction of AGAP1 with the GC subunits. Immunofluorescence analyses demonstrated that AGAP1 co-localizes with GC in the cytoplasm of COS-1 cells.
In Northern blots, AGAP1 mRNA was detected in various human and murine tissues showing a comparable expression pattern described for the mRNA of α1 and β1. Using an AGAP1-specific antibody, endogenous protein was precipitated from lysates of HEK-293 cells derived from human embryonic kidney. The same antibody efficiently cross-reacted with the rat homologue (rAGAP1) and immunoprecipitated endogenous rAGAP1 from lysates of PC-12 cells, aorta and heart. The molecular mass of rAGAP1 is larger than that of the human protein, possibly due to an additional exon present in the rat genome. Like β1, AGAP1 is a substrate for tyrosine kinases. Phosphorylation of AGAP1 was detected after inhibition of PTPs or by coexpression of Src. Furthermore, the kinase inhibitor PP2 strongly impaired phosphorylation of AGAP1 after pervanadate treatment suggesting that tyrosine kinases of the Src family are involved. Measurements of cGMP production showed that AGAP1 has no influence on the activity of NO-sensitive GC. Interestingly, inhibition of PTPs potently increased the complex formation between AGAP1 and GC indicating that the interaction between these two proteins is modulated by reversible tyrosine phosphorylation. Whether this effect is due to the phosphorylation of AGAP1 or GC is still unknown. AGAP1 associates with endosomes and exposes Arf-GAP activity towards Arf1 and Arf5 which are involved in vesicular transport. Thus, one may hypothesize that binding of α1β1 to AGAP1 targets GC to distinct subcellular compartments in close proximity to cGMP-dependent effectors, thereby optimizing cGMP generation and fostering cGMP-driven actions.
Taken together, these results demonstrate that beside the modulation of GC by NO the enzyme is regulated by tyrosine phosphorylation and interaction with AGAP1.
Bioactive small molecules are used in many research areas as important tools to uncover biological pathways, interpret phenotypic changes, deconvolute protein functions and explore new therapeutic strategies in disease relevant cellular model systems. To unlock the full potential of these small molecules and to ensure reliability of results obtained in cellular assays, it is crucial to understand the properties of these small molecules. These properties encompass their activity and potency on their designated target(s), their selectivity towards unintended off-targets and their phenotypic effects in a cellular system. Approved drugs often engage with multiple targets, which can be beneficial for some applications such as treatment of cancer where several pathways need to be inhibited for treatment efficacy. However, targeting multiple key proteins in diverse pathways also increases the possibility for unspecific or unwanted side effects. For many drugs the entire target space that they modulate is not known. This makes it difficult to use these drugs for target deconvolution or functional assays with the aim to understand the underlying biological processes. In contrast to drugs, for mechanistic studies, a good alternative are chemical tool compounds so called chemical probes that are usually exclusively selective as well as chemogenomic compounds, that inhibit several targets but have narrow selectivity profiles. Because they are mechanistic tools, chemical tool compounds must meet stringent quality criteria and they are therefore well characterized in terms of their potency, selectivity and cellular on-target activity. To ensure that an observed phenotypic effect caused by a compound can be attributed to the described target(s), it is essential to study also properties of chemical tools leading to unspecific cellular effects. There are a variety of unspecific effects that can be caused by physiochemical compound properties that can interfere with phenotypic assays as well as functional compound evaluations. One of these effects is low solubility causing toxicity or intrinsic fluorescence potentially interfering with assay readouts. But unanticipated cellular responses can also arise from unspecific binding, accumulation in cellular compartments or damage caused to organelles such as mitochondria or the cytoskeleton that can result in the induction of diverse forms of cell death.
In this study, we investigated the influence of a variety of small molecules on distinct cell states, by establishing and validating high-content imaging assays, which we called Multiplex assay. This assay portfolio enabled us to detect different cellular responses using diverse fluorescent reporters, such as the influence of a compound on cell viability, induction of cell death programs and modulation of the cell cycle. Additionally, general compound properties such as precipitation and intrinsic fluorescence were simultaneously detected. The assay is adaptable to assess other cellular properties of interest, such as mitochondrial health, changes in cytoskeletal morphology or phospholipidosis. A significant advantage of the assay is that we are using live cells, so we can capture dynamic cellular changes and fluctuations that can be crucial for the understanding of cellular responses.
The introduction of a trigonal boron atom into a polyaromatic hydrocarbon (PAH) core is an extremely powerful tool to provide organic scaffolds with optoelectronic properties as well as optimal packing in the solid state. However, boron-doped PAHs (B-PAHs) often display low processability due to their poor solubility. The distortion of the molecular scaffold provides a suitable strategy to enhance the solubility properties of B-PAHs while maintaining good stacking properties and sufficient electronic conjugation.
Extreme distortion of the molecular structure can be achieved in helical-shaped PAHs, namely helicenes which are screw-shaped inherently chiral polycycles, formed by ortho-fused aromatic or heteroaromatic rings. The presence of a helical structure in B-PAHs is expected to strongly influence their physico-chemical properties leading to compounds characterized by peculiar features promising for applications in next generation functional materials. Despite the great potential of this class of compounds, only few examples of borahelicenes have been reported in the literature and those mainly consist of carbohelicene-based structures. However, the considerable structural diversity achievable by introducing different boraheterocycles (oxaborine, borole, borepin) and other heteroaromatic rings (thiophene, furan, pyrrole) into the same helical scaffold, suggests that a large variety of compounds with intriguing features could be accessible via currently unexplored synthetic routes. The design, synthesis, and properties investigation of new boraheterohelicenes (BHHs) is therefore a relevant research topic and is the object of this PhD project, aimed to obtain several BHHs with structural diversity, as well as to study their reactivity, electrochemical and photophysical features for better understanding their potential as building blocks for material science.
The thesis work was carried out in part at the University of Milan in the laboratories of Prof. Emanuela Licandro and in part at the Goethe Universität Frankfurt am Main under the supervision of Prof. Dr. Matthias Wagner, within a co-tutelle programme. Owing to the long-standing expertise of Prof. Licandro group in the synthesis of tetrathia helicenes and that of Prof. Dr. Wagner group in the synthesis of boron-doped PAHs (e.g. boron helicene 4BH; Figure 1), I conceived this PhD project designing a series of thiahelicenes containing one or more B-O bond into the helical scaffold.Tetrathia helicenes, consisting of thiophene and benzene rings fused in an alternating fashion, are configurationally stable heterohelicenes which exist as pair of enantiomers.
This class of molecules is particularly interesting since it merges the properties of oligothiophenes with those of helicenes, giving rise to systems with peculiar electronic and chiroptical properties which make them appealing building blocks for applications in manifold fields of science, including optoelectronics, catalysis and biology.
The introduction of trigonal boron atom into a thiahelicene scaffold gives rise to a novel class of unexplored boron π-conjugated molecules with potentially interesting features.
The present Ph.D. thesis was therefore intended to provide a meaningful contribution in the development of innovative and versatile syntheses of BO-doped tetrathia helicenes as well as the study of their stereochemical and optoelectronic properties to identify potential applications of these systems in material science. The first selected structures containing one or two oxaborine rings in the helical scaffold are shown in figure 2. The presence of the bulky mesityl group at the boron atom is necessary to ensure stability to the molecule.
It is noteworthy that compound 2 is the skeletal isomer of 1, as the direction of the B-O bond is opposite in the two molecules. In the course of the research work, after the evaluation of the photophysical properties of 1, helicene 2 was designed to get information on the structure-property relationship and evaluate how the position of the BO-bond into the helical scaffold can influence the electronic properties of BO-doped thiahelicenes.
N6-methyladenosine (m6A) is the most abundant and well understood modification in eukaryotic mRNA and was first identified in polyadenylated parts of the mRNA.The distinct distribution of m6A in the transcriptome with special enrichment in long internal exons, 39UTRs and around stop codons was uncovered by early biochemical work and later on antibody based sequencing techniques. The so called m6A writer, reader and eraser machinery is responsible for the dynamic and with that regulatory nature of the m6A modification. As m6A writer, the human N6-methyltransferase complex (MTC) cotranscriptionally methylates the central adenine within a RRACH (preferably GGACU) sequence context to form m6A in the nascent RNA chain.9–15 The catalytic core of the complex is formed by the two proteins METTL3 and METTL14, with the active site located in the methyltransferase domain (MTD) of METTL3.16–18 The DPPW motif near the methyl donor S-adenosylmethionine (SAM) binding site in this MTD was postulated to bind the target adenine during catalysis. Moreover, a positively charged groove in the METTL3-METTL14 interface, the C-terminal RGG domain in METTL14 and the zinc finger motifs in METTL3 were identified as important domains for RNA binding. However, to date there are no full-length or substrate-RNA-bound structures of the catalytic METTL3-METTL14 complex.
In addition, a set of accessory proteins assembles to the METTL3-METTL14 heterodimer to form the full MTC, mediated by WTAP that firmly binds to the N-terminal leader helix in METTL3.20 WTAP was shown to locate the whole complex to the nuclear speckles and can modulate m6A deposition to specific sites in the RNA. Moreover, WTAP acts as binding platform for other accessory proteins including VIRMA, RBM15, ZC3H13 and HAKAI that are mostly identified to mediate position specific methylation. For example, RBM15 was shown to mediates region-selective methylation in a WTAP dependent manner, directing specificity towards U-rich sequences.
The observed specificity of the methyltransferase complex to methylate only site specific DRACH sequenced is still poorly understood. Some possible modulators like the role of the accessory proteins are under investigation, however, the structural context of the RNA methylation sites or a structural preference of the complex have been mainly neglected so far. Moreover, the structural dynamics of this methylation process still remain elusive. This thesis contributes to the afore-mentioned aspects by analysis of the methylation process regarding RNA structure sensitivity with enzymatic activity assays and its dynamic nature by implementing a smFRET approach.
We hypothesized the target RNA secondary structure to be an additional important modulator of methylation efficiency, based on the RNA binding elements of the complex (positively charged binding groove, zinc finger domain, RGG domain) and the supposed target adenine binding in the active site. Here, we postulated the possibility for a flipped-out adenine to be of special relevance, which is closely related to the local stability of the target adenine containing structure. Moreover, efficient binding of the protein complex to the RNA should require the ability to anchor the RNA on both sides of the target sequence.
Protein quality control (PQC) machinery is in charge of ensuring protein homeostasis in the cell, i.e. proteostasis. Chaperones assist polypeptides throughout their maturation until functionality is achieved. This process might be disrupted in the presence of mutations or external damaging agents that affect the folding and stability of proteins. In this case, proteins can be efficiently recognized and targeted for degradation in a controlled manner. Ubiquitylation refers to the covalent attachment of one or more ubiquitin moieties to faulty proteins, thus triggering their degradation by the 26S proteasome.
More than 30% of proteins need cofactor molecules. Lack of cofactors renders proteins non-functional. We wanted to understand how the PQC deals with wild-type proteins in the absence of their cofactors. Several studies have indicated the importance of the riboflavin-derived cofactor FAD in the stability of individual flavoproteins, and hence we assumed that loss of flavin should mediate a targeted degradation of this group of proteins. Indeed, our mass spectrometry experiments showed that flavoproteome levels decreased under riboflavin starvation. The oxidoreductase NQO1 was used as a model enzyme to further investigate the mechanism of flavoproteome targeting by the PQC. We showed that cofactor loading determines ubiquitylation of NQO1 by the co-chaperone CHIP, both in vivo and in vitro. Furthermore, subtle changes in the C-terminus of NQO1 in the absence of FAD seemed to be crucial for this recognition event. ApoNQO1 interactome differed from holoNQO1. Chaperones and degradation factors were enriched on NQO1 upon cofactor withdrawal, probably to support maturation and prevent aggregation of the enzyme.
Loss of protein folding and stability, even to a small extent, can enhance the aggregating behavior of proteins. Proper loading with FAD reduced the co-aggregation of NQO1 with Aβ1-42 peptide. We assumed that the flavoproteome might represent aggregating-prone species under riboflavin deprivation. Supportingly, reversible apoNQO1 aggregates were observed in vivo in the absence of cofactor. General amyloidogenesis in vivo also increased under these conditions, apparently as a result of flavoproteome destabilization. In this context, we think that our data might have important implications considering the onset and development of conformational diseases.
This work has shed some light on the therapeutic implications of riboflavin deficiency as well. The sensitivity of melanoma cells towards the alkylating agent methyl methanesulfonate (MMS) increased under riboflavin starvation. Subsequent analyses indicated that a complex metabolic reorganization, mostly affecting proliferation and energy metabolism, occurs in response to starvation. What we suggest to call “flavoaddiction” can be understood as the dependence of melanoma cells on the flavoproteome structural and functional intactness to survive chemotherapy. Understanding this cellular reprogramming in detail might reveal new possibilities for future therapies.
The membrane protein Green Proteorhodopsin (GPR), found in an uncultured marine γ-proteobacterium, is a retinal binding protein and contains a conserved structure of seven transmembrane helices (A-G). The retinal is bound to a conserved lysine residue (K231) in helix G via Schiff base linkage. It belongs to the widespread family of microbial rhodopsins and functions as a light dependent outward proton pump that bacteria may utilize for establishing a proton gradient across the cellular membrane. Proton pumping takes place after photon absorption, where GPR goes through a series of conformational changes, termed photocycle, causing the proton to be transported across the cellular membrane from the intra-cellular to the extracellular space. It is further mediated by the highly conserved functional residues D97 and E108, which function as the primary proton acceptor and primary proton donor for the protonated Schiff base, respectively. Another functionally important residue is the highly conserved H75 in helix B. It forms an intra-molecular cluster with D97 and is responsible for the high pKa value of the primary proton acceptor, stabilized by a direct interaction between D97 and H75.
Different Proteorhodopsin variants are globally distributed and colour tuned to their environment, depending on the water depth in which they occur. A single residue in the retinal binding pocket at position 105 is responsible for determining the absorption wavelength of the protein. GPR (from eBAC31A08) contains a leucine at position 105, while BPR (blue proteorhodopsin, from Hot75m4) in deeper waters possesses a glutamine. Although GPR shows 79% sequence identity with BPR, a single amino acid substitution (L105Q) in GPR is able to switch the absorption maximum to the one of BPR.
Protein oligomerisation describes the association of subunits (protomers) through non-covalent interactions, forming macromolecular complexes. It is an important structural characteristic of microbial rhodopsins, contributing to structural stability and promoting tight packing of the protomers in the bacterial membrane. GPR was shown to assemble into radially arranged oligomers, mainly pentamers and hexamers. No high resolution crystal structure of the whole GPR complex is available, but the structurally related BPR (Hot75m4) was successfully crystallized, showing pentameric oligomers.
The BPR crystal structure model reveals detailed information about complex assembly of the whole proteorhodopsin family. It reveals the oligomeric structures and shows residues that are part of the protomer interfaces, forming cross-protomer contacts, which is valuable information for the elaborate analysis of cross-protomer interactions of GPR oligomers.
Based on the knowledge of GPR and BPR oligomeric complexes, the aim of this study is to analyse specific cross-protomer contacts and to characterize the functional role of GPR oligomerisation. This includes the identification of residues, which are part of charged cross-protomer contacts and play an important role for the formation of the GPR oligomeric complex. Furthermore, this study deals with a detailed characterization of a potentially functional cross-protomer triad between the residues D97-H75-W34, which was detected in the BPR structural model. Hereby, the focus lies especially on the functional role H75, which is highly conserved and is positioned in between the primary proton acceptor D97 and W34 across the protomer interface. In summary, this study addresses GPR oligomerisation via specific cross-protomer contacts and its potential role for the functional mechanism of the protein.
The fundamental technique used in this study is solid-state NMR. Furthermore, an elaborate characterization of GPR oligomerisation was executed using a variety of biochemical methods and mutational approaches. Solid-state NMR is a powerful biophysical method to analyse membrane proteins in their native lipid environment and can be used to obtain diverse information about structure, molecular dynamics and orientation of the protein in the lipid bilayer.
Solid-state NMR naturally has a low sensitivity. In order to detect the low number of spins, DNP signal enhancement is of particular importance in this study. It is exhibited under cryogenic conditions and allows to drastically enhance the solid-state NMR signal by transferring magnetization from highly polarized electrons to the nuclear spins.
By applying these methods and techniques on GPR oligomers, this study reveals new insights in specific cross-protomer interactions in the complex. First the oligomeric states of GPR were determined for the specific experimental conditions used in this study. LILBID-MS, BN-PAGE and SEC analysis identified the pentameric state to be dominant for GPR. Furthermore, specific interactions across the protomer interface, which drive GPR oligomerisation, were identified. This was conducted by creating mixed 13C-15N labelled complexes. These mixed complexes show a unique isotope labelling pattern across their protomer interfaces. Solid-state NMR 13C-15N-correlation spectroscopy (TEDOR) was used to identify through-space dipole-dipole couplings, which indicate specific cross-protomer contacts. The results indicated that the residues R51, D52, E50 and T60 are important for GPR oligomerisation, and further analysis via single mutations of these residues showed a severe impact of the GPR oligomerisation behaviour.
The functional importance of GPR oligomerisation was analysed by DNP-enhanced solid-state NMR on the cross-protomer D97-H75-W34 triad. The DNP cryogenic conditions allowed to trap GPR in distinct stages of the photocycle. It could be shown that trapping GPR in a specific intermediate leads to a drastic conformational effect for the highly conserved H75 residue. Furthermore, DNP-enhanced solid-state NMR was used to characterize the cross-protomer contact between H75 and W34. Mutations of W34 could show that the cross-protomer interaction is highly important for the functionality of the protein, as negative mutants such as W34E showed a reverse proton transport across the bacterial membrane.
In summary this study represents a detailed analysis of GPR cross-protomer interactions and sheds light into the cause and functional importance of oligomeric complex formation in the microbial rhodopsin.
Cytochrome P450 enzymes are a large superfamily of membrane-bound heme-containing monooxygenases. They are essential for the oxidative metabolism of endogenous substrates such as steroids and fatty acids, and biotransformation of xenobiotic substrates such as pollutants and drugs. Although the highest expression of CYPs is found in the liver, their cardiovascular expression is not negligible with CYP450 subfamilies being responsible for the production of vasoactive lipids. Of importance, the enzymatic activity of all microsomal CYP450 isoenzymes is dependent on the cytochrome P450 reductase (POR), an electron donor.
In the first part of this work, the role of cytochrome P450 monooxygenases on the biotransformation of organic nitrates was investigated. Recombinant SupersomesTM were selected and incubated with NTG and PETN, where nitrite release was measured as a nitric oxide (NO) footprint. The capacity of the recombinant POR/CYP450 system to release nitrite from NO prodrugs was shown to be CYP-specific and dose-dependent. To study the involvement of CYP450 enzymes in the vascular biotransformation of organic nitrates in vivo, a smooth muscle-cell specific, inducible knockout model of POR (smcPOR-/-) was generated. Organ chamber experiments revealed that the vascular POR/CYP450 system had no impact on the dilator response of NTG and PETN. In line with previous publications, inhibition of ALDH2, known as the main enzyme responsible for the activation of NTG and PETN, and/or abolishment of the endogenous NO production did not reveal a contribution of the POR/CYP450 system to the dilator response of NTG and PETN. To better understand these results, we looked at the expression of the hepatic and vascular expression of the POR/CYP450 system where the hepatic was increased by 10- to 40-fold as shown by Western blot analysis. We concluded that due to insufficient vascular expression of CYP450 enzymes their contribution to the bioactivation of NTG and PETN is only minor.
The second part of this work focused on the cardiac relevance of endothelial isoenzymes. For that purpose, an endothelial cell-specific, tamoxifen-inducible knockout model of POR was generated and characterized in the present study. RNA-sequencing of the heart of healthy mice revealed that the CYP450 expression is cell-specific with cardiac endothelial cells (ECs) exhibiting an enrichment in the expression of the Cyp4 family (ω-oxidation of fatty acids) and of the Cyp2 family (production of EETs). Under non-stredded conditions (i.e. 30 days after inducing the knockout by tamoxifen feeding), endothelial deletion of POR was associated with cardiac remodelling as observed by an increase in the ratio of heart weight to body weight and an increase in the cardiomyocyte area. RNA-sequencing of cardiac ECs suggested that loss of POR might alter ribosomal biogenesis and protein synthesis, which could potentially affect the cardiac contractility in ecPOR-/- mice. Metabolomics from cardiac tissue of CTL and ecPOR-/- mice were not indicative for an important metabolic function of the endothelial POR/CYP450 system in the heart. The combination of transverse aortic constriction (TAC) with endothelial deletion of POR accelerates the development of heart failure in mice as detected by a reduction in cardiac output and stroke volume. These effects were mediated most likely by a reduction in vascular EETs production, which increases vascular stiffness, resulting in cardiac remodeling.
In the recent years, myxobacteria have emerged as a novel source of natural compounds with structural diversity and biological activity for drug discovery. In this work, the two myxobacterial compounds archazolid and vioprolide were characterized for their potential pharmacological effects in vascular endothelial cells. Archazolid is a wellestablished v-ATPase inhibitor found in Archangium gephyra and Cystobacter spec. As the v-ATPase represents a promising target in cancer treatment, the effects of archazolid have been intensively studied in cancer cells, but rarely in endothelial cells. Vioprolide is an antifungal and cytotoxic metabolite obtained from Cystobacter violaceus. There are only few studies on vioprolide, most of them focusing on its biosynthesis. Preliminary studies revealed that it inhibited TNF-induced expression of ICAM-1, indicating possible anti-inflammatory properties. As the endothelium plays an important role in cancer and inflammation, it represents an attractive drug target. Therefore, the archazolid and vioprolide were investigated regarding their effects on endothelial cells.
V-ATPase inhibition by archazolid resulted in anti-tumor and anti-metastatic effects in vitro and in vivo. Archazolid was used to study the consequences of v-ATPase inhibition in endothelial cells that might contribute to the anti-metastatic activities observed in vivo. To analyze the impact of archazolid on the interaction endothelial and cancer cells, in vitro cell adhesion and transmigration assays were performed using primary HUVEC or immortalized HMEC-1 and different cancer cell types (MDA-MB-231, PC-3 and Jurkat cells). For these experiments, only the endothelial cells were treated with archazolid. VATPase inhibition by archazolid led to an increased adhesion of the metastatic breast cancer cell line MDA-MB-231 and prostate cancer cell line PC-3 onto endothelial cells whereas the adhesion of Jurkat cells was unaffected. Interestingly, archazolid treatment of HUVECs decreased the transendothelial migration of MDA-MB-231 cells. Endothelial ICAM-1, VCAM-1, E-selectin and N-cadherin are potential ligands of interacting cancer cells. Therefore, the mRNA and surface protein levels of these cell adhesion molecules were measured via qRT-PCR and flow cytometry, respectively. These adhesion molecules were not responsible for the archazolid-induced cancer cell adhesion, as archazolid treatment of HUVECs did not upregulate their mRNA or surface expression. Instead, cell adhesion assays using a monoclonal antibody against integrin subunit β1 showed that β1-integrins expressed on MDA-MB-231 and PC-3 cells mediated the archazolid-induced cancer cell adhesion. Cell adhesion assays onto plastic coated with ECM components which are the major ligands of β1-integrins, revealed that MDA-MB231 and PC-3 cells preferably interact with collagen. So next, we investigated the influence of archazolid on surface collagen levels in HUVECs by immunostaining, which demonstrated an increase of nearly 50 % upon archazolid treatment. We confirmed the hypothesis that the expression and activity of cathepsin B, a lysosomal enzyme that degrades extracellular matrix components including collagen, was inhibited by archazolid in endothelial cells. Finally, overexpression of cathepsin B reduced the cancer cell adhesion on archazolid-treated HUVECs, but also in control cells, indicating a negative correlation between cathepsin B expression and cancer cell adhesion.
The influence of vioprolide on the interaction of endothelial cells with leukocytes was analyzed by in vitro cell adhesion assays using HUVECs and primary monocytes, THP-1 or Jurkat cells. Vioprolide inhibited the adhesion of these cells onto TNF-activated HUVECs. In addition, the endothelial-leukocyte interaction was observed in vivo by intravital microscopy in the mouse cremaster muscle. Vioprolide prevented the TNFinduced firm adhesion and transmigration of leukocytes, while leukocyte rolling was not affected. ICAM-1, VCAM-1 and E-selectin are cell adhesion molecules, which are upregulated by TNF and mediate leukocyte adhesion onto endothelial cells. Therefore, flow cytometric analysis was performed to measure their surface expression. Vioprolide significantly decreased TNF-induced expression of surface ICAM-1, VCAM-1 and E-selectin, which was in line with the in vitro results. In vivo, vioprolide may act in a different way on E-selectin expression, so that leukocyte rolling, which is governed by E-selectin, remained unaffected. qRT-PCR experiments revealed that the mRNA expression of ICAM-1 and VCAM-1 were also reduced by vioprolide, indicating a regulation on transcriptional level. In contrast, the mRNA expression of E-selectin was not decreased at the timepoint when surface protein expression was diminished. The induction of these cell adhesion molecules is mainly mediated by the transcription factor NFκB. A Dual-Luciferase® reporter assay was used to study the impact of vioprolide on the TNF-induced NFκB promotor activity. Vioprolide blocked the TNF-induced NFκB promotor activity while the TNF-induced IκBα degradation and nuclear translocation of the NFκB subunit p65 was not altered by vioprolide. Western blot analysis revealed that vioprolide had no effect on the activation of MAPK (p38, JNK) and AKT by TNF, which could interfere with the NFκB-dependent gene expression.
Taken together, archazolid and vioprolide are interesting myxobacterial compounds with different modes of actions. The study suggests that the v-ATPase inhibitor archazolid impairs the expression and activity of cathepsin B in endothelial cells, which leads to a higher amount of collagen on the endothelial surface. As a result, the adhesion of β1-integrin expressing metastatic cancer cells onto archazolid-treated endothelial cells increased while transendothelial migration was reduced. Further, archazolid represents a promising tool to elucidate the role of v-ATPase in endothelial cells. Vioprolide was able to prevent TNF-induced endothelial-leukocyte interaction in vitro and in vivo by interfering with NFκB-dependent gene expression. Further research is required to enlighten the underlying mechanism and the direct target of vioprolide.
Intrinsische und extrinsische Faktoren wie die Darreichungsform, Komedikation und genetische Polymorphismen können einen signifikanten Einfluss auf die Exposition des Wirkstoffes haben und in der Folge zu Veränderungen in der Wirksamkeit oder Sicherheit eines Wirkstoffes führen. Die Fähigkeit die Auswirkungen solcher Faktoren auf die Exposition und die pharmakologische Aktivität eines Wirkstoffes zu quantifizieren und zu extrapolieren, repräsentiert einen Meilenstein bei der Bestimmung der erforderlichen Dosisanpassungen und der Umsetzung von Risikomanagementstrategien in der klinischen Pharmakologie. Unter dem Blickwinkel der modellbasierten Arzneimittelforschung und -entwicklung (engl. model-informed drug discovery and development (MID3)) können dynamisch mechanistische Modelle, wie z. B. whole-body PBPK/PD-Modelle, für die Vorhersage des Effekts sowie der Wechselwirkung mehrerer Faktoren auf PK und PD nützlich sein und könnten daher als Orientierung für die Wahl der Formulierung und für klinische Dosierungsempfehlungen dienen.
Obwohl PBPK-Modelle in der Pharmabranche inzwischen routinemäßig zur internen Entscheidungsfindung und zur Unterstützung der regulatorischen Bewertung eingesetzt werden, bleibt das Vertrauen Waiver von speziellen klinischen pharmakologischen Studien für biopharmazeutische Anwendungen durch PBPK- Modellanalysen zu stützen eher gering. Andererseits hat sich die virtuelle Bioäquivalenz im Zusammenhang mit der Simulation klinischer Studien als ein vielversprechendes, aber noch unterentwickeltes Feld erwiesen, mit dessen Hilfe der Anwendungsbereich der PBPK-Modellierung in der Biopharmazeutik erweitert werden kann. So werden beispielsweise BCS-basierte Biowaiver für Wirkstoffe der BCS-Klassen II und IV derzeit von den Gesundheitsbehörden nicht akzeptiert. In einigen Fällen hat die PBPK-Modellierung durch Verknüpfung der In-vitro-Freisetzung mit der In-vivo-Performance der Formulierung jedoch gezeigt, dass ein solcher Ansatz unter Umständen wissenschaftlich gerechtfertigt sein könnte. Auf ähnliche Weise können PBPK-Modellierung und VBE verwendet werden, um klinisch relevante Spezifikationen für die Wirkstofffreisetzung festzulegen und den "safe space" der Freisetzung zu definieren (oder zu erweitern). Doch selbst bei Wirkstoffen, die Unterschiede im Umfang und in der Rate der Absorption außerhalb der Bioäquivalenzgrenzen aufweisen, was bedeutet, dass sie nicht als bioäquivalent und damit austauschbar angesehen werden können, kann die therapeutische Äquivalenz beibehalten werden, sofern dies durch eine Expositions-Wirkungs-Analyse und/oder eine Expositions-Sicherheits-Analyse unter Verwendung empirischer, halb- oder vollmechanistischer PK/PD-Modelle angemessen begründet wird.
Wie bereits erwähnt bieten PK/PD- und insbesondere PBPK/PD-Modelle einen mechanistischen Ansatz, der die Gewebekonzentrationen am Wirkort des Wirkstoffes mit der pharmakologischen Wirkung verknüpft. Im Rahmen dieser Arbeit wird zunächst ein Überblick über bestehende PK/PD-Modelle und deren mathematischen Umsetzung vorgestellt. Darüber hinaus sind wirkstoffspezifische Fallbeispiele mit einer offensichtlichen Entkopplung von PK und PD von besonderem Interesse, bei denen Expositionsschwankungen weniger kritisch, wenn nicht gar irrelevant für die pharmakologische Reaktion sind (Publikation 1).
In diesem Zusammenhang bietet PBPK Modellierung und Simulation die Möglichkeit die oben genannten wissenschaftlichen Überlegungen zu untersuchen, ungetestete Szenarios zu erforschen und schließlich evidenzbasiert und arzneimittelspezifische Empfehlungen für Bioäquivalenzprüfungen zu erteilen. Daher bestand das Hauptziel darin PBPK/PD-Modelle zu entwicklen, zu validieren und anzuwenden sowie virtuelle Trials zu simulieren, um den relativen Effekt der In-vitro/ In-vivo-Freisetzung, PK-Charakteristiken (z.b. die Halbwertszeit) und die intraindividuelle Variabilität bei der In-vivo-Arnzeimittelwirkung von BCS Klasse II schwach sauren Verbindungen zu beurteilen und einen PBPK-IVIVE integrierten Arbeitsablauf vorzuschlagen, um virtuelle Bioäquivalenzstudien durchzuführen.
Es wurden drei BCS Klasse II schwach saure Wirkstoffe (Naproxen, Flurbiprofen, Ibuprofen) mit ähnlicher Disposition und ähnlichen metabolischen Eigenschaften zur Untersuchung ausgewählt. Allgemein sind alle drei Wirkstoffe stark an Plasmaproteine gebunden und haben daher ein niedriges Verteilungsvolumen, niedrigen First-Pass-Effekt, niedrige systemische Clearance und eine nahezu vollständige Bioverfügbarkeit (F>0.9). Allerdings unterscheiden sie sich signifikant in ihrer Halbwertszeit: Für Naproxen beträgt t1/2≃20-24 h, für Flurbiprofen t1/2≃7 h und für Ibuprofen t1/2≃2 h, was moderate bis lange, moderate und kurze Halbwertszeiten widerspiegelt.
Für alle drei Wirkstoffe wurde ein systematischer Arbeitsablauf erstellt einschließlich: i) Charakterisierung von in vitro biopharmazeutischen Eigenschaften (z.b. Löslichkeit, Freisetzung) gefolgt von modellbasierten Analysen von In-vitro-Ergebnissen, ii) Entwicklung und umfassende Validierung von PBPK/PD-Modellen und iii) Simulierung und Risikoeinschätzung von Bioäquivalenzstudien. Die Fallstudien von Naproxen (Publikation 2) und Ibuprofen (Publikation 3) konzentrieren sich auf bewährte Verfahren der IVIVE für biopharmazeutische Parameter, Risikoabschätzung und Simulation von Bioäquivalenzstudien mit PBPK-Modellen, welche die inter-occasion Variabilität miteinbeziehen. Das Beispiel von Flurbiprofen (Publikation 4) hebt die Wichtigkeit des Verständnisses des relativen Einflusses von intrinsischen (z.b. genetische Polymorphismen) und extrinsischen (z.b. Komedikationen) Faktoren auf die PK und PD des Wirkstoffes hervor, wenn Empfehlungen für die Bioäquivalenz und die therapeutische Gleichwertigkeit gemacht werden. Alle drei Fallbeispiele liefern mechanistische Erkenntnisse über die Freisetzungssgrenzen, die für die In-vivo-Arneimittelwirksamkeit kritisch ist, unter Berücksichtigung der PK-Eigenschaften des Wirkstoffes und der physiologischen Variabilität mit dem Ziel den Status quo des aktuellen BCS-basierten Biowaiveransatzes in Frage zu stellen und integrierte In-vitro-, In-vivo- und In-silico-Paradigma der Risikobewertung für Waiver von In-vivo-Bioäquivalenzstudien einzuführen.
In dem letzten Teil der Arbeit werden Herausforderungen, Kenntnislücken und Möglichkeiten von PBPK/PD-Modellierung zur Unterstützung von Waivern von in vivo klinischen Studien im Bereich von oralen Biopharmazeutika diskutiert (Publikation 5).
Im Großen und Ganzen schlägt diese Dissertation biorelevante In-vitro-Methoden für die Vorhersage von In-vivo-Formulierungsperformance und neue PBPK/PD-Methoden vor, um Daten von in vitro biopharmazeutischen Experimenten zu den In-vivo-Bedingungen zu extrapolieren. Außerdem ist dies das erste Mal nach unserem Kenntnisstand, dass PBPK/PD-Ansätze zur Durchführung virtueller Bioäquivalenzstudien vorgeschlagen werden, die auch die inter-occasion Variabilität der Pharmakokinetik berücksichtigen. Desweiteren hebt diese Arbeit die Bedeutung von pharmakokinetischen Eigenschaften auf Bioäquivalenz-Ergebnissen hervor und stellt ein neues Konzept zur Risikoeinschätzung von Bioäquivalenz vor, in welchem die Bewertung des Bedarfs eines Waivers von einer In-vivo-Bioäquivalenzstudie sowohl auf biopharmazeutischen als auch pharmakokinetischen Wirkstoffeigenschaften basiert und quantitativ mit PBPK/PD-Modellierung bewertet wird.
Natural science is only just beginning to understand the complex processes surrounding transcription. Epitranscriptional regulation is in large parts conveyed by transcription factors (TFs) and two recently discovered small RNA (smRNA) species: microRNAs (miRNAs) and transfer RNA fragments (tRFs). As opposed to the fairly well-characterised function of TFs in shaping the phenotype of the cell, the effects and mechanism of action of smRNA species is less well understood. In particular, the multi-levelled combinatorial interaction (many-to-many) of smRNAs presents new challenges to molecular biology. This dissertation contributes to the study of smRNA dynamics in mammalian cells in several ways, which are presented in three main chapters.
I) The exhaustive analysis of the many-to-many network of smRNA regulation is reliant on bioinformatic support. Here, I describe the development of an integrative database capable of fast and efficient computation of complex multi-levelled transcriptional interactions, named miRNeo. This infrastructure is then applied to two use cases. II) To elucidate smRNA dynamics of cholinergic systems and their relevance to psychiatric disease, an integrative transcriptomics analysis is performed on patient brain sample data, single-cell sequencing data, and two closely related in vitro human cholinergic cellular models reflecting male and female phenotypes. III) The dynamics between small and large RNA transcripts in the blood of stroke victims are analysed via a combination of sequencing, analysis of sorted blood cell populations, and bioinformatic methods based on the miRNeo infrastructure. Particularly, importance and practicality of smRNA:TF:gene feedforward loops are assessed.
In both analytic scenarios, I identify the most pertinent regulators of disease-relevant processes and biological pathways implicated in either pathogenesis or responses to the disease. While the examples described in chapters three and four of this dissertation are disease-specific applications of miRNeo, the database and methods described have been developed to be applicable to the whole genome and all known smRNAs.
Protein ubiquitination is a post-translational modification that typically involves the conjugation of ubiquitin to substrate proteins via a three-enzyme cascade and regulates a wide variety of cellular processes. Recent studies have revealed that SidE family of Legionella effectors such as SdeA catalyzes novel phosphoribosyl-linked ubiquitination (PR-ubiquitination) of serines in host substrate proteins utilizing NAD+, without the need of E2, E3. The catalytic core of SdeA comprises a mono-ADP-ribosyltransferase (mART) domain that functions to ADP-ribosylate ubiquitin, and a phosphodiesterase (PDE) domain that processes ADP-ribosylated ubiquitin and transfers the resulting phosphoribosylated ubiquitin to serines of substrates.
To date, extensive efforts have been made to study the function of SdeA and mechanism of SdeA mediated PR-ubiquitination, however, the cellular effects of this novel ubiquitination and phosphoribosylation of ubiquitin remained poorly understood. In our study, using biochemical and cell biological approaches, we explored the biological effect of phosphoribosylation of ubiquitin caused by SdeA in cells. We found that phosphoribosylated ubiquitin is not available for conventional ubiquitination, thereby phosphoribosylation of ubiquitin impairs numerous classical ubiquitination related cellular processes including mitophagy, TNF-α signaling and proteasomal degradation.
The precise temporal regulation of the functions of bacterial effectors during Legionella infection by other effectors with antagonizing activities has been well studied so far. Not surprisingly, PR-ubiquitination catalyzed by SidE family effecters is tightly controlled as well, it has been long known that effector SidJ counteracts the toxicity of SdeA to yeast cells. Interestingly, in an experiment for verifying the activity of SidJ, we found that Legionella lysate lacking SidJ was still able to remove ubiquitin from PR-ubiquitinated substrates. Using biochemical approach we identified DupA and DupB, two Legionella bacterial effectors that specifically reverse the novel serine PR-ubiquitination catalyzed by SdeA. We found that DupA and DupB possess a highly homologous PDE domain that removes ubiquitin from PR-ubiquitinated substrates by cleaving the phosphodiester bond between the phosphoribosylated-ubiquitin and serines of substrates. Catalytically deficient mutant DupA H67A strongly binds to PR-ubiquitinated proteins but not capable of cleaving PR-ubiquitin, using it as a trapping bait we identified over 180 substrates of PR-ubiquitination, including a number of ER and Golgi proteins.
In particular, we found that exogenously expressed SdeA localizes to the Golgi apparatus via its C-terminal region and disrupts the Golgi. We validated the identified potential substrates of SidE effectors and found that SdeA modifies Golgi tethering proteins GRASP55 and GRASP65. Using mass spectrometry analyses we identified four serine targets (S3, S408, S409, S449) of GRASP55 PR-ubiquitinated by SdeA in vitro. Ubiquitination of GRASP55 serine mutant in cells co-expressing SdeA or infected with Legionella was markedly decreased, compared with that of the wild-type GRASP55. In addition, with co-immunoprecipitation analyses we found that SdeA-catalyzed ubiquitination regulates the function of GRASP55. PR-ubiquitinated GRASP55 exhibited reduced self-interaction compared to unmodified GRASP55, expression of GRASP55 serine mutant in cells in part rescued Golgi damage caused by SdeA. Furthermore, our study reveals that Golgi structure disruption caused by SdeA does not result in the recruitment of Golgi membranes to the Legionella-containing vacuoles. Instead, it affects cellular secretory pathway including cytokine secretion in cells.
Taken all together, this work expands the understanding of this unconventional PR-ubiquitination catalyzed by Legionella effectors and sheds light on the functions of PR-ubiquitination by which Legionella regulates the Golgi function and secretion pathway during bacterial infection.
Die Forschung beschrieben in dieser Dissertation ist ein Teil der "European Research and Innovation Programme - PEARRL", und wurde von Horizon 2020 Marie Sklodowska-Curie actions der Europäischen Union, unter Förderungsnummer 674909 unterstützt.
In den letzten Jahren, wurde Senkung der Intensität der pharmazeutischen Forschung und Entwicklung beobachtet, da die Weiterentwicklung der Wirkstoffmolekülen hinzu einer "handlichen" Formulierung viele Schwierigkeiten aufweist. Meiste der neuen Wirkstoffkandidaten, die sich in Entwicklung befinden, haben suboptimale Eigenschaften in Bezug zur Löslichkeit und Auflösung und zeigen schlechte Bioverfügbarkeit, wenn eingenommen. Deswegen verlangen meiste neue Wirkstoffkandidate einen besonderen Ansatz in Bezug auf Formulierung, um akzeptable orale Bioverfügbarkeit zu erreichen. Diese neue Formulierungen werden meistens als “bio-enabling” Formulierungen bezeichnet und werden in Heilmittelentwicklung immer häufiger verwendet.
Hauptziel dieser Dissertation ist zu erforschen ob, durch Verbinden von biorelevanten in vitro Werkzeugen mit in silico Modeling und Simulationen, die in vitro Löslichkeit und Auflösung von bio-enabling Formulierungen mechanistisch erkläert und besser verstanden werden kann und somit eine erfolgreiche Simulation von in vivo Leistung erreicht werden kann.
Als Erstes wurden die physiologische Parameter, die die pharmakokinetik oraler Formulierungen beeinflüssen, identifiziert, indem die Auswirkung der Wirkstoffe, die zur Behandlung Magen-Darm-Krankheiten genutzt werden, sowie deren Pharmakokinetik, beurteilt wurde. Unter anderem wurde pH als einer der entscheinenden phyisiologischen Parameter erkannt, da es die Pharmakokinetik peroral verabreichter Stoffe signifikant beeinflüssen kann.
Als zweiter Schritt, mit besonderer Beachtung auf die Verwendung der biorelevanten in vitro Werkzeugen für die Erforschung der in vivo Auflösungsprozesse von bio-enabling Formulierungen, Fokus auf die biorelevante Medien und in vitro Apparaturen, die mögliche Prezipitationskinetik einschätzen können, wurde gesetzt. Biorelevante Medien sind wässrige Flüssigkeiten, die die Zusammensetzung der gastrointestinaler Flüssigkeiten nachmachen und für die Auflösungsuntersuchungen genutzt werden. Bis heute beinhalten die Aspirationsstudien die wichtigsten Hinweise und Informationen für den Design biorelevanter Medien. Es wurde beobachtet, dass die berichteten Werte mancher phyisiologisher Parameter erhebliche Unterschiede zwischen den Aspirationsstudien zeigen. Deswegen wurde untersucht, ob die Ergebnisse durch die Auswahl an Methodologie, die für die Entnahme und die Auswertung der Proben genutzt worden sind, beeinflusst werden können, wobei besondere Aufmerksamkeit den pH und der Pufferkapazität geschenkt wurde. Es wurde gezeigt, dass Unterschiede im Prozess der Probenhandhabung, z.B. Zentrifugieren und Lagerung einen deutlichen Einfluss auf die gemessenen Werte haben kann. Ausserdem, wurden in dieser Arbeit die in vitro Setups, die bisher in der Literatur zur Beurteilung der Übersättigung u.o. Ausfällung von Arzneimitteln im oberen Magen-Darm-Trakt vorgeschlagen wurden, überprüft und ihre Nützlichkeit und aktuelle Anwendung bewertet.
Nach Behebung der oben genannten Probleme, wurden zwei Fallbeispielformulierungen ausgewählt, um die Haupthypothese zu untersuchen. Die erste Formulierung ist auf den Markt unter dem Namen EMEND® und enthält den Wirkstoff in Nanoform. Die zweite Formulierung wird als INTELENCE® vermarktet und ist eine amorphe feste Dispersion des Wirkstoffs Etravirin. Durch die Wahl zwei unterschiedlicher Formulierungsansätzen konnten unterschiedliche Fallszenarien untersucht werden, wodurch umfassendere Vorschläge für die Bewältigung der Herausforderungen bei in vitro Experimenten und in silico Modelling mit bio-enabling Formulierungen möglich waren.
Bezogen auf den in dieser Dissertation beschriebenen Ansatz, ein mechanistisches Verständnis des in vivo Absorptionsprozesses, sowie eine erfolgreiche Simulation der nach der Verabreichung resultierenden Plasmaprofile einer bio-enabling-Formulierung der Nanoskala- und einer amorphen festen Dispersion wurde erreicht. Darüber hinaus wurden mögliche Wege vorgeschlagen, um einige Herausforderungen im Hinblick auf die Entwicklung von PBPK-Modellen für biofähige Formulierungen anzugehen. Diese Arbeit zeigt die mögliche Anwendung und Bedeutung der Absorptionsmodellierung für die rationale Formulierungsentwicklung und für die Stärkung des Wissens über Bio-Heilmittel in Bezug auf bio-enabling Formulierungen. Mithilfe dieses Ansatzes können die wesentlichen Parameter identifiziert werden, die das pharmakokinetische Verhalten schwerlöslicher Wirkstoffe beeinflussen, die als bio-enabling Formulierungen formuliert sind, und ermöglichen wiederum eine robuste Vorhersage der klinischen Ergebnisse.
Many processes in living cells involve interaction and cooperation of multiple proteins to fulfill a specific function. To understand biological processes in their full complexity, it is not sufficient to only identify the molecules being involved but also to understand the kinetic aspects of a reaction. Mass spectrometry (MS) is a very powerful tool which allows to precisely identify the molecules of a reaction. Usually this is done with tandem-MS experiments for purpose of de-novo peptide sequencing. However, since this involves protein digestion, a statement of the in-vivo constitution of non-covalently bound protein complexes is not possible. In order to detect an intact protein complex it is necessary to analyze the biological system softly and in a near-native environment with native MS. Native MS allows the non-destructive analysis of these non-covalent protein complexes as well as to detect their components. However, up to now native MS does not offer a possibility to resolve the timing of the constitution of protein complexes on a fast time-scale. Therefore, the progress of reactions on fast time-scales is invisible. However, a method which delivers both types of information - identification of the components of a protein complex, as well as time-resolving their interaction - would be of high interest.
A suitable ionization technique for native MS is laser-induced liquid-bead ion desorption (LILBID). LILBID employs well-defined droplets which are irradiated by IR laser pulses to generate gas phase ions. The not-continuous, repetitive nature of ion generation offers itself to the development of a time-resolved (TR) native MS system which is able to investigate protein complexes on a fast time scale. The LILBID-droplets can serve as reaction vessels if they are levitated in an electrodynamic Paul-trap. This new setup would allow sample manipulation and MS analysis on precise and fast reaction time-scales. The first part of this dissertation presents the construction and characterization of a setup for TR-LILBID-MS.
An example for a complex biological system is the self-assembly of beta-amyloid (Aβ). This small peptide is the major component in plaques related to Alzheimer’s disease. Clinically relevant is especially the 42 amino acid peptide Aβ42 which aggregates from monomers to oligomers through to fibrils. The oligomers are the neurotoxic species in this process and thus of high interest. Nevertheless, standard analytical techniques are unable to detect those oligomers which makes MS an optimal tool to study the oligomerization process of Aβ with the focus on disease relevant oligomers. TR-LILBID-MS allows to follow the oligomerization of Aβ enabling to study molecules which influence this kinetic. Combining MS with ion-mobility spectrometry adds an additional dimension - the collision cross section - to the mass-to-charge ratio obtained from MS. Therewith structural alterations induced by ligands can be correlated to differences in the aggregation kinetic. This allows to draw a picture of the aggregation process of Aβ for the development of disease-relevant small oligomers on a molecular level.
To this day, stroke is the leading cause of death and disability worldwide. Due to increasing age of the world population and poor lifestyle, the incidence is further rising. Besides mechanical thrombectomy as a surgical option, there is a lack of therapeutic options with recombinant tissue plasminogen activator (rt-PA) being the only approved drug for treatment for ischemic stroke. However, there are various problems that make the administration of rt-PA difficult. In particular, it can only be given for ischemic (not hemorrhagic) stroke, and there is a narrow time frame of 4.5 hours after onset of stroke, in which it can be successfully applied. While the success rates of combined thrombectomy with rt-PA are around 60%, less than 5% of patients receive this therapy.
ß-Hydroxybutyrate (BHB) is a ketone body that is formed in high amounts during fasting and lipolysis. Ketone bodes and the ketogenic diet have been shown to have neuroprotective properties in neurodegenerative diseases. In prior work of our group, the ketogenic diet was shown to have beneficial effects in mice after transient ischemia. In the present work, a single dose of BHB was tested for beneficial effects. For this purpose, microdialysis was used to demonstrate that BHB can cross the blood-brain barrier. For the next series of experiments, transient cerebral ischemia was induced in mice for 90 minutes by unilaterally occluding the middle cerebral artery (MCAO) with a silicone-covered filament. Behavioral tests one day after BHB administration showed that the moderate dose of 30 mg/kg, given immediately after reperfusion, improved the neurological score significantly whereas a lower (10 mg/kg) and a higher dose (100 mg/kg) had no effects The main part of the experiments focused on mitochondrial respiration as a potential mechanism of action for BHB. In isolated mitochondria from mouse brain, BHB (1-10 mM) was able to stimulate mitochondrial respiration stronger than pyruvate, but not as strong as succinate.. In the following experiments, MCAO was induced in vivo, and mitochondria were isolated and investigated ex vivo. Experiments were conducted 60 minutes, 24 hours, 72 hours, and 7 days after cerebral ischemia and reperfusion. Besides mitochondrial respiration (normalized to mitochondrial protein content or citrate synthase activity), several other parameters were monitored: the development of bodyweight throughout the experiment, citrate synthase activity, plasma metabolites and behavior to assess motor functions. Three behavioral tests were conducted: first, the Corner test, an experiment for measuring the extent of unilateral movement. Here, if a stroked mouse is put into a narrow corner (30°), it is most likely to turn unilaterally to the right, whereas an unimpaired mouse will turn to both sides randomly. From a total of 10 turns, a laterality index was calculated. Second, in the Chimney test, the mouse walks heads first into a tube. Once it reaches the end, the tube is tipped 90 degrees to stand on the table vertically. Motorically impaired animals have difficulties crawling backwards up to the top of the tube. The experiment was stopped if an animal did not reach the top of the tube within 60 seconds. Third, in the Rotarod test, the mouse is placed on a rotating beam on which it is supposed to walk for at least 60 seconds, and the time when the animal falls off the rotating tube is measured.
All animals that had undergone ischemia showed massive weight loss until 72 hours after reperfusion. Weight loss then stagnated and there was a trend of increasing weight 7 days after reperfusion. The behavioral analysis showed that 24 hours after reperfusion, BHB-treated animals performed significantly better in the Corner test, meaning their moving patterns were more heterogeneous than those of saline-treated animals and in the Chimney test. 72 hours after reperfusion, BHB-treated animals still performed significantly better in the Chimney test, but 7 days after reperfusion, the performances of BHB- and saline-treated animals were no longer different from each other in any of the behavioral tests. In separate experiments, the plasma metabolites glucose, lactate, and pyruvate were changed in the animals that had undergone ischemia but were not affected by BHB administration.
Mitochondrial respiration was tested at four time points after the administration of BHB after reperfusion – 60 minutes, 24 hours, 72 hours, and 7 days after transient cerebral ischemia. 60 minutes later, data showed an increase of oxygen consumption of the complexes I and II. OxPhos was also increased but the effect at this point, did not reach statistical significance. 24 hours after reperfusion, this effect was consolidated: complex I, complex II and OxPhos respiration were significantly improved in the BHB-treated group compared to saline...
The human Long Interspersed Nuclear Element-1 (LINE-1, L1) is a member of the group of autonomous non-LTR retrotransposons found in almost every eukaryotic genome. L1 elements generate copies of themselves by reverse transcription of an RNA intermediate and integrate into the host genome by a process called Target Primed Reverse Transcription (TPRT). They are responsible for the generation of approximately 35% of the human genome, cover about 17% of the genome and represent the only group of active autonomous transposable elements in humans. L1 activity bears several risks for the integrity of the human genome, since the L1-encoded protein machinery generates DNA double-strand breaks (DSBs) and is capable of conducting numerous genome-destabilizing effects, e.g. causing deletions at insertion sites, disrupting or rearranging coding sequences and deregulating transcription of functional host genes. On the other side, L1 elements have had and still exert a great impact on human genome structure and evolution by increasing the genome size and rearranging and modulating gene expression. Furthermore, due to its endogenous and generally non-pathogenic nature, L1 is a promising candidate as vector for gene delivery in somatic gene therapy. The structure of the flanking regions between de novo L1 integrants and the genomic sequence suggests an involvement of cellular DSB repair pathways in L1 mobilization. To elucidate the role of DSB repair proteins in L1 retrotransposition, I disabled DSB repair factors ATM, ATR, DNA-PK, p53 and Ku70 by knock down (KD) using short hairpin RNA (shRNA) expression constructs. To inhibit the function of DSB repair factors PARP and Rad51, I used dominant negative (DN) PARP and Rad51 mutants. Applying a well established L1-retrotransposition reporter assay in HeLa cells, de novo retrotransposition events were launched in order to test L1 for its retrotransposition activity in the context of altered DSB repair conditions. I could show that L1 retrotransposition frequency after ATM KD had increased by 3-fold, while ATR and p53 KD reduced L1 retrotransposition by approximately one third. Unfortunately, the cytotoxic effects of the DNA-PK and Ku70 shRNA expression constructs were too strong to determine potential effects of DNA-PK and Ku70 KD on L1 retrotransposition. Inhibition of PARP function by expression of the DN mutant and overexpression of wild type PARP were found to increase L1 retrotransposition by 1.8 and 1.5, respectively, while Rad51 DN had no detectable effect. Interestingly, overexpression of wild type Rad51 seemed to roughly double L1 retrotransposition frequencies. Since in my experiments KD or expression of DN mutants was time-delayed to the onset of L1 retrotransposition after transfection into the cells, I developed a temporally controllable, tetracyclin transactivator (tTA)-dependent L1 retrotransposition reporter assay which will be of great value for future L1 retrotransposition studies that rely on temporally controllable retrotransposition. Due to a previously published hypothesis of L1 playing a role in brain development by contributing to somatic mosaicism in neuronal precursor cells, I generated a transgenic mouse (LORFUS) using the tTA-dependent L1 construct to further test this hypothesis. LORFUS harbors a bidirectional cassette driving simultaneous expression of a GFP-tagged L1 retrotransposition reporter and beta-galactosidase. It was bred to another transgenic mouse line expressing tTA in the forebrain. The double transgenic offspring was used to characterize L1 expression and retrotransposition patterns in the brain at postnatal day 15 (P15). General transgene expression indicated by beta-galactosidase activity was found in hippocampus, cortex and striatum, while retrotransposition events revealed by GFP expression were found in hippocampus, cortex, striatum, olfactory bulb and brainstem. These results suggested L1 retrotransposition in the granule layer of the dentate gyrus earlier than P15 and migration of cells carrying these events along the rostral migratory stream into the olfactory bulb. To facilitate the use of L1 as gene delivery tool in gene therapy or genetic engineering, I furthermore intended to manipulate the L1 target site recognition to allow the site-specific integration into defined genomic locations. To this end, I performed crystal structure-guided mutational analysis exchanging single amino acid residues within the endonuclease (EN) domain of L1 to identify residues influencing target site recognition. However, individual point mutations did not change the nicking pattern of L1-EN, but resulted in a reduction of endonucleolytic activity reflected by a reduced retrotransposition frequency. This suggests that additional factors other than the DNA nicking specificity of L1-EN contribute to the targeted integration of non-LTR retrotransposons in the host genomes.
In this research project we aimed to generate genetically modified megakaryocytes and platelets, by targeting protein expression to their secretory alpha-granules to delivery ectopic or therapeutic proteins, to be stored and kept there until an external stimulus triggers platelet activation and platelet secretion takes place. During platelet activation, the therapeutic proteins would then be released to the extracellular space, either as a soluble protein or exposed as a transmembrane protein on the cell surface of platelets. For long-term approaches, genetic modifications must be introduced at the hematopoietic stem cell level.
AIMS: As first approach, we aimed to characterize the lineage-specificity of expression of six different promoter fragments in lentiviral vectors: the murine platelet factor 4 (mPf4) 1222 bp (-1074 to +148), human glycoprotein Ib alpha (hGP1BA) 595 bp (-265 to +330), a short and a longer fragment of the human glycoprotein 6 (hGP6 / hGP6s) 351 bp (-322 to +29) / 726 bp (-697 to +29), as well the human glycoprotein 9 (GP9) promoter 794 bp (-782 to -12). These promoter fragments were included as internal cellular promoters in self-inactivating lentiviral vectors (SIN), using an enhanced green fluorescent protein (eGFP) as gene reporter. GFP detection was evaluated in vitro (in transduced non-megakaryocitc blood cell progenitors and in-vitro differentiated megakaryocytes) and in vivo (Bone marrow cells, blood cells and spleen cells). For targeting of proteins to the secretory alpha granules of megakaryocytes and platelets, we followed two strategies: A) The sorting signal of the cytokine RANTES was fused N-terminally to the destabilized GFP, d2eGFP (RANTES. d2eGFP), to deliver the protein into the granules as soluble cargo. B) The transmembrane granular targeting sequence of P-selectin (the transmembrane domain and cytoplasmic tail (referred as TDCT) was fused to d2eGFP or the B domain deleted codon optimized human coagulation Factor VIII cDNA (referred as BDcohFVIII_TDCT or FVIII_TDCT), to deliver the protein into the membrane of alpha granules. These two strategies were tested in-vitro, from transduced differentiated megakaryocytes in liquid cultures, and in-vivo, by analysis of genetically modified platelets by means of Laser Scanning Confocal Microscopy (LSM) in colocalization analysis (performed at the single cell level) and fluorescence intensity analysis.
RESULTS: GFP expression in blood cells from transplanted mice was significantly higher in platelets, with a smaller background promoter activity in leukocytes and erythrocytes. The highest expression was observed from the mPf4-vector, followed by hGP1BA, hGP6 and hGP6s vectors, identifying the hGP6 vectors as the most restricted to the megakaryocyte and platelet lineage. Analysis in bone marrow cells showed that hGP6-vectors have the lowest activity in the hematopoietic stem and progenitor cells (HSPC) with less than 10% of GFP positive stem cells. Surprisingly, the mPf4 and hGP1BA vectors were both highly active in the HSPC, in a range of 20 to 70% of GFP-positive cells. Polyploidization in later stages of MK-maturation of in-vitro Mks differentiated from Mpl-/- lineage marker negative cells were recovered after gene transfer of the thrombopoietin receptor Mpl, under the control of MK-specific vectors in differentiated into MKs. These results were corroborated in in-vivo analysis, where Mpl-/- mice transplanted with lin-BM cells transduced with the mPf4.Mpl and hGP6.Mpl vectors, showed significantly elevated platelet counts compared to control mice transplanted with a GFP-encoding control vector (PGK-GFP). In the Fluorescent intensity and colocalization analysis of transduced megakaryocytes with the targeting vectors, we observed a significant difference in the GFP targeting compared with those MK transduced with the non-targeting vectors. The median of the WCC values observed from the RANTES.d2eGFP targeting vector was 0.8 (80 % of colocalization) with P-selectin stained granules, and 0.7 (70%) with von Willebrand Factor stained granules. In the case of the non-targeting vector SFFV.d2eGFP the median of the WCC observed were <0.3 (30%) both in P-selectin and von Willebrand Factor stained granules. We observed as well that the GFP signal of MK transduced with the P-selectin.d2eGFP fusion overlapped the signals emitted by P-selectin and von Willebrand factor stained granules, not just in LSM-digitalized images but in the fluorescens intensity analysis as well, indicating a clear signal of GFP colocalization. Likewise, an evident signal overlap between the targeted FVIII (FVIII_TDCT) with the P-selectin / von Willebrand marker was observed. Colocalization and fluorescens intensity analysis performed on activated platelets from transplanted mice with the targeting vectors, corroborated what was previously observed in in-vitro megakaryocytes. The genetic modification of megakaryocyte and platelets will allow in the furture, not just the development of new generation of cells with advanced functions, but it will help us to elucidate new mechanisms and pathways of important cellular processes, by modifying cell function and cell interactions.
The role of lncRNAs in the CVS and the endothelium is highly diverse and has been subject to a substantial amount of research over the last decade. The identification of lncRNAs as clinically relevant biomarkers and as co-regulatory molecules let to the appreciation of the functional relevance of lncRNAs.
In the present study, LINC00607 was identified as an endothelial-enriched, human-specific lncRNA. With its distinct functions, LINC00607 maintains and supports the endothelial homeostasis especially in response to VEGF-A signalling.
In the first part of this study, LINC00607 was functionally characterized in human endothelial cells. LINC00607 is highly and specifically expressed in endothelial cells and is differentially regulated in CVDs. Depletion of LINC00607 resulted in decreased angiogenic sprouting, reduced integration of ECs in a newly formed vascular network in vivo, enhanced endothelial migration and differential expression of many important genes for endothelial cell homeostasis. Functionally, LINC00607 maintains ERG-driven endothelial gene expression programs through BRG1. BRG1 secures stably accessible enhancer regions as well as TSS of ERG target genes, thus enabling transcription of endothelial gene programs.
The second part of this study proposes an additional mode of action for LINC00607. The strongly impaired response to VEGF-A after LINC00607 KO can only be partially explained by its’ expression control of ERG target genes. It rather appears that LINC00607 is involved in the control of alternative splicing of VEGF receptor FLT1. The differential splicing of FLT1 produces the anti-angiogenic soluble isoform of FLT1. Even though further validation is needed to uncover the underlying mechanism, there is the potential of a more general role of LINC00607 in splicing control through BRG1. As AS of FLT1 is a clinical marker in preeclampsia, LINC00607 might qualify to be an additional marker for the onset and manifestation of the pregnancy disorder.
Taken together, LINC00607 is a target in future for molecular therapy in CVD to restore a healthy endothelial phenotype and has the potential to serve as a biomarker in preeclampsia.
KMT2A-rearrangements are causative for 70-80% all infant acute lymphoblastic leukemias (Pieters et al., 2019, 2007). Among these, the translocation t(4;11)(q21;23) generating the oncogenic fusion genes KMT2A::AFF1 and AFF1::KMT2A is the most frequent one, accounting for almost every second case of KMT2A-r infant ALL (Meyer et al., 2018). Despite passing a multimodal chemotherapy, 64% of patients achieve an event including relapse or death within four years from diagnosis, and overall survival three years from relapse remains poor with only 17% (Driessen et al., 2016; Pieters et al., 2019, 2007). Vari-ous studies have shown that relapse and therapy resistance were not mediated by chemotherapy-induced mutagenesis as there was no accumulation of secondary mutations in the dominant leukemic clone between diagnosis and relapse (Agraz-Doblas et al., 2019; Andersson et al., 2015; Bardini et al., 2011; Dobbins et al., 2013; Driessen et al., 2013; Mullighan et al., 2007).
Intriguingly, exclusively infant t(4;11) ALL patients were reported to subdivide in two groups depending on the level of HOXA gene cluster expression (Trentin et al., 2009). The HOXAlo group displayed a high expression of IRX1 and the HOXAhi group a low expression of IRX1 (Symeonidou and Ottersbach, 2021; Trentin et al., 2009). Importantly, the HOXAlo/IRX1hi group was characterized to possess a strongly ele-vated relapse incidence compared to the HOXAhi/IRX1lo group (Kang et al., 2012; Stam et al., 2010). IRX1 was identified to upregulate the Early growth response genes EGR1, EGR2 and EGR3 (Kühn et al., 2016).
The doctoral project “EGR-mediated relapse mechanisms in infant t(4;11) acute lymphoblastic leuke-mia” aimed to investigate a potential correlation between the HOXAlo-IRX1-EGR axis and relapse development in infant t(4;11) ALL. The primary objective was to clarify through which molecular mechanism(s) relapse development despite continuous chemotherapy could be achieved. In this context, the role of the EGR genes has been investigated. In addition, this project aimed to disclose molecular targets which could offer novel therapeutic interventions to interfere with therapy resistance and relapse formation.
In the past decade, tissue-resident innate lymphoid cells (ILC) have become a central field of immunological research. ILC are a family of innate immune cells comprising cytotoxic Natural Killer (NK) cells and the non-cytotoxic helper like ILC1, ILC2 and ILC3. They mirror the functions and phenotypes of T cells, but do not require rearranged antigen-specific receptors for their rapid response to signals from injured or infected tissue. As potent cytokine producers being enriched in mucosal tissue, ILC play an essential role in tissue maintenance and regulating immunity to chronic inflammation and infection (Vivier et al., 2018). Although heterogeneity and plasticity of ILC complicates their classification, the pathophysiology of a broad variety of autoimmune and chronic inflammatory diseases have been associated with dysregulations in ILC subset distribution and functions (Dzopalic et al., 2019). This highlights their importance in human health and disease and accounts for the need for markers unambiguously describing the different ILC subtypes. This work introduces NKp65, a C-type lectin-like receptor (CTLR) encoded in the natural killer gene complex by the KLRF2 gene, as an exclusive marker for human ILC3. NKp65 expression especially discerns ILC3-like NK cell precursor from mature NK cells which express the NKp65-relative NKp80. Moreover, flow cytometric analysis of NKp65 expression aids in the demarcation of natural cytotoxicity receptor (NCR) expressing ILC3, from the closely related but functionally distinct RORt+ LTi cells and NCR- ILC3. This work further provides insights into NK cell development by in vitro differentiation studies in which NKp65 expressing cells are generated in presence of OP9 feeder cells and cytokines to support development. In such cultures, NKp65 expressing in vitro ILC (ivILC) acquire NKp80 expression in a Notch-dependent manner indicating their differentiation into mature NK cells. Acquisition of NK cell phenotypic markers is accompanied by NKp65 downregulation which leads to the mutually exclusive expression of NKp80 on NK cells and NKp65 on ILC3-like cells. Further insights are provided into the functional consequences of NKp65 engagement by its cognate high affinity ligand ‘keratinocyte-associated C-type lectin’ (KACL) which is selectively expressed on human keratinocytes (Bauer et al., 2015; Spreu et al., 2010). Expressed on ivILC, NKp65 mediates killing of KACL expressing target cells, suggesting that NKp65-KACL interaction promotes cellular cytotoxicity. In this context, the observed metalloproteinase dependent shedding of NKp65 might play a role in the termination of the cellular interaction. The findings on the regulation of NKp65 expression demonstrate the presence of a functional STAT5 response element in the KLRF2 promoter endowing a transcriptional control of NKp65 expression by IL-7 signaling. This provides an interesting link between the dependency of ILC3 on IL-7 signaling for their maintenance and the specific expression of NKp65 on these cells.
In summary, this study provides new insights into the physiologic expression of the CTLR NKp65 on human ILC3. The dependency of NKp65 surface expression on sustained STAT5 signaling provided by IL-7 underlines the connection of NKp65 expression and an ILC3 phenotype which might contribute to promote future research in discerning the interspersed pathways of ILC3 and NK cell development. The tissue and cell specific expression of NKp65 on ILC3 and its ligand KACL on keratinocytes of the human skin further suggests an important role of this genetically coupled receptor-ligand pair in tissue specific immunosurveillance.
T-cell development is a highly dynamic and stepwise process comprimising T lineage commitment, T-cell receptor (TCR) gene rearrangements and subsequent selection. From a quantitative point of view, only a few hundred progenitor cells migrate from the bone marrow into the thymus. Developing thymocytes (termed double negative (DN), CD4-CD8-) can be further divided into DN1-4 cells based on the expression of CD25 and CD44. These developmental events are interspersed by proliferative bursts which ultimately lead to the generation of millions of double positive (DP, CD4+CD8+) thymocytes that then undergo selection. As a consequence, a proportion of naïve T-cells evolves to ensure adaptive, but not autoreactive immunity.
Previous studies of our lab focused on the quantification of thymus colonization and identified thymus entry to be dependent on expression of the chemokine receptors CCR7 and CCR9 (Krueger et al., 2010; Ziętara et al., 2015). CCR7/9 double knockout (DKO) mice are almost completely devoid of the most immature thymocyte populations (DN1 and DN2), but show near normal DN3 cellularity. Interestingly, a similar defect during early development but a virtually complete recovery of later stages and total thymocyte numbers was also observed in thymi of miR-17~92 deficient mice. Here, a failure of prethymic IL-7 signaling dampens early T-cell development (Regelin et al., 2015). For this reason, we hypothesized a tight regulation of thymocyte population size through alterations in the underlying cell cycle kinetics.
In this thesis, we employed in vivo single- and dual-nucleoside pulse labeling combined with determination of DNA replication over time in different WT thymocyte subsets at steady-state. Based on this, we assessed alterations in cell cycle kinetics of CCR7/9 and miR-17~92 defcicient mice and identified compensatory mechanisms of thymocytes on the level of cell cycle phase distribution and cell cycle speed. In addition, single-cell RNA sequencing helped to obtain information on cell cycle dynamics of early thymocyte subsets, exemplarily shown for WT and CCR7/9 DKO mice. Lastly, we performed cell cycle analyses in a model of endogenous thymic repair upon sublethal total body irradiation which provided insight into intrathymic cell cycle regulation as an adjustable system to re-establish normal thymus cellularity.
In the second part of the thesis, we addressed the role of miR-21 in the thymus. In various studies, we and others identified miRNAs as key posttranscriptional regulators of the immune system and especially for T-cell development (Regelin et al. 2015; Mildner et al. 2017; Li et al. 2007; Ebert et al. 2009; Ziętara et al. 2013; Schaffert et al. 2015). The dynamic expression of miR-21 during T-cell development (Neilson et al. 2007; Kirigin et al. 2012; Kuchen et al. 2010) prompted us to hypothesize that miR-21 has a regulatory function in the thymus. A miR 21-knockout mouse model allowed us to study the role of this miRNA for the development of T-cells in the thymus and the maintenance of T-cells in the periphery. In addition, we performed competitive bone marrow chimera experiments in the context of miR-21 deficiency and overexpression. Further insights were provided by exploring the function of miR-21 in negative selection in vivo as well as in T-cell differentiation in coculture experiments in vitro. To unravel implications of miR-21 to regulate cellular stress responses, we assessed the contribution of miR-21 in a model of endogenous regeneration of the thymus after sublethal irradiation. We could not provide evidence for a prominent role for miR-21 during T-cell development. Together, our experiments revealed that miR-21 is largely dispensable for physiologic T-cell development despite high and dynamic expression in the thymus (Kunze Schumacher et al., 2018). The apparent discrepancy between dynamic expression but lack of a regulatory function in the thymus led us to conclude that miR-21 is rather fine tuning T-cell responses than controlling a developmental event.
Infections with the hepatitis B virus (HBV) or the hepatitis C virus (HCV) lead to complications like the development of cirrhosis or hepatocellular carcinoma. These complications end up in 887,000 and 500,000 deaths per year, respectively. Since the development of new direct acting antiviral agents for HCV in the past years a complete cure of an HCV infection can be achieved in the majority of the patients. In contrast, a complete cure of a chronic HBV infection still remains a challenging problem as current treatment regimens mainly suppress the viral replication and cccDNA as well as integrated DNA still persist in these patients. Several viral and host factors were described to impair the efficacy of treatment regimens or influence the course of the infection. Therefore, in this work viral factors as well as host factors were investigated in HBeAg negative chronic HBV infected patients and in chronic HCV infected patients. In the present study, it was demonstrated that mutations and/or deletions in the HBV basal core promoter (BCP), the precore and the preS domain occur in a genotype-specifc pattern in HBeAg negative HBV infected patients. While the BCP double mutation A1762T/G1764A was found with the highest prevalence in genotype E infected patients, the precore mutation G1896A occurred mostly in genotype B infected patients. Variants in the preS domain could be detected with the highest frequency in patients infected with genotype C. In patients, who had to start an antiviral therapy during the course of the disease, mutations in the precore region could be detected with a higher frequency in the samples right before treatment start in comparison to the baseline sample.
While different HBV genotypes and preS mutations were not associated with HBV-DNA serum levels, precore mutations as well as BCP mutations were significantly associated with HBV-DNA levels. Furthermore, precore mutations showed lower and preS mutations higher HBsAg levels. The HBsAg serum levels varied significantly among the different genotypes. Since HBsAg levels < 1000 IU/ml have been described as a prognostic marker in several studies, the prevalence of patients with HBsAg < 1000 IU/ml was analyzed among the genotypes A - E. While most of the patients infected with HBV genotype B had HBsAg < 1000 IU/ml, only a few patients infected HBV genotype E and A had HBsAg < 1000 IU/ml.
Furthermore, HBV genotype A genomes derived from patients harboring a) A1762T/ G1764A (BCP), b) G1896A/G1899A (precore), c) 15 aa deletion in preS1, d) no mutation (reference genome) were cloned and analyzed in vitro. An enhanced expression but reduced secretion of viral genomes was found in the preS-deletion- and the precore-variant. No differences in the HBsAg production and secretion were observed in the cloned precore- or BCP-variant, while the preS-deletion-variant was characterized with an elevated HBsAg release.
Regarding the secretion of viral and subviral particles, a genotype-specifc pattern of the L/M/SHBs ratio was detected in the serum of patients infected with genotypes A - E. This pattern did not change in the serum of patients, who started antiviral treatment. Secreted HBsAg containing particles displayed a higher density as well as a higher filaments/spheres ratio in genotypes B and D compared to genotypes A, C and E. Population-based and deep sequencing revealed large deletions in the preS domain or preS2 start codon mutations in a certain number of the viral genomes. Theoretically, these mutations/deletions should influence the molecular weight of the expressed protein or abolish the expression of the protein at all. In contrast, LHBs/MHBs were detectable and appeared at the same molecular weight in these patient samples in comparison to patient samples without these mutations. Furthermore, in the in vitro analyses comparing the reference genome and the preS1-deletion genome, it was shown that the deletion indeed influenced the molecular weight of LHBs. Therefore, HBsAg might be expressed from a genetically different source than the released viral genomes, meaning the integrated DNA.
Additionally, in the present study the prevalence of resistance associated substitutions (RASs) in the viral genes NS3, NS5A and NS5B of chronic HCV infected patients was analyzed in correlation to single nucleotide polymorphisms (SNPs) in the interferon-λ4 (IFNL4) gene of the infected patients. No significant correlation was found between IFNL4 SNPs and RASs within NS3/NS5B in the present cohort. In contrast, the frequently detected NS5A RAS Y93H could be significantly associated with beneficial IFNL4 SNPs and a high baseline viral load in HCV genotype 1-infected patients.
Taken together, the present study demonstrated that viral genome mutations as well as the morphology of secreted particles occur in a genotype-dependent pattern in HBeAg negative HBV infected patients with no need of antiviral therapy. As the amount of serum qHBsAg levels varied among the different genotypes, the HBsAg cut-off < 1000 IU/ml should be adapted individually among the various genotypes. Because the composition of the secreted subviral particles varied between the different genotypes, a genotype-specific immune-response might be induced in these patients. Additionally, the results of the present study indicate that in HBeAg negative HBV infected patients with mutations or deletions in the preS domain MHBs and LHBs might be expressed from the integrated DNA and therefore from a genetically different source than the released viral genomes.
Aside from that, the finding of a significant association of the NS5A RAS Y93H with beneficial IFNL4 SNPs in chronic HCV infected patients may explain a lack of a correlation or an inverse correlation of treatment response with the IFNL4 genotype in some NS5A inhibitor-containing IFN-free regimens.